
<html lang="en"     class="pb-page"  data-request-id="2f7121d6-43f9-4604-a6ae-272aa8cb60d3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm5014743;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Biphenyl-4-carboxylic Acid [2-(1H-Indol-3-yl)-ethyl]-methylamide (CA224), a Nonplanar Analogue of Fascaplysin, Inhibits Cdk4 and Tubulin Polymerization: Evaluation of in Vitro and in Vivo Anticancer Activity" /></meta><meta name="dc.Creator" content="Sachin  Mahale" /></meta><meta name="dc.Creator" content="Sandip B.  Bharate" /></meta><meta name="dc.Creator" content="Sudhakar  Manda" /></meta><meta name="dc.Creator" content="Prashant  Joshi" /></meta><meta name="dc.Creator" content="Sonali S.  Bharate" /></meta><meta name="dc.Creator" content="Paul R.  Jenkins" /></meta><meta name="dc.Creator" content="Ram A.  Vishwakarma" /></meta><meta name="dc.Creator" content="Bhabatosh  Chaudhuri" /></meta><meta name="dc.Description" content="Biphenyl-4-carboxylic acid-[2-(1H-indol-3-yl)-ethyl]-methylamide 1 (CA224) is a nonplanar analogue of fascaplysin (2) that specifically inhibits Cdk4–cyclin D1 in vitro. Compound 1 blocks the growt..." /></meta><meta name="Description" content="Biphenyl-4-carboxylic acid-[2-(1H-indol-3-yl)-ethyl]-methylamide 1 (CA224) is a nonplanar analogue of fascaplysin (2) that specifically inhibits Cdk4–cyclin D1 in vitro. Compound 1 blocks the growt..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5014743" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5014743" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5014743" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5014743" /></link>
        
    
    

<title>Biphenyl-4-carboxylic Acid [2-(1H-Indol-3-yl)-ethyl]-methylamide (CA224), a Nonplanar Analogue of Fascaplysin, Inhibits Cdk4 and Tubulin Polymerization: Evaluation of in Vitro and in Vivo Anticancer Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5014743" /></meta><meta property="og:title" content="Biphenyl-4-carboxylic Acid [2-(1H-Indol-3-yl)-ethyl]-methylamide (CA224), a Nonplanar Analogue of Fascaplysin, Inhibits Cdk4 and Tubulin Polymerization: Evaluation of in Vitro and in Vivo Anticancer Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0013.jpeg" /></meta><meta property="og:description" content="Biphenyl-4-carboxylic acid-[2-(1H-indol-3-yl)-ethyl]-methylamide 1 (CA224) is a nonplanar analogue of fascaplysin (2) that specifically inhibits Cdk4–cyclin D1 in vitro. Compound 1 blocks the growth of cancer cells at G0/G1 phase of the cell cycle. It also blocks the cell cycle at G2/M phase, which is explained by the fact that it inhibits tubulin polymerization. Additionally, it acts as an enhancer of depolymerization for taxol-stabilized tubulin. Western blot analyses of p53-positive cancer cells treated with compound 1 indicated upregulation of p53, p21, and p27 proteins together with downregulation of cyclin B1 and Cdk1. Compound 1 selectively induces apoptosis of SV40 large T-antigen transformed cells and significantly reduces colony formation efficiency, in a dose-dependent manner, of lung cancer cells. It is efficacious at 1/10th of the MTD against human tumors derived from HCT-116 and NCI-H460 cells in SCID mouse models. The promising efficacy of compound 1 in human xenograft models as well as its excellent therapeutic window indicates its potential for clinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5014743"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5014743">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5014743&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5014743&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5014743&amp;href=/doi/10.1021/jm5014743" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9658-9672</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501399d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501497m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Biphenyl-4-carboxylic Acid [2-(1<i>H</i>-Indol-3-yl)-ethyl]-methylamide (CA224), a Nonplanar Analogue of Fascaplysin, Inhibits Cdk4 and Tubulin Polymerization: Evaluation of in Vitro and in Vivo Anticancer Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sachin++Mahale">Sachin Mahale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandip+B.++Bharate">Sandip B. Bharate</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sudhakar++Manda">Sudhakar Manda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prashant++Joshi">Prashant Joshi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonali+S.++Bharate">Sonali S. Bharate</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+R.++Jenkins">Paul R. Jenkins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ram+A.++Vishwakarma">Ram A. Vishwakarma</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bhabatosh++Chaudhuri">Bhabatosh Chaudhuri</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">School of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span></div><div class="aff-info" id="aff6"><span class="aff-text"><sup>‡</sup>Medicinal Chemistry Division, <sup>§</sup>Academy of Scientific & Innovative Research (AcSIR), <sup>∥</sup>Preformulation Laboratory, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>(S.B.B.) Tel.: +91-191-2569000 (ext. 345). Fax: +91-191-2569333. E-mail: <a href="/cdn-cgi/l/email-protection#9be8f9f3fae9faeffedbf2f2f2f6b5faf8b5f2f5"><span class="__cf_email__" data-cfemail="2457464c4556455041644d4d4d490a45470a4d4a">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>(R.A.V.) Tel.: +91-191-2569111. Fax: +91-191-2569333. E-mail: <a href="/cdn-cgi/l/email-protection#691b0804290000000447080a470007"><span class="__cf_email__" data-cfemail="f98b9894b990909094d7989ad79097">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>(B.C.) Tel.: 44(0)116 250 7280. Fax: +44(0) 116 257 7287. E-mail: <a href="/cdn-cgi/l/email-protection#0567666d6470616d70776c456168702b64662b706e"><span class="__cf_email__" data-cfemail="a5c7c6cdc4d0c1cdd0d7cce5c1c8d08bc4c68bd0ce">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5014743&amp;href=/doi/10.1021%2Fjm5014743" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9658–9672</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 4, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 September 2014</li><li><span class="item_label"><b>Published</b> online</span>14 November 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5014743" title="DOI URL">https://doi.org/10.1021/jm5014743</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9658%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSachin%2BMahale%252C%2BSandip%2BB.%2BBharate%252C%2BSudhakar%2BManda%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D22%26contentID%3Djm5014743%26title%3DBiphenyl-4-carboxylic%2BAcid%2B%255B2-%25281H-Indol-3-yl%2529-ethyl%255D-methylamide%2B%2528CA224%2529%252C%2Ba%2BNonplanar%2BAnalogue%2Bof%2BFascaplysin%252C%2BInhibits%2BCdk4%2Band%2BTubulin%2BPolymerization%253A%2BEvaluation%2Bof%2Bin%2BVitro%2Band%2Bin%2BVivo%2BAnticancer%2BActivity%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9672%26publicationDate%3DNovember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5014743"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1531</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5014743" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Biphenyl-4-carboxylic Acid [2-(1H-Indol-3-yl)-ethyl]-methylamide (CA224), a Nonplanar Analogue of Fascaplysin, Inhibits Cdk4 and Tubulin Polymerization: Evaluation of in Vitro and in Vivo Anticancer Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sachin&quot;,&quot;last_name&quot;:&quot;Mahale&quot;},{&quot;first_name&quot;:&quot;Sandip&quot;,&quot;last_name&quot;:&quot;B. Bharate&quot;},{&quot;first_name&quot;:&quot;Sudhakar&quot;,&quot;last_name&quot;:&quot;Manda&quot;},{&quot;first_name&quot;:&quot;Prashant&quot;,&quot;last_name&quot;:&quot;Joshi&quot;},{&quot;first_name&quot;:&quot;Sonali&quot;,&quot;last_name&quot;:&quot;S. Bharate&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;R. Jenkins&quot;},{&quot;first_name&quot;:&quot;Ram&quot;,&quot;last_name&quot;:&quot;A. Vishwakarma&quot;},{&quot;first_name&quot;:&quot;Bhabatosh&quot;,&quot;last_name&quot;:&quot;Chaudhuri&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;9658-9672&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5014743&quot;},&quot;abstract&quot;:&quot;Biphenyl-4-carboxylic acid-[2-(1H-indol-3-yl)-ethyl]-methylamide 1 (CA224) is a nonplanar analogue of fascaplysin (2) that specifically inhibits Cdk4–cyclin D1 in vitro. Compound 1 blocks the growth of cancer cells at G0/G1 phase of the cell cycle. It also blocks the cell cycle at G2/M phase, which is explained by the fact that it inhibits tubulin polymerization. Additionally, it acts as an enhancer of depolymerization for taxol-stabilized tubulin. Western blot analyses of p53-positive cancer cells treated with compound 1 indicated upregulation of p53, p21, and p27 proteins together with downregulation of cyclin B1 and Cdk1. Compound 1 selectively induces apoptosis of SV40 large T-antigen transformed cells and significantly reduces colony formation efficiency, in a dose-dependent manner, of lung cancer cells. It is efficacious at 1/10th of the MTD against human tumors derived from HCT-116 and NCI-H460 cells in SCID mouse models. The promising efficacy of compound 1 in human xenograft models as well as its exc&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5014743&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5014743" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5014743&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5014743" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5014743&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5014743" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5014743&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5014743&amp;href=/doi/10.1021/jm5014743" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5014743" /></input><a href="/doi/pdf/10.1021/jm5014743" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5014743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5014743%26sid%3Dliteratum%253Aachs%26pmid%3D25368960%26genre%3Darticle%26aulast%3DMahale%26date%3D2014%26atitle%3DBiphenyl-4-carboxylic%2BAcid%2B%255B2-%25281H-Indol-3-yl%2529-ethyl%255D-methylamide%2B%2528CA224%2529%252C%2Ba%2BNonplanar%2BAnalogue%2Bof%2BFascaplysin%252C%2BInhibits%2BCdk4%2Band%2BTubulin%2BPolymerization%253A%2BEvaluation%2Bof%2Bin%2BVitro%2Band%2Bin%2BVivo%2BAnticancer%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D22%26spage%3D9658%26epage%3D9672%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292232" title="Polymerization">Polymerization</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jmcmar.2014.57.issue-22/20141126/jmcmar.2014.57.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Biphenyl-4-carboxylic acid-[2-(1<i>H</i>-indol-3-yl)-ethyl]-methylamide <b>1</b> (CA224) is a nonplanar analogue of fascaplysin (<b>2</b>) that specifically inhibits Cdk4–cyclin D1 in vitro. Compound <b>1</b> blocks the growth of cancer cells at G<sub>0</sub>/G<sub>1</sub> phase of the cell cycle. It also blocks the cell cycle at G<sub>2</sub>/M phase, which is explained by the fact that it inhibits tubulin polymerization. Additionally, it acts as an enhancer of depolymerization for taxol-stabilized tubulin. Western blot analyses of p53-positive cancer cells treated with compound <b>1</b> indicated upregulation of p53, p21, and p27 proteins together with downregulation of cyclin B1 and Cdk1. Compound <b>1</b> selectively induces apoptosis of SV40 large T-antigen transformed cells and significantly reduces colony formation efficiency, in a dose-dependent manner, of lung cancer cells. It is efficacious at 1/10th of the MTD against human tumors derived from HCT-116 and NCI-H460 cells in SCID mouse models. The promising efficacy of compound <b>1</b> in human xenograft models as well as its excellent therapeutic window indicates its potential for clinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mammalian cell division is a highly controlled process, and the loss of this control results in the development of a cancer phenotype. Mammalian cells undergo a proliferative cycle composed of various stages (G<sub>0</sub>, G<sub>1</sub>, S, G<sub>2</sub>, and M phase), and the transition of cells from one phase to another involves various check-point mechanisms, including cyclin-dependent kinases, checkpoint kinases, and their partner cyclins. The malfunctioning of any of these checkpoint mechanisms leads to uncontrolled cell division and proliferation.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> Cyclin-dependent kinase 4 and its cyclin partner D1 (a check-point mechanism) control the transition of cells from G1 to S phase of the cell cycle.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> Active Cdk4–cyclin D complexes inactivate retinoblastoma protein (pRb) by phosphorylating it specifically at Ser780 and Ser795, which allows the G<sub>1</sub>/S transition of the cell cyle to proceed.<a onclick="showRef(event, 'ref6 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref10">(6, 10)</a> Hyperphosphorylation of pRb leads to a loss of control over gene transcription through the E2F family of transcription factors, which ultimately turns into uncontrolled cell division. In contrast, pRb phosphorylation by Cdk2 or Cdk3 along with their cyclin partners, A and C, is not sufficient to inactivate pRb’s functions.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> A large number of human tumors (around 96%) lose their normal cell cycle transition check-point mechanism due to a variety of genetic and biochemical adaptations, including hyperactivity of Cdk4, downregulation of Cdk4’s positive regulator p16<sup>INK4A</sup>, and mutations in pRb. The vital role of Cdk4–cyclin D1 in tumor development has been confirmed by experiments in Cdk4 and cyclin D1 knockout mice, which have been shown to be resistant to tumor development. On the other hand, antisense nucleotide-based targeting of cyclin D decreases tumor size and growth in vivo. On the basis of these experimental observations, the Cdk4–cyclin D complex is considered to be a promising target for combating cancer.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a></div><div class="NLM_p">Inhibition of Cdk4–cyclin D1 with small molecules has been an area of major interest in the field of anticancer drug discovery during the last 2 decades. There have been numerous scientific reports highlighting the role of Cdk4–cyclin D1 inhibitors in cancer treatment.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17-22)</a> Pfizer’s palbociclib (6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one; PD-0332991), a selective inhibitor of Cdk4 and Cdk6, has received FDA approval for the treatment of patients with breast cancer.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Other Cdk4/Cdk6 dual inhibitors, LY2835219 (<i>N</i>-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1<i>H</i>-benzimidazol-6-yl]-2-pyrimidinamine methanesulfonate) and LEE011 (7-cyclopentyl-<i>N</i>,<i>N</i>-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-6-carboxamide), are in phase I and III clinical studies for breast cancer (<a href="http://clinicaltrials.gov" class="extLink">http://clinicaltrials.gov</a>).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a></div><div class="NLM_p">The main objective of our studies was to develop potent and specific small molecule inhibitors of Cdk4–cyclin D1 based on the structure of fascaplysin (<b>2</b>), which is a pentacyclic quaternary salt originally isolated from the Fijian sponge <i>Fascaplysinopsis Bergquist</i> sp.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It is known to possess antimicrobial, antimalarial, and antiacetylcholinesterase activities.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> It also displays potent cytotoxicity against small cell lung cancer cells and induces cell cycle arrest in G<sub>0</sub>/G<sub>1</sub> at lower concentrations and in S-phase at higher concentrations.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Compound <b>2</b> also showed antitumor effects in a sarcoma mouse model through apoptotic and antiangiogenic pathways.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Fascaplysin is a specific inhibitor of Cdk4–cyclin D1, with an IC<sub>50</sub> value of 410 nM.<a onclick="showRef(event, 'ref9 ref32'); return false;" href="javascript:void(0);" class="ref ref9 ref32">(9, 32)</a> It inhibits Cdk4–cyclin D1 in vitro and blocks the growth of normal and cancer cells at G<sub>0</sub>/G<sub>1</sub> phase of the cell cycle, which correlates with the accumulation of hypophosphorylated pRb, implying that there is no phosphorylation of pRb at Cdk4-specific serine residues.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Compound <b>2</b> has also been reported to inhibit Cdc25B with an IC<sub>50</sub> of 1 μg/mL (3.26 μM).<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> An analogue of fascaplysin, 1-deoxysecofascaplysin A, has been reported to inhibit the growth of the MCF-7 breast cancer and OVCAR-3 ovarian cancer cell lines in vitro.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">Nonetheless, it is unlikely that fascaplysin will ever be used therapeutically as an anticancer agent because it is highly toxic. The potential for its planar structure to intercalate double-stranded DNA has been suggested as a possible explanation for its unusual biological activity and toxicity. The DNA binding property of fascaplysin is similar to that of structurally related DNA intercalating agents like cryptolepine and ellipticine.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> We have explored the possibility of separating the DNA intercalating ability of fascaplysin from its potent Cdk4-specific inhibitory activity. The aim of the current study was, therefore, to devise nonplanar (nontoxic) Cdk4–cyclin D1 inhibitors based on the structure of fascaplysin.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37-40)</a></div><div class="NLM_p last">Biphenyl-4-carboxylic acid [2-(1<i>H</i>-indol-3-yl)-ethyl]-methylamide <b>1</b> (CA224)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was initially identified as a Cdk4–cyclin D1-specific inhibitor lacking the ability to intercalate DNA. As expected, compound <b>1</b> manifested its Cdk4-specific inhibitory ability by blocking cancer cells at G<sub>0</sub>/G<sub>1</sub> phase of the cell cycle. Surprisingly, however, compound <b>1</b> also inhibited the cells at G<sub>2</sub>/M phase in a Cdk-independent manner. Further investigations showed that compound <b>1</b> inhibited the growth of a panel of 10 cancer cell lines (some of which were potentially resistant to cancer chemotherapy) in the low micromolar range. The validity of these results was corroborated by the observation that compound <b>1</b> has the ability to diminish the colony formation efficiency of cancer cells. A Cdk-independent G<sub>2</sub>/M block was found to be associated with its anti-tubulin activity. Compound <b>1</b> inhibited the polymerization of tubulin in vitro and also showed an enhancing effect on tubulin depolymerization in live cells. In human xenograft models, compound <b>1</b> was found to inhibit the growth of HCT-116 and H-460 tumors at 1/10th of the MTD, 100 mg/kg. Here, we present the in vitro and in vivo anticancer activity of compound <b>1</b> in detail.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Our efforts toward discovery of nontoxic analogues of fascaplysin led to the identification of compound <b>1</b>, a nonplanar analogue of fascaplysin (<b>2</b>). Briefly, the synthesis of compound <b>1</b> involves three steps starting from commercially available tryptamine (<b>3</b>). The treatment of tryptamine (<b>3</b>) with ethyl chloroformate produced carbamate ester <b>4</b>, which, on further reduction using LAH, led to formation of <i>N</i>-methyl tryptamine <b>5</b>. Compound <b>5</b>, on reaction with 4-biphenyl carbonyl chloride (<b>6</b>), produced compound <b>1</b>. The detailed lead optimization and SAR have been described in previous publications.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41">(37-41)</a> Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> shows the synthesis of compound <b>1</b>. It is worth noting that nonplanar analogues with opened C and D rings of fascaplysin (<b>2</b>) demonstrated a loss of DNA intercalation activity. Among C and D-ring opened analogues, compounds with para-substituted E rings (structures shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) maintained their ability to inhibit Cdk4 in a selective manner.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Biphenyl-4-carboxylic Acid [2-(1<i>H</i>-Indol-3-yl)-ethyl]-methylamide (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl chloroformate, NaOH 4 N, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, 90%; (b) LiAlH<sub>4</sub>, THF, N<sub>2</sub>, reflux, 1 h, 85%; (c) NaOH 4 N, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, 45%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity of Fascaplysin (<b>2</b>) and Its Nonplanar Analogues <b>1</b>, <b>7</b>, and <b>8</b> in in Vitro Kinase and DNA Binding Assays<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are presented in micromolar. All fascaplysin analogues were dissolved in 100% DMSO and were further diluted in kinase assay buffer or ethidium bromide displacement assay buffer. ND, not determined.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Selective Inhibition of Cdk4–Cyclin D1</h3><div class="NLM_p">A series of new compounds based on the structure of fascaplysin was identified as specific inhibitors of Cdk4–cyclin D1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>1</b> was found to be the most potent inhibitor of Cdk4–cyclin D1 (IC<sub>50</sub> = 6 μM) as well as selective when the Cdk4 IC<sub>50</sub> was compared with the IC<sub>50</sub>’s obtained from assays with Cdk2–cyclin A, Cdk1–cyclin B1, and Cdk9–cyclin T1. Compound <b>1</b> was superior to its other two structural analogues, <i>N</i>-(2-(1<i>H</i>-indol-3-yl)ethyl)-4-chloro-<i>N</i>-methylbenzamide (CA223, <b>7</b>) and <i>N</i>-(2-(1<i>H</i>-indol-3-yl)ethyl)-4-<i>tert</i>-butyl-<i>N</i>-methylbenzamide (CA225, <b>8</b>),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> with >6-fold better activity against Cdk4–cyclin D1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Unlike fascaplysin, compound <b>1</b> does not intercalate DNA.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Compound <b>1</b> was also tested against 58 represenative kinases at Millipore Bioscience Division, UK. It was found that compound <b>1</b> was inactive at 10 μM against all kinases, including Cdk5–p35, Cdk6–cyclin D1, Cdk7–cyclin H, EGFR, GSK3β, MAPK1, MEK1, PDGFR, Plk3, PKA, PKCα, IGF-1R, and others. Results are shown in the <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>. These results support compound <b>1</b>’s selective ability to inhibit Cdk4–cyclin D1 in vitro while having a reduced or no affinity for other kinases tested.</div><div class="NLM_p">In order to understand the observed selectivity toward Cdk4–cyclin D1 versus Cdk2–cyclin A, molecular modeling studies were carried out. The ATP binding sites of these two Cdks are well-conserved and share 45% sequence homology with each other; however, compound <b>1</b> displayed varying degrees of affinity to these Cdks. These two Cdks differ from each other primarily by the following three sequences: 94–97(Glu-His-Val-Asp)<sup>Cdk4</sup>/81–84(Glu-Phe-Leu-His)<sup>Cdk2</sup>, 101–102(Arg-Thr)<sup>Cdk4</sup>/88–89(Lys-Lys)<sup>Cdk2</sup>, and Glu144<sup>Cdk4</sup>/Gln131<sup>Cdk2</sup>. Compound <b>1</b> interacts flexibly with the ATP binding pockets of Cdk4 and Cdk2 with 84-fold selectivity toward Cdk4 due to the flexible conformational movement of compound <b>1</b>’s amide bond (<b>1</b> interacts with Cdk4 and Cdk2 in two different conformational states), which allows free rotation of the biphenyl ring. This subsequently leads to a loss of major hydrophobic interactions with Cdk2. Two conformations of compound <b>1</b> include (a) a <i>trans</i> conformation (green ligand in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a; dihedral angle, Ψ = −151.5), which was found to interact selectively with the side chains of Arg101 in Cdk4 by a hydrophobic π–cation interaction. However, in Cdk2, this interaction is missing because the corresponding residue, Lys88, is far away from compound <b>1</b>’s binding cavity. (b) A <i>cis</i> conformation (orange ligand in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a; dihedral angle, Ψ = 2.6) that interacts with Cdk2. On the other hand, the <i>trans</i> conformation of compound <b>1</b> is stabilized in the Cdk4 binding site because the negatively charged side chain of Glu144 opposes the biphenyl aromatic ring. In the case of Cdk2, the <i>cis</i> conformation is stabilized because the biphenyl aromatic rings are well-accommodated by the corresponding neutral residue, Gln131. A comparison of the binding site amino acids of Cdk4 and Cdk2 is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>c.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular modeling studies of compound <b>1</b> with Cdk4 and Cdk2. (a) Interactions of the <i>cis</i> and <i>trans</i> conformations of compound <b>1</b> with Cdk2 and Cdk4, respectively. (<i>Cis</i> and <i>trans</i> conformations of compound <b>1</b> are shown in orange and green, respectively. Similarly, labels for the residues of Cdk2 and Cdk4 are shown in orange and green, respectively.) (b) Compound <b>1</b>–Cdk4 interaction histogram with different binding site residues during a 10 ns MD simulation of the compound <b>1</b>–Cdk4 protein complex. (c) Amino acid comparison between Cdk4 and Cdk2 at the ATP binding site (black residues indicate common interacting residues of Cdk4/Cdk2, whereas red residues are those that differ in the interaction pattern of these two Cdks).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cancer Cell Growth Inhibition</h3><div class="NLM_p">All fascaplysin analogues, including the most potent compound in the series, compound <b>1</b>, were tested against a panel of 10 different cancer cell lines (some of which are known to be relatively resistant to known chemotherapeutic agents) for their ability to inhibit cancer cell growth in vitro. The inhibitory effects of the compounds were quantified using MTT assay, and IC<sub>50</sub>’s were determined (i.e., the concentration, expressed in micromolar, of a compound at which 50% of cell growth is inhibited). The results of these cell proliferation assays indicated that compound <b>1</b> inhibits the growth of cancer cells in vitro at low micromolar concentrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Among all of the analogues,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> compound <b>1</b> was found to be the most potent molecule even at the cellular level. The inhibition of cell growth was both p53- and pRb-independent, with the latter indicating that Cdk4–cyclin D1 inhibition is not the only cellular target for the mechanism of action of these molecules.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Concentrations (μM) for in Vitro Cell Growth Inhibition Induced by Exposure to Compound <b>1</b> and Its Analogues, <b>7</b> and <b>8</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> for 48 h</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">LS174T: colorectal carcinoma (p53+, pRb+); PC-3: prostate (p53 null, pRb+); MiaPaCa: pancreatic (p53His273 mut, pRb+); A549: NSCLC (p53+, pRb+); Calu-1: NSCLC (p53 null, pRb+); NCI-H460: NSCLC (p53+, pRb+); NCI-H1299: NSCLC (p53 null, pRb+); NCI-H358: NSCLC (p53 null, pRb null); BNL CL2: mouse normal hepatic cells; BNL SV A.8: mouse hepatic; SV-40 mediated transformed cells. ND, not determined.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Compound <b>1</b> Retains the G<sub>0</sub>/G<sub>1</sub> Block in Serum-Starved p53-Null Calu-1 Cells</h3><div class="NLM_p last">Compound <b>1</b>, although identified as a Cdk4-specific inhibitor in the in vitro enzyme assay, generally tends to block cancer cells more profoundly at G<sub>2</sub>/M than at G<sub>0</sub>/G<sub>1</sub> phase of the cell cycle. Moreover, compound <b>1</b> inhibits tubulin polymerization in vitro with a higher potency than it inhibits Cdk4–cyclin D1. In Calu-1 cells, the mitotic spindle checkpoint is impaired, implying that these cells cannot be blocked at G<sub>2</sub>/M. Hence, Calu-1 cells were treated with compound <b>1</b> after they were released from synchronization at G<sub>0</sub>/G<sub>1</sub> (by serum-starving the cells using 0.1% FBS for 24 h). At IC<sub>50</sub> and IC<sub>70</sub> concentrations of compound <b>1</b>, the G<sub>0</sub>/G<sub>1</sub> block was either partially or full maintained.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Because the maintenance of the G<sub>0</sub>/G<sub>1</sub> block after serum starvation requires Cdk4 to be inactive, these results indicate that compound <b>1</b> probably inhibits cellular Cdk4 at these concentrations and thereby maintains the G<sub>0</sub>/G<sub>1</sub> block. In the absence of any other kinase inhibitory data, the results obtained with Calu-1 cells confirm the Cdk4 inhibitory potential of compound <b>1</b> in live cells.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>1</b> at Its IC<sub>50</sub> Concentration Induces a Profound G<sub>2</sub>/M Block in Asynchronous A549 (p53+) and NCI-H1299 (p53-Null) Cancer Cells</h3><div class="NLM_p">Incubation of A549 (p53+) cells with compound <b>1</b> at its IC<sub>50</sub> concentration for 24 h induced a profound block at G<sub>2</sub>/M, as indicated by the percentage of cells at G<sub>2</sub>/M. As seen in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, at the IC<sub>50</sub> concentration of compound <b>1</b>, 89% of cells appear to be arrested in G<sub>2</sub>/M phase (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B), and at the IC<sub>70</sub> concentration, 91% of cells were blocked at G<sub>2</sub>/M (not shown). Incubation of NCI-H1299 (p53-null) with the IC<sub>50</sub> concentration of compound <b>1</b> resulted in the accumulation of a large number of cells (71% cells) at G<sub>2</sub>/M (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D). These results confirm that a profound G<sub>2</sub>/M block can be observed in cells (A549 and NCI-H1299) where the mitotic spindle checkpoint is intact.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cell cycle analysis of compound <b>1</b>-treated cells. (A–D) Response of mitotic spindle checkpoint-proficient human lung cancer cell lines, A549 and NCI-H1299, to compound <b>1</b>. Flow cytometric analysis of asynchronous cells show that the majority of cells are arrested in G<sub>2</sub>/M phase of the cell cycle (4n DNA content) in both cell lines: A549 untreated (A), treatment with the IC<sub>50</sub> concentration of compound <b>1</b> for 24 h (B), NCI-H1299 untreated or control (C), and treatment with the IC<sub>50</sub> concentration of compound <b>1</b> for 24 h (D). (E–L) Analysis of NCI-H358 cells using flow cytometry. G<sub>2</sub>/M and G<sub>1</sub>/S synchronized cells, by nocodazole and hydroxyurea, respectively, were released either in fresh medium or in fresh medium containing the IC<sub>50</sub> concentration of compound <b>1</b>, which demonstrated a greater tendency of compound <b>1</b> to block cell growth at G<sub>2</sub>/M. For the nocodazole block experiment, shown are untreated or control cells (E), cells treated with 1 μM nocodazole for 18 h (F), cells treated with 1 μM nocodazole for 18 h and released in fresh medium (G), and cells treated with 1 μM nocodazole for 18 h and released in the presence of compound <b>1</b> at its IC<sub>50</sub> (H). For the hydroxyurea block experiment, shown are untreated or control cells (I), cells treated with 250 μM hydroxyurea for 18 h (J), cells treated with 250 μM hydroxyurea for 18 h and released in fresh medium (K), and cells treated with 250 μM hydroxyurea for 18 h and released in the presence of compound <b>1</b> at its IC<sub>50</sub> (L). (M–P) Selective apoptosis of SV-40 transformed cells by compound <b>1</b>, analyzed by FACS. BNL CL2 (mouse embryonic normal hepatic cells) exposed to compound <b>1</b> for 48 h at its IC<sub>50</sub> concentration (N) show prominent G<sub>2</sub>/M arrest. BNL SV A.8 (mouse embryonic SV-40 transformed hepatic cells) underwent apoptotic cell death upon incubation with compound <b>1</b>. The apoptosis was quantitated by measuring the percent of cells appearing in the sub-G<sub>1</sub> peak: 31 and 44% of cells were found in the sub-G<sub>1</sub> peak after a 48 h exposure with compound <b>1</b> at its IC<sub>50</sub> (P) concentration. The untreated cells (O) did not show any apoptosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Nocodazole- and Paclitaxel-Induced G<sub>2</sub>/M Block Is Maintained by Compound <b>1</b> in NCI-H358 Lung Cancer Cells</h3><div class="NLM_p last">NCI-H358 (p53-null) cells were treated with nocodazole (1 μM, a suboptimal concentration) for 18 h in order to induce a partial block at G<sub>2</sub>/M so that treated cells are minimally stressed. When the blocked cells were released in fresh medium, they readily entered the cell cycle without any apoptosis. When blocked cells were released in the presence of compound <b>1</b> for 12 h, the cells maintained the G<sub>2</sub>/M block, and >50% of G<sub>0</sub>/G<sub>1</sub> and S phase cells entered G<sub>2</sub>/M (compare Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E–H). Even though only the nocodazole treatment experiment is shown, similar results were obtained when paclitaxel-blocked cells were released in the presence of compound <b>1</b> for 12 h. These observations suggest that, at least in p53-null/pRb-null NCI-H358 cells, compound <b>1</b> maintains the pro-metaphase block induced by nocadozole or paclitaxel during mitosis.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>1</b> Blocks NCI-H358 Cells in G<sub>2</sub>/M after Release from Hydroxyurea-Mediated G<sub>1</sub>/S Cell Synchronization</h3><div class="NLM_p last">Hydroxyurea (250 μM, 18 h) was used to block cells at G<sub>1</sub>/S (77%; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>J), a stage of the cell cycle where Cdk2-specific inhibitors normally act. When released in the presence of compound <b>1</b>, cells proceeded from G<sub>1</sub>/S, confirming that compound <b>1</b> does not inhibit cellular Cdk2. Cells ultimately accumulate at G<sub>2</sub>/M (72%; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>L). These results again indicate that compound <b>1</b> has an inherent tendency to induce block at G<sub>2</sub>/M phase of the cell cycle, at least in cells where the mitoic spindle checkpoint is normal.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Selective Killing of SV40 Large T-Antigen Transformed Normal Mouse Embryonic Liver Cells by Compound <b>1</b></h3><div class="NLM_p last">SV40 large T-antigen inactivates tumor suppressor proteins p53 and pRb and thereby transforms normal cells into tumorigenic cells. We used normal mouse embryonic hepatic (liver) cells, BNL CL2, and its SV-40 large T-antigen transformed counterpart, BNL SV A.8, to study the effects of compound <b>1</b>. The normal cells, upon 48 h incubation with <b>1</b>, exhibited prominent G<sub>2</sub>/M arrest at both the IC<sub>50</sub> and IC<sub>70</sub> concentrations, with less than 5% of cells detected in sub-G<sub>0</sub>/G<sub>1</sub> phase (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>N) and more than 50% of cells appearing at G<sub>2</sub>/M phase of the cell cycle. Interestingly, in the SV40 large T-antigen transformed cell line, significant apoptotic cell death was observed. After 48 h of treatment at the IC<sub>50</sub> concentration of compound <b>1</b>, 31% of cells were detected in sub-G<sub>1</sub> phase (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>P), indicating apoptosis. The percent apoptosis increased further from 31 to 44% at the IC<sub>70</sub> concentration after 48 h of incubation (data not shown). Similar results were obtained using normal and SV-40 large T-antigen transformed human lung fibroblast cells, WI-38 (data not shown).</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Effect of Compound <b>1</b> on the Cellular Level of Cyclin B1, Cdk1, p53, p21<sup>CIP1/WAF1</sup> (p21), and p27<sup>KIP1</sup> (p27) in p53+ Cells</h3><div class="NLM_p">Western blot analyses of p53+ cells, A549 and LS174T, after treatment with compound <b>1</b> (at the IC<sub>50</sub> concentration) for 24 h demonstrated a more than 10-fold induction of p53. Therefore, it is likely that the global Cdk inhibitor p21<sup>CIP1/WAF1</sup> (p21) was also induced. The levels of p27<sup>KIP1</sup> (p27) were also elevated after compound <b>1</b> treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The proteins Cdk1 and cyclin B1 were downregulated in the treated cells as compared with that in untreated control cells. Repression of cyclin B1 and Cdk1 and elevated levels of p21 and p27 are a possible explanation for the G<sub>2</sub>/M block seen in A549 and LS174T cells that bear functional copies of the tumor suppressor protein p53 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><div class="NLM_p">The effects of compound <b>1</b> on the cellular level of cyclin B1, Cdk1, p53, p21<sup>CIP1/WAF1</sup> (p21), and p27<sup>KIP1</sup> (p27), in p53-null cells, were also investigated. Western blot analyses on proteins from MIAPaCa-2 cells (carrying a <i>p53</i> mutation) showed that p53, p21, and p27 levels remained unchanged, indicating that the p21 and p27 induction seen in p53-positive cells is probably p53-dependent. Interestingly, cyclin B1 and Cdk1 levels were elevated, and phosphorylation of Cdk1 at Tyr15 remained unaffected (data not shown), indicating that Cdk1–cyclin B1 is still active in p53-mutated cells after compound <b>1</b> treatment.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis of p53+ cells, A549 and LS174T. Treatment with compound <b>1</b> at its IC<sub>50</sub> concentration for 24 h resulted in induction of tumor suppressor protein p53; thereby, global Cdk inhibitor p21<sup>CIP1/WAF1</sup> (p21) was also induced. The levels of global p27<sup>KIP1</sup> (p27) were elevated, whereas cyclin B1 and Cdk1 levels were downregulated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cell-Free Tubulin Polymerization Assays in Vitro Indicate Inhibition of Tubulin Polymerization by Compound <b>1</b></h3><div class="NLM_p">Compound <b>1</b> inhibited the growth of cancer cells in vitro at relatively low concentrations compared to those at which it inhibited Cdk4–cyclin D1. FACS analysis and mitotic index experiments (data not shown) indicated that compound <b>1</b> blocked cell growth at the pro-metaphase stage of the cell cycle. In addition to these observations, the 2–3-fold increase of compound <b>1</b>’s IC<sub>50</sub> in cells with an impaired mitotic spindle checkpoint suggested another cellular role for compound <b>1</b>, possibly as an anti-microtubule agent. We investigated the action of compound <b>1</b> on tubulin polymerization in vitro. The results indicated a strong anti-tubulin activity of compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a), whereas fascaplysin did not show any interaction with tubulin (data not shown). Representative polymerization curves of compound <b>1</b>, paclitaxel, and nocodazole are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a. Compound <b>1</b> inhibits the polymerization of tubulin, which can be concluded from the dose-dependent decrease in <i>V</i><sub>max</sub> (mOD/min) and the reduction of final polymer mass (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). When tested at four different concentrations, compound <b>1</b> decreased the <i>V</i><sub>max</sub> from 17 mOD/min to 6.2, 2.1, 1.1, and 0.4 mOD/min at 2.5, 5, 10, and 25 μM, respectively. As a consequence of decreased <i>V</i><sub>max</sub>, up to an 80% reduction in the final polymer mass was observed.</div><div class="NLM_p">Microtubules, the key components of the cytoskeleton, are made up of α/β-tubulin heterodimers. Microtubule assembly has been targeted using a number of polymerization inhibitors and inducers by binding at different sites including (a) the colchicine binding site (at the interphase of the α/β-tubulin heterodimer) and (b) the taxol and vinblastine binding site deep inside β-tubulin. The mechanism of inhibition of tubulin polymerization involves binding at the interphase of α/β-tubulin and forming a complex with tubulin like that with colchicine. This complex is added to the microtubule assembly, where it induces unfavorable conformational changes in tubulin dimer (M-loop) and thus further polymerization gets stopped. Furthermore, the tubulin–polymerization inhibitor complex perturbs microtubule growth by sterically blocking further addition of the tubulin dimers to form the microtubule assembly.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a> From molecular docking studies performed at the colchicine binding site, it was observed that compound <b>1</b> binds at the α/β-tubulin interphase by H-bonding. Compound <b>1</b> interacts with Thr353 of β-tubulin by H-bonding. In addition to this, the hydrophobic biphenyl ring fits in the hydrophobic core of β-tubulin formed by Leu248, Ala250, Leu252, Cys241, Leu255, Ala316, Ala317, and Ala354 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). Interestingly, these interactions were missing with fascaplysin. The binding of compound <b>1</b> at the interphase of α/β-tubulin is supposed to induce conformational changes in the protein that further perturbs tubulin polymerization, preventing microtubule assembly.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Purified tubulin polymerization assay in vitro. The ability of compound <b>1</b> to inhibit tubulin polymerization in vitro was investigated as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Paclitaxel and nocodazole were used in the assay as a known enhancer and inhibitor of tubulin polymerization, respectively. Compound <b>1</b> was tested over a range of concentrations for which it show inhibition of cell growth in vitro. The change in the <i>V</i><sub>max</sub> value was used as an indicator of tubulin–ligand interactions. The polymerization curves indicate that 2.5, 5, 10, and 25 μM compound <b>1</b> reduced the <i>V</i><sub>max</sub> value from 19 mOD/min (control) to 6.2, 2.1, 1.1, and 0.4 mOD/min, respectively. The curves shown are the average of three independent experiments. (B) Compound <b>1</b> interactions at the α/β-tubulin interphase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound <b>1</b> Inhibits Paclitaxel-Mediated Tubulin Polymerization and Enhances Tubulin Depolymerization in Live Cells</h3><div class="NLM_p">The tubulin polymerization experiments performed on whole cells (A549 and NSCLC, with an intact mitotic spindle checkpoint) confirmed the observation that compound <b>1</b> inhibits the polymerization of tubulin. Moreover, compound <b>1</b> also enhances the depolymerization of stabilized tubulin protein. The polymerized and depolymerized (soluble) forms of tubulin were gauged (via western blotting) from the accumulation/disappearence of tubulin protein from the pellet and supernatant fractions of cell lysates treated with the IC<sub>50</sub> concentration of compound <b>1</b>. In the first set of experiments, where cells were treated with compound <b>1</b> in the presence of the microtubule-stabilizing agent paclitaxel, compound <b>1</b> prevented tubulin polymerization (mediated by paclitaxel) in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, upper two panels). In the second set of experiments, where intracellular tubulin was stabilized with paclitaxel and then subjected to compound <b>1</b> treatment, an enhancement of tubulin depolymerization was observed with increasing concentrations of compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, lower two panels).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Western blot analysis of the effect of compound <b>1</b> on tubulin polymerization. Western blots show the response of tubulin polymerization to compound <b>1</b> in the presence of paclitaxel and the effect of compound <b>1</b> on paclitaxel-stabilized tubulin. The assay was performed in whole cells (A549) after 30 min of compound treatment at the concentrations indicated. Supernatant and pellet represent unassembled and assembled tubulin, respectively. Tubulin polymerization is indicated by an increase of tubulin in the pellet and its disappearance from the supernatant. The simultaneous treatment with paclitaxel and compound <b>1</b> inhibited tubulin polymerization by compound <b>1</b> in a dose-dependent manner and resulted in accumulation of unassembled tubulin in the supernatant. It was observed that compound <b>1</b> also acts as an enhancer for tubulin depolymerization in a dose-dependent manner when paclitaxel-stabilized tubulin was subjected to compound <b>1</b> treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound <b>1</b> Inhibits Colony Formation Efficiency of A549 and Calu-1 Cells</h3><div class="NLM_p">The ability of compound <b>1</b> to kill cancer cells was explored using a long-term survival assay that monitors a cancer cells’ colony-forming capacity in vitro. A549 (with a normal mitotic spindle checkpoint normal, pRb+) and Calu-1 (with an impaired mitotic spindle checkpoint, pRb+) cells were used in colony formation assays. The colony formation efficiency of A549 and Calu-1 cells is significantly reduced after compound <b>1</b> treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The concentration at which colony formation efficiency is reduced by 50% is comparatively lower than the IC<sub>50</sub> concentration for cell growth inhibition in the MTT assay, indicating that a large number of cells loose the ability to form colonies or do not survive for a long time after compound <b>1</b> treatment. For A549 cells, a 50% reduction in colony formation efficiency was observed at an average concentration of compound <b>1</b> of 1.4 μM (cell growth inhibition IC<sub>50</sub> = 3.5 μM), and for Calu-1 cells, a 50% colony formation efficiency reduction was observed at an average concentration of compound <b>1</b> of 3 μM (cell growth inhibition IC<sub>50</sub> = 11.5 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), indicating that compound <b>1</b> may be quite efficacious in in vivo mouse tumor models.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>1</b> in colony formation assays. A549 and Calu-1 cells were investigated for their long-term survival efficiency after treatment with different concentrations of compound <b>1</b>. Colony formation efficiency is expressed as the percentage of colonies formed in the treated cultures compared with that in untreated cultures. (A) Representative plates show A549 untreated (a), treated with compound <b>1</b> at 3.12 μM (b), treated with <b>1</b> at 6.25 μM (c), treated with compound <b>1</b> at 12.5 μM (d), and treated with compound <b>2</b> at 0.8 μM (e); Calu-1 untreated (f), treated with <b>1</b> at 3.12 μM (g), treated with compound <b>1</b> at 6.25 μM (h), treated with compound <b>1</b> at 12.5 μM, and (i) treated with compound <b>2</b> at 1 μM (j). (B) The curves represent the colony formation efficiencies of A549 and Calu-1 cells with increasing concentrations of compound <b>1</b>. All results represent the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Compound <b>1</b> Induces Apoptotic Cell Death in Cancer Cells</h3><div class="NLM_p">When A549 cells were treated with increasing concentrations of compound <b>1</b> for 24 h, a dose-dependent induction of fragmented nuclei, disrupted cell membrane, and apoptotic cell death was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A, c–e). The induction of apoptosis in NCI-H460, NCI-H358, and NCI-H1299 cells was also measured with flow cytometry (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B). A dose- and time-dependent increase in apoptotic cell death was observed.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Induction of apoptotic cell death analyzed by DAPI staining and FACS. Incubation of A549 cells with increasing concentrations of compound <b>1</b> for 24 h shows a dose-dependent induction of fragmented nuclei, distrupted cell membrane, and apoptotic cell death (A). The fluorescence microscopic images were captured at 40× magnification after staining with DAPI. (A) A549 untreated (a), treated with compound <b>1</b> at 1 μM (b), treated with compound <b>1</b> at 2.5 μM (c), treated with compound <b>1</b> at 5 μM (d), and treated with compound <b>1</b> at 10 μM (e). The preapoptotic and apoptotic cells are indicated with arrows. (B) Percent of apoptosis induced in three cancer cell lines by treatment with compound <b>1</b>, as determined by FACS analysis. The percent apoptosis is depicted as the percent of cells in the sub-G<sub>1</sub> peak during cell cycle analysis. Apoptosis increased with the concentration of <b>1</b> and with its time of incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Aqueous Solubility, Cytochrome P450 Liability, and Caco-2 Permeability of Compound <b>1</b></h3><div class="NLM_p last">The solubility of compound <b>1</b> in water, phosphate buffered saline (PBS), simulated gastric fluid (SGF), and simulated intestinal fluid (SIF) was found to be 80, 125, 125, and 5 μg/mL, respectively. In cytochrome P450 liability studies, at 10 μM, compound <b>1</b> showed 50, 14, 51 and 19% inhibition of CYP3A4, CYP2D6, CYP2C9, and CYP2C19, respectively. In a permeability experiment, the efflux ratio [<i>P</i><sub>app</sub> (B–A)/<i>P</i><sub>app</sub> (A–B)] was 1.1, indicating that compound <b>1</b> is not a substrate of efflux pumps.</div></div><div id="sec2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Experiments: Pharmacokinetics and Maximum Tolerated Dose (MTD)</h3><div class="NLM_p">In order to check the plasma exposure of the compound in animals, the pharmacokinetics of compound <b>1</b> was studied in BALB/c mice following a single 10 mg/kg dose administered orally (PO) and a 1.0 mg/kg dose administered intravenously (IV). The time versus plasma concentration profile of compound <b>1</b> is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>. Compound <b>1</b> showed good plasma exposure, with a <i>C</i><sub>max</sub> of 190 and 371 ng/mL (537 and 1048 nM) by the PO and IV routes, respectively. The AUC<sub>0–∞</sub> values were 182 and 189 ng h/mL (514 and 534 nM), respectively.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Time versus plasma concentration profile of compound <b>1</b> in BALB/c mice; (B) pharmacokinetics parameters determined for compound <b>1</b> after IV and PO administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The MTD determination studies were performed in Swiss albino mice for 2 weeks. The concentration at which compound <b>1</b> should be tested in vivo was thus ascertained. A loss of body weight in the animals was considered to be a measure of overtoxicity for the test compound. The concentration of the compound at which ≥10% weight loss was observed was determined and designated as the MTD, although a weight loss that is below 20% of the animal’s initial weight is usually harmless, and animals can recover once the treatment is stopped.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The toxicity results obtained from these studies indicated that for compound <b>1</b> the MTD in mice was ∼1000 mpk (mg/kg). On the basis of the MTD experiment and pharmacokinetics data, compound <b>1</b> was tested at 1/10th of the MTD concentration, i.e., 100 mg/kg, in in vivo xenograft studies.</div></div><div id="sec2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Effects of <b>1</b> on HCT-116 and NCI-H460 Tumor Growth</h3><div class="NLM_p">The severe combined immunodeficient (SCID) mouse, lacking both T and B immune cells, is an established model to study the in vivo efficacy of molecules that have potential for use in the treatment of human cancers. When evaluated, compound <b>1</b> showed statistically significant (<i>p</i> < 0.05) tumor growth inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A) at 1/10th of the MTD concentration (100 mg/kg) in the HCT-116 tumor model. Mice injected with compound <b>1</b> exhibited approximately 80% tumor growth inhibition as compared to that of untreated mice injected with vehicle solution alone. In the second set of experiments, the antitumor potential of compound <b>1</b> was confirmed when it was proven to be highly efficacious in NCI-H460 tumor models at a 100 mg/kg concentration (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>C,D). These results indicate that compound <b>1</b> has strong anticancer properties in vivo when administered at a concentration 10 times less than its MTD. Thus, with these studies, compound <b>1</b> has shown efficacy as a new class of anticancer compound.</div><div class="NLM_p">During this study, the effect on the animal’s body weight during compound treatment was also noted. The weight loss observed in treated animals was found to be ≤10% of the starting weight of the animals (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B) in the HCT-116 tumor model. This loss of weight is statistically insignificant, indicating that compound treatment caused no major toxicity or harm to the animals. The body weight of the animals at the beginning of the treatment was measured, and this was considered to be 100%. The percent weight loss or gain was calculated using the initial weight as a reference. Similar results were obtained in the NCI-H460 tumor model (data not shown). Compound <b>1</b> shows minimal toxicity in animal models and can be tolerated up to 1000 mg/kg without any significant toxicity.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Tumor growth inhibition curves for compound <b>1</b> in an in vivo HCT116 xenograft model. Graphs depict tumor growth inhibition in a group of animals treated with compound <b>1</b> at 100 mg/kg compared to that of the untreated group (shown in the graphs as the control group). Tumor sizes were recorded at 2–5 day intervals. Tumor weight (mg) was estimated according to the formula for a prolate ellipsoid: length (mm) × width (mm)<sup>2</sup> × 0.5, assuming specific gravity to be 1 and π to be three. Compound <b>1</b> shows statistically significant tumor growth inhibition in vivo, <i>p</i> < 0.05 (Student’s <i>t</i> test was used for comparisons of different groups versus control). (B) Animal weight profile in the HCT116 SCID mice xenograft model. The body weight of animals untreated or treated with compound <b>1</b> (100 mg/kg) was monitored by taking measurements daily during the treatment schedule. By considering the body weight at the start of treatment as 100%, the percent weight loss was calculated on subsequent days of treatment. (C) Tumor growth inhibition curves for compound <b>1</b> in the in vivo NCI-H460 tumor model. Graphs depict tumor growth inhibition in a group of animals treated with a specific compound compared to that of the untreated group (shown in the graphs as the control group). Tumor sizes were recorded at 2–5 day intervals. Tumor weight (mg) was estimated according to the formula for a prolate ellipsoid: length (mm) × width (mm)<sup>2</sup> × 0.5, assuming specific gravity to be 2 and π to be three. Compound <b>1</b> shows statistically significant tumor growth inhibition in vivo, <i>p</i> < 0.05 (Student’s <i>t</i> test was used for comparisons of different groups versus control). (D) Control and treatment groups of SCID mice showing NCI-H460 tumor growth inhibition followed by treatment with compound <b>1</b>. These pictures were obtained after treatment with compound <b>1</b> at 100 mg/kg. The treatments were continued for 9 consecutive days (intraperitoneally) when tumors had reached about 4–6 mm in diameter, which was about 6 days following tumor cell injection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have presented data supporting the potential of compound <b>1</b> as a novel anticancer agent. The finding of its dual inhibition of both Cdk4–cyclin D1 and tubulin polymerization may address the problems of resistance that currently limit the efficacy of valuable anti-microtubule agents. The promising efficacy of compound <b>1</b> in xenograft models (HCT116 and NCI-H460 tumor models) and its excellent therapeutic window indicate the promise of this compound regarding its development as an anticancer agent.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Information</h3><div class="NLM_p last">All chemicals were obtained from Sigma-Aldrich Company and used as received. <sup>1</sup>H, <sup>13</sup>C, and DEPT NMR spectra were recorded on Bruker-Avance DPX FT-NMR 400 MHz instrument. Chemical data for protons are reported in parts per million (ppm) downfield from tetramethylsilane and are referenced to the residual proton in the NMR solvent (CDCl<sub>3</sub>, 7.26 ppm). Carbon nuclear magnetic resonance spectra (<sup>13</sup>C NMR) were recorded at 100 MHz: chemical data for carbons are reported in parts per million (ppm, δ scale) downfield from tetramethylsilane and are referenced to the carbon resonance of the solvent (CDCl<sub>3</sub>, 77.00 ppm). ESI-MS and HRMS spectra were recorded on Agilent 1100 LC-Q-TOF and HRMS-6540-UHD machines. IR spectra were recorded on PerkinElmer IR spectrophotometer. HPLC analysis was done on Shimadzu HPLC system (model LC-6AD) equipped with a PDA detector (model SPD-M20A) using an Inertsil C8 (3.5 μ, 4.6× 250 mm) column. The mobile phase was ACN/water (80:20) with isocratic elution at flow rate of 1 mL/min. The purity of all compounds was determined by HPLC. The purity of final compound <b>1</b> was determined by HPLC and HRMS analysis. All compounds have ≥95% purity.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of Ethyl 2-(1<i>H</i>-Indole-3-yl)ethylcarbamate (<b>4</b>)</h3><div class="NLM_p last">To a suspension of tryptamine (<b>3</b>, 1.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) at 0 °C was slowly added an aqueous solution of 4 N NaOH (1.2 mmol). After 5 min of stirring at 0 °C, ethyl chloroformate (1.2 mmol) was added dropwise. The resulting mixture was stirred for 5 min at 0 °C and further stirred at rt for 3 h. Completion of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The organic layer was separated and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the crude product was purified by silica gel (no. 100–200) column chromatography using EtOAc/hexane as the mobile phase to obtain title compound <b>4</b> as a light pink oil; yield, 90%; HPLC: <i>t</i><sub>R</sub> = 3.7 min (95% purity); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, ppm): δ 8.15 (brs, NH, 1H), 7.60 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (d, <i>J</i> = 8 Hz, 1H), 7.25–7.10 (m, 2H), 7.01 (s, 1H), 4.75 (brs, NH, 1H), 4.13–4.08 (m, 2H), 3.52 (d, <i>J</i> = 6 Hz, 2H), 2.97 (t, <i>J</i> = 6.8 Hz, 2H), 1.22 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, ppm): δ 156.85 (CO), 136.49 (C), 127.34 (C), 122.17 (CH), 122.11 (CH), 119.40 (CH), 118.72 (CH), 112.81 (C), 111.30 (CH), 60.77 (CH<sub>2</sub>), 41.25 (CH<sub>2</sub>), 25.81 (CH<sub>2</sub>), 14.66 (CH<sub>3</sub>); IR (KBr): ν<sub>max</sub> 3409, 3332, 3057, 2980, 2932, 1917, 1695, 1620, 1524, 1479, 1456, 1380, 1338, 1258, 1230, 1171, 1141, 1093, 1035, 1010 cm<sup>–1</sup>; ESI-MS: <i>m</i>/<i>z</i> 233.10 [M + H]<sup>+</sup>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of [2-(1<i>H</i>-Indol-3-yl)-ethyl]-methylamine (<b>5</b>)</h3><div class="NLM_p last">To the solution of carbamate ester <b>4</b> (0.1 g, 59.4 mmol) in dry THF (5 mL) under N<sub>2</sub> flux at 0 °C was added LAH (178 mmol) portion-wise. After the addition was completed, the mixture was heated under reflux for 1 h. The reaction was then cooled to 0 °C, and the excess LAH was hydrolyzed by successively and very carefully adding water (2 mL), a 15% aqueous solution of NaOH (2 mL), and water (3 mL). During these steps, it was necessary to add THF (10 mL) to prevent the mixture from becoming very thick. The suspension was filtered, and the white solid, made up of LiOH and Al(OH)<sub>3</sub>, was washed with THF (10 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated under reduced pressure to obtain title compound <b>5</b> as a beige solid; yield, 85%; HPLC: <i>t</i><sub>R</sub> = 3.75 min (95% purity); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, ppm): δ 8.81 (brs, NH, 1H), 7.60 (s, 1H), 7.30 (s, 1H), 7.17–7.10 (m, 2H), 6.94 (s, 1H), 2.97–2.91 (m, 4H), 2.41 (s, 3H); <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>, ppm): δ 136.19 (C), 127.18 (C), 122.57 (CH), 120.82 (CH), 118.24 (CH), 118.12 (CH), 112.24 (C), 111.31 (CH), 51.94 (CH<sub>2</sub>), 35.62 (CH<sub>3</sub>), 24.80 (CH<sub>2</sub>); IR (KBr): ν<sub>max</sub> 3670, 3646, 3403, 2922, 2851, 1658, 1650, 1456, 1340, 1233, 1016 cm<sup>–1</sup>; ESI-MS: <i>m</i>/<i>z</i> 175.0 [M + H]<sup>+</sup>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of Biphenyl-4-carboxylic Acid [2-(1<i>H</i>-Indol-3-yl)-ethyl]-methyl Amide (<b>1</b>)</h3><div class="NLM_p last">To a suspension of [2-(1<i>H</i>-indol-3-yl)-ethyl]-methylamine (<b>5</b>, 1.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) at 0 °C was slowly added an aqueous solution of 4 N NaOH (1.2 mmol). After 5 min of stirring at 0 °C, 4-biphenyl carbonychloride (<b>6</b>, 1.2 mmol) was added dropwise. The mixture was stirred for 5 min at 0 °C and further stirred at rt for 3 h. Completion of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The organic layer was separated and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the crude product was purified by silica gel (no. 100–200) column chromatography using EtOAc/hexane as the mobile phase to obtain title compound <b>1</b> as a beige solid; yield, 45%; HPLC: <i>t</i><sub>R</sub> = 4.62 min (98% purity); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, ppm): δ 8.21 (brs, NH, 1H), 7.58–7.09 (m, 13H), 6.88 (t, <i>J</i> = 6.8 Hz, 1H), 3.88 (t, <i>J</i> = 6.4 Hz, 1H), 3.61 (t, <i>J</i> = 6.8 Hz, 1H), 3.20 (s, 3H), 2.98 (t, <i>J</i> = 6.8 Hz, 2H); δ (distinct peaks for minor rotamer) 7.73 (d, <i>J</i> = 7.2 Hz, 1H), 7.01 (d, <i>J</i> = 7.6 Hz, 1H), 2.93 (s, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>, ppm): δ (major rotamer) 170.58 (CO), 139.42 (C), 136.18 (C), 128.99 (CH), 127.76 (CH), 127.47 (CH), 126.91 (C), 126.69 (CH), 126.41 (CH), 120.88 (C), 120.87 (CH), 118.06 (CH), 117.82 (C), 117.81 (CH), 111.34 (CH), 51.43 (CH<sub>2</sub>), 32.33 (CH<sub>3</sub>), 23.84 (CH<sub>2</sub>); δ (distinct peaks for minor rotamer) 169.55 (CO), 140.55 (C), 135.72 (C), 123.06 (CH), 118.28 (CH), 110.40 (C), 47.87 (CH<sub>2</sub>), 37.44 (CH<sub>3</sub>), 22.52 (CH<sub>2</sub>); IR (KBr): ν<sub>max</sub> 3411, 3284, 3056, 2924, 2853, 1717, 1609, 1520, 1480, 1456, 1401, 1299, 1258, 1230, 1076, 1018 cm<sup>–1</sup>; ESI-MS: <i>m</i>/<i>z</i> 355.10 [M + H]<sup>+</sup>; HRMS: <i>m</i>/<i>z</i> 355.1840 calcd for [C<sub>24</sub>H<sub>23</sub>N<sub>2</sub>O + H<sup>+</sup>] (355.1810).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Kinase Profiling</h3><div class="NLM_p last">Compound <b>1</b> was tested against a panel of kinases at 10 μM. The in vitro kinase assays for testing against Cdk4–cyclin D1, Cdk2–cyclin A, Cdk2–cyclin E, Cdk1–cyclin B1, and Cdk9–cyclin T1 were performed in-house. The methodology and results have been reported previously.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41">(37-41)</a> The kinase profiling for 58 representative kinases was done commercially at Millipore Bioscience Division, UK.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vitro Cell Proliferation Assays</h3><div class="NLM_p last">All 10 human cancer cell lines were maintained at 37 °C under 5% CO<sub>2</sub> in RPMI-1640 medium supplemented with 10% fetal calf serum and 100 μg/mL normocin. The 10 cancer cell lines used for screening were non-small cell lung carcinoma (NSCLC; a form of cancer that is resistant to chemotherapy) cell lines NCI-H460 (pRb<sup>+</sup>, p53<sup>+</sup>) and A549 (pRb<sup>+</sup>, p53<sup>+</sup>) (obtained from the Glenfield Hospital, Leicester in June 2006) as well as Calu-1 (pRb<sup>+</sup>, p53-null), NCI-H1299 (pRb<sup>+</sup>, p53-null), and NCI-H358 (pRb-null, p53-null) (obtained from Pat Browne, Morvus Technology, in July 2007). The colon cancer cell line LS174T (pRb<sup>+</sup>, p53<sup>+</sup>) and the prostate cancer cell line PC3 (pRb+, p53-null) were also gifts from Pat Browne (Morvus Technology) in July 2007. The pancreatic cancer cell line MIAPaCa (pRb<sup>+</sup>, p53 mutant) was kindly provided by Prof. Bill Greenhalf (University of Liverpool) in July 2007. The genotypes within brackets indicate the status of the tumor suppressor proteins pRb and p53. The mouse embryonic normal hepatic cell line (BNL CL2) and its SV-40 large T-antigen transformed counterpart cell line (BNL SV A.8) were purchased from ATCC in January 2006. The large T antigen inactivates the tumor suppressor proteins p53 and pRb. The obtained cell lines were tested and authenticated via (a) short tandem repeat (STR) profiling, (b) monitoring of cell morphology, (c) karyotyping, and (d) cytochrome C oxidase I (COI) assay. The last tests were performed by ATCC before the cell lines were purchased. The cell lines were revived immediately after receipt. The detailed procedures for the cell proliferation (MTT) assay and IC<sub>50</sub> determination were described previously.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Flow Cytometric Analysis</h3><div class="NLM_p last">The untreated (control) and treated (with test compounds) cells were harvested by trypsinization, washed once with PBS, and then fixed in 70% chilled (−20 °C) ethanol for a minimum of 1 h. After the fixation step, cells were centrifuged for 5 min at 3000<i>g</i> at room temperature, and the pellet was then suspended in PBS containing 50 μg/mL propidium iodide (Sigma cat. no. P-4170) and 0.5 mg/mL DNase-free ribonuclease (Sigma cat. no. R-5503). The cells were stained for 1 h in the dark at 4 °C. Cell cycle analysis was performed on a Beckman Coulter (Epics Altra) fluorescence-activated cell sorter. In order to gate all of the events that represent single cells and to exclude cell doublets or cell clumps, the following analyses were performed on the samples. Cytograms of propidium iodide fluorescence peak signal versus integrated fluorescence or the linear signal were plotted. All data points on the straight line were isolated in a single gate, and the gated data were further used for plotting a histogram that represents a complete cell cycle. The total number of events was not allowed to exceed 200 events/second. Data acquisition was stopped after a minimum of 10 000 events had been collected.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Western Blotting</h3><div class="NLM_p last">A549, LS174T, and MIAPaCa cells were seeded in 25 cm<sup>2</sup> tissue culture flasks in complete growth medium. When the culture flasks reached 40–50% confluence, cells were treated with <b>1</b> (IC<sub>50</sub> concentration) for 24 h. Cells were harvested by trypsinization, washed in ice-cold PBS, and then lysed in buffer (Sigma cat. no. C-2978) containing protease inhibitor cocktail (Sigma cat. no. P8340). The lysates were centrifuged at 14 000 rpm for 10 min at 4 °C, and the total protein concentration was estimated in the cleared supernatants using the Bradford method. Equal amounts of protein (40 μg) were loaded and electrophoresed on 10% SDS-polyacrylamide gels and transferred onto Immobilon-P transfer membrane (Millipore cat. no. IPVH20200). The blots were probed with primary antibodies (at 4 °C, overnight) at the following dilutions: cdc2 (New England Biolabs cat. no. 9110) at 1:1000 to detect Cdk1, cyclin B1 (CR-UK cat. no. V152) at 1:1500 dilution to detect cyclin B1, Pab 1801 (Santa Cruz Biotechnology cat. no. sc-98) at 1:500 dilution to detect p53, N-20 (SantaCruz Biotechnology cat. no. sc-469) at 1:500 dilution to detect p21, C-19 (SantaCruz Biotechnology cat. no. sc-528) at 1:250 dilution to detect p27, and AC-40 (Sigma-Aldrich cat. no. A4700) at 1:2000 dilution to detect actin. Appropriate secondary antibodies conjugated with horseradish peroxidase were used, and the protein bands were visualized by chemiluminescence using an ECL kit (SantaCruz Biotechnology cat. no. sc-2048).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Tubulin Polymerization Assay in Vitro</h3><div class="NLM_p last">Purified tubulin was obtained commercially (Cytoskeleton Inc., Denver, CO, USA), and the polymerization assays were carried out according to a method previously described.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> The tubulin polymerization assay is based on an adaptation of the original method of Lee and Timasheff,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> which demonstrated that light is scattered by microtubules to an extent that is proportional to the concentration of the microtubule polymer. The resulting polymerization curves are representative of three phases of microtubule polymerization, namely, nucleation, growth, and steady-state equilibrium. Paclitaxel and nocodazole were used in the assay as a known enhancer and inhibitor of tubulin polymerization, respectively. The ability of compound <b>1</b> to inhibit tubulin polymerization in vitro was determined according to the manufacturer’s instructions. Briefly, tubulin protein (3 mg/mL) was polymerized in GTP buffer (80 mM PIPES, pH 6.9, 2 mM MgCl<sub>2</sub>, 0.5 mM EGTA, 10.2% glycerol, and 1 mM GTP) in the presence of a range of concentrations of compound <b>1</b> at 37 °C in a temperature-regulated Biotech spectrophotometer. The absorbance kinetic (at 340 nm) of 61 cycles for each sample was studied, and the readings were recorded at intervals of 1 min.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Western Blot Analysis to Test Effects of Compound <b>1</b> on Tubulin Polymerization and Depolymerization of Stabilized Tubulin in Live Cells</h3><div class="NLM_p last">A549 cells were plated at a concentration of 10 000 cells per well in 1 mL of complete growth medium in 24-well/15 mm plates. The plates were incubated for 24 h for stabilization. In the first set of experiments, the cells were treated for 30 min with 10 nM paclitaxel and different concentrations of compound <b>1</b> (simultaneous treatment of paclitaxel and compound <b>1</b>). In the second set, in order to study the effect of <b>1</b> on the stabilized form of tubulin, the cells were treated first with 10 nM paclitaxel for 30 min. The cell monolayer was then washed twice with sterile PBS, and fresh growth medium containing different concentrations of compound <b>1</b> was added. The plates were further incubated for 30 min, the cell monolayers were washed twice with sterile PBS at room temperature, and then 100 μL of tubulin extraction buffer (1 mM MgCl<sub>2</sub>, 2 mM EGTA, 0.5% NP40, and 20 mM Tris-HCl, pH 6.8) supplemented with 2 mM phenylmethylsulfonyl fluoride and a protease inhibitor cocktail (Sigma cat. no. P8340) was added per well. After a brief and vigorous vortex, the cell lysates were incubated at room temperature for 5 min and then centrifuged at 16 000<i>g</i> for 10 min in order to separate the soluble and polymerized tubulin fractions. Each supernatant and pellet fraction was mixed with 10× sample buffer, heated for 7 min at 95 °C and resolved on 10% SDS-polyacrylamide gels. The resolved proteins were then subjected to western blotting (as described above) with a specific α-tubulin antibody (B-7, Santa Cruz Biotechnology cat. no. sc-5286).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Detection of Apoptosis Using DAPI Staining</h3><div class="NLM_p last">Apoptosis and nuclear fragmentation were detected using DAPI staining followed by observation under a fluorescence microscope.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> A549 cells were seeded at a concentration of 50 000 cells per well in 35 mm/6-well plates in a total of 2 mL of complete growth medium. After a 24 h stabilization period, cells were further incubated in the presence of different concentrations of compound <b>1</b> for 24 h. Followed by exposure to compound <b>1</b>, the cells along with the floating cells were collected by trypsinization, washed in sterile PBS, and fixed in ethanol/acetic acid (3:1) for 10 min. The cell suspension was dropped onto a glass slide in order to break open the cells, allowing them to be dried in air. The smear formed on the slide was mounted in medium containing 1 μg/mL DAPI and covered with coverslip. The slides were observed using a fluorescence microscope (Olympus), and a minimum of 500 nuclei were counted for each sample.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Clonogenic Assay</h3><div class="NLM_p last">A549 and Calu-1 cells were plated at a concentration of 500 cells per well in 35 mm/6-well plates in 2 mL of complete medium. The plates were incubated for 24 h for stabilization and further incubated with a range of concentrations of fascaplysin and compound <b>1</b> (0.1–10 μM) for 24 h. Plates were then gently washed with PBS, replaced with fresh medium, and incubated at 37 °C. After 10–12 days, cells were fixed in methanol/acetic acid (2:1) for 10 min, washed, air-dried, and stained with 1% crystal violet. The colonies were evaluated by visual counts. The number of colonies in treated cultures was expressed as a percentage of the control cultures. All results represent the mean ± SD from at least three independent experiments.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Determination of Aqueous Solubility</h3><div class="NLM_p last">The thermodynamic aqueous solublity was determined using a 96-well plate protocol. The dissolution media, PBS (pH 7.4), SGF (pH 1.2), and SIF (pH 6.8), were prepared as per USP procedures. Briefly, compound <b>1</b> was loaded into a 96-well plate in the form of methanolic solution, followed by evaporation of solvent to obtain 1, 2, 4, 8, 16, 25, 40, 80, 160, and 300 μg of compound in solid form in the wells. Thereafter, 200 μL of dissolution medium was added to the wells, and plates were shaken horizontally at 300 rpm for 4 h at room temperature (25 ± 1 °C). The plates were covered with aluminum foil and kept overnight at room temperature for equilibration. Later, the plates were centrifuged at 1000 rpm for 20 min (Jouan centrifuge BR4i). Supernatant (50 μL) was withdrawn into UV 96-well plates (Corning 96-well clear flat bottom UV-transparent microplate) for analyses with a microplate reader (Molecular Devices, USA) at the corresponding λ<sub>max</sub> of the sample. The analysis was performed in triplicate for each compound. The solubility curve of concentration (μg/mL) vs absorbance was plotted to find the saturation point, and the corresponding concentration was noted.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> hrCYP P450 Isoenzyme Assay</h3><div class="NLM_p last">hrCYP P450 isoenzymes were aliquoted at the total concentration required to conduct the study and stored at −70 °C until use. The total assay volume was adjusted to 200 μL and consists of three components: cofactors, inhibitor/vehicle, and enzyme–substrate (ES) mix. Fifty microliters of working cofactor stock solution was dispensed to all of the specified wells in a black Nunc microtiter polypropylene plate. Fifty microliters of diluted working concentrations of test compounds/positive control/vehicle was dispensed in triplicates to the specified wells as per the plate map design. The reaction plate with the cofactor and test item was preincubated at 37 ± 1 °C in a shaking incubator for 10 min. Simultaneously, the ES mix was prepared by mixing the hrCYP P450 isoenzyme. The remaining volume was made up with buffer and preincubated for 10 min at 37 ± 1 °C. One-hundred microliters of ES mix was dispensed per well as per the plate map design and incubated at 37 ± 1 °C in a shaking incubator for a predetermined time. A set of controls was incubated with hrCYP P450 isoenzymes and substrate without the test or reference item. A set of blanks was incubated with the substrate and test or reference item in the absence of hrCYP P450 isoenzymes. The reaction was terminated by adding specific quenching solutions (for CYP1A2, CYP2C19, and CYP3A4, 75 μL of 100% acetonitrile; for CYP2C9, 20 μL of 0.25 M Tris in 60% methanol; for CYP2D6, 75 μL of 0.25 M Tris in 60% methanol). The reaction was quenched by thoroughly mixing the final contents of the wells by repeated pippeting using a multichannel pipet. The product fluorescence per well was measured using a multimode reader at excitation and emission wavelengths of the respective hrCYP P450 isoenzyme fluorogenic metabolites. Data was analyzed using Excel, and the percent inhibition was calculated.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Caco-2 Permeability Assay</h3><div class="NLM_p last">A permeability study was conducted with a Caco-2 monolayer cultured for 21 days (TEER full form values >500 cm<sup>2</sup> in each well) by adding an appropriate volume of buffer (HBSS buffer containing 10 mM HEPES) containing the test compound to the apical chamber. A test sample was taken from both the apical and basolateral chambers at 0 and 90 min after incubation at 37 °C and analyzed by LC–MS/MS. The same experiment was repeated by adding an appropriate volume of buffer (HBSS buffer containing 10 mM HEPES) containing the test compound to the basolateral chamber. The AUC defined the net influx and outflow of the test compound across the Caco-2 cell monolayer.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Pharmacokinetics Study</h3><div class="NLM_p last">The pharmacokinetics study of compound <b>1</b> was carried out in BALB/c male mice (4–6 weeks of age) by administering the compound PO and IV at doses of 10 and 1 mg/kg, respectively. Plasma samples were collected at time points between 0 and 24 h and analyzed by LC–MS-MS. Mean plasma concentration was calculated, and data was further analyzed for PK parameters using WinNonlin 5.3.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Maximum Tolerated Dose (MTD) Studies for in Vivo Experiments</h3><div class="NLM_p last">Swiss albino mice were used to determine the maximum tolerated dose of the compound. Compound <b>1</b> was weighed and mixed with 0.5% w/v carboxymethyl cellulose (CMC) and triturated with Tween 20 (secundum artum) with gradual addition of water to make up the final concentration. Care was taken not to exceed >0.25% Tween 20 in the final formulation of compound <b>1</b>. In this study, 6 animals per group were administered compound <b>1</b> at different doses for 5 days (Q1D × 5) via an intraperitoneal route. Animals were monitored for weight loss, morbidity symptoms, and mortality for up to 2 weeks, which was the end of treatment. Weight loss was considered to be significant for a mean animal weight drop of ≥10% and was considered to be highly significant when the drop was ≥20%.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> In Vivo Efficacy Study in SCID Mice</h3><div class="NLM_p">The in vivo efficacy of compound <b>1</b> was determined in two human xenograft models: HCT-116 and NCI-H460.</div><div id="sec4_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> HCT-116 Experiments</h4><div class="NLM_p last">A group of 60 SCID (strain-CBySmn.CB17-<i>Prkdc</i><sup><i>scid</i></sup>/J, The Jackson Laboratory, stock no. 001803) male mice weighing 18–25 g, 6–8 weeks of age, was used for the studies. Human colon carcinoma HCT-116 cells (ATCC cat. no. CCL-247) were grown in McCoy’s 5A medium supplemented with 10% FBS (Sigma-Aldrich). The cultured cells were injected subcutaneously into the dorsal side of the SCID mice at a dose of 6.6 × 10<sup>6</sup> cells in 0.2 mL of suspension. When tumor growth reached to about 4–6 mm in diameter (about 5 days), the animals were randomly divided into eight groups, with each containing 7 mice. The treatments were continued for 9 consecutive days intraperitoneally.</div></div><div id="sec4_18_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> NCI-H460 Experiments</h4><div class="NLM_p last">A group of 65 SCID (strain-CBySmn.CB17-<i>Prkdc</i><sup><i>scid</i></sup>/J, The Jackson Laboratory, stock no. 001803) female mice weighing 15–24 g, 6–8 weeks of age, were used. Human non-small-cell lung carcinoma NCI-H460 (ATCC cat. no. HTB-177) cells were grown in RPMI-1640 medium supplemented with 10% FBS (Sigma-Aldrich). The cultured cells were injected subcutaneously into the dorsal side of the SCID mice at a dose of 5.3 × 10<sup>6</sup> cells in 0.2 mL of suspension. When tumor growth reached about 4–6 mm in diameter (about 6 days), the animals were randomly divided into eight groups, with each containing 6 or 7 mice. The treatments were continued for 9 consecutive days intraperitoneally.</div></div><div id="sec4_18_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Tumor Weight Measurements</h4><div class="NLM_p last">Tumor size was recorded at 2–5 day intervals. Tumor weight (mg) was estimated according to the formula for a prolate ellipsoid: length (mm) × width (mm)<sup>2</sup> × 0.5, assuming specific gravity to be 1 and π to be 3. Tumor growth in compound-treated animals was calculated as T/C (treated/control) × 100%, and growth inhibition percent (% GI) was 100 – % T/C.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50-52)</a></div></div><div id="sec4_18_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Body Weight Measurements</h4><div class="NLM_p last">Body weights of the animals in different treatment and control groups were monitored by taking the measurements daily during the treatment schedule. By considering the body weight at the start of the treatment as 100%, the percent weight loss was calculated on subsequent days of treatment.</div></div><div id="sec4_18_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Statistical Analysis</h4><div class="NLM_p last">Data from each experiment was analyzed by Microsoft Excel 2000. Statistically significant differences were identified and analyzed using Student’s <i>t</i> test for comparisons versus control group.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50-52)</a></div></div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Molecular Docking and Molecular Dynamic Simulation</h3><div class="NLM_p">The available crystal structures of Cdk4 are in the apo-form and have several missing residues; thus, they cannot be used for molecular modeling.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In the present study, we used a hybrid homology model of Cdk4 described by Shafiq et al.,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which was developed from the Cdk4–cyclin D apo-crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W96">2W96</a>) by incorporating positions of missing gaps and activation loops from Cdk2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FIN">1FIN</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(54)</a> This hybrid homology model was subjected to Protein Preparation Wizard for H-bond optimization, heterogeneous state generation, protonation, and overall minimization. A grid file of the docking was constructed using <i>XYZ</i> coordinates of the N atom of Val96, with a binding site having a 12 Å radius grid box (<i>X</i> = −10.521, <i>Y</i> = 208.683, <i>Z</i> = 107.944). For Cdk2 docking, the Cdk2 apoprotein (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FIN">1FIN</a>) was subjected to Protein Preparation Wizard for filling missing loops and side chains (using prime), ionization, H-bond optimization, heterogeneous state generation, protonation, and overall minimization. A grid file of the docking was constructed using <i>XYZ</i> coordinates of the N atom of Leu83, with a binding site having a 12 Å radius grid box (<i>X</i> = −10.406, <i>Y</i> = 209.105, <i>Z</i> = 107.576).</div><div class="NLM_p">For tubulin docking, the tubulin–colchicine complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>) was retrieved from the Protein Data Bank.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(55)</a> In this complex, the protein is heterodimeric in nature, consisting of two α-chains (451 residues), two β-chains (452 residues), and the Stathmin like domain (142 residues). The crystal structure was subjected to Protein Preparation Wizard for filling missing loops and side chains (using prime), ionization, H-bond optimization, heterogeneous state generation, protonation, and overall minimization. All other ligands, water, and ions were removed except colchicine. A grid file for docking was constructed considering the colchicine ligand as a centroid having a grid box of 10 Å size at the interphase of α/β-tubulin (C and D chains). All ligands were sketched in Maestro, prepared using LigPrep, and docked by Glide molecular docking software in XP mode.</div><div class="NLM_p last">The Cdk4–compound <b>1</b> docked complex obtained from XP docking was subjected to system builder, in which TIP4P-Ew was used as an aqueous solvent model. A cubic box having a 12 Å radius was used to define the core, and the overall complex was neutralized by adding one Cl<sup>–</sup> counterion for simulation. Furthermore, this complex was minimized by steepest descent method followed by the Broyden–Fletcher–Goldfarb–Shanno algorithm with a convergence threshold of 2.0 kcal/mol and 1000 iterations. MD simulations were carried out at normal temperature and pressure (300 K and 1.01325 bar, respectively). The thermostat and barostat method used was Langevin, with the ensemble pathway comprising NVT (constant number of particles, volume, and temperature) and the isotropic coupling method. The overall model system was relaxed before a 10 ns simulation, and Coulombic interactions were defined by a short-range cutoff radius of 9.0 Å and by a long-range smooth particle mesh Ewald tolerance to 1 × 10<sup>–9</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/jm5014743">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">NMR and HPLC spectra scans and kinase profiling results. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5014743/suppl_file/jm5014743_si_001.pdf">jm5014743_si_001.pdf (1.08 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5014743" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandip B. Bharate</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Medicinal Chemistry
Division, §Academy of Scientific & Innovative Research
(AcSIR), ∥Preformulation Laboratory, CSIR-Indian
Institute of Integrative Medicine, Canal Road, Jammu 180001, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#215243494053405544614848484c0f40420f484f"><span class="__cf_email__" data-cfemail="493a2b21283b283d2c092020202467282a672027">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ram A. Vishwakarma</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Medicinal Chemistry
Division, §Academy of Scientific & Innovative Research
(AcSIR), ∥Preformulation Laboratory, CSIR-Indian
Institute of Integrative Medicine, Canal Road, Jammu 180001, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a6d4c7cbe6cfcfcfcb88c7c588cfc8"><span class="__cf_email__" data-cfemail="6012010d200909090d4e01034e090e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bhabatosh Chaudhuri</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#eb8988838a9e8f839e9982ab8f869ec58a88c59e80"><span class="__cf_email__" data-cfemail="92f0f1faf3e7f6fae7e0fbd2f6ffe7bcf3f1bce7f9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sachin Mahale</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudhakar Manda</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Medicinal Chemistry
Division, §Academy of Scientific & Innovative Research
(AcSIR), ∥Preformulation Laboratory, CSIR-Indian
Institute of Integrative Medicine, Canal Road, Jammu 180001, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prashant Joshi</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Medicinal Chemistry
Division, §Academy of Scientific & Innovative Research
(AcSIR), ∥Preformulation Laboratory, CSIR-Indian
Institute of Integrative Medicine, Canal Road, Jammu 180001, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonali S. Bharate</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, De Montfort University, Leicester LE1 9BH, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">‡Medicinal Chemistry
Division, §Academy of Scientific & Innovative Research
(AcSIR), ∥Preformulation Laboratory, CSIR-Indian
Institute of Integrative Medicine, Canal Road, Jammu 180001, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul R. Jenkins</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Leicester, Leicester LE1 7RH, United Kingdom</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.Mah. performed all Cdk assays and in vitro biology experiments; P.R.J. designed fascaplysin analogues for chemical syntheses; B.C. designed all biology experiments both in vitro and in vivo; S.Man. synthesized compound 1 for pharmacokinetic studies; P.J. carried out molecular modeling studies; P.J. and S.B.B. interpreted modeling results; S.S.B. determined solubility of 1 in various biological fluids; and S.B.B., R.A.V., and B.C. contributed to manuscript writing.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">IIIM Communication Number. IIIM/1731/2014</p></div></li></ul></div><div class="ack" id="ACK-d1473e2453-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research work was funded by Cancer Research UK (B.C. and P.R.J.) and CSIR 12th FYP BSC-0205 project.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i52" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i52"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i53" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i53"> Abbreviations Used</h2><tr><td class="NLM_term">AUC<sub>0–<i>t</i></sub></td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve from 0 to the last measurable time point</p></td></tr><tr><td class="NLM_term">AUC<sub>0–∞</sub></td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve from time zero to infinity</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum observed plasma concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>0</sub></td><td class="NLM_def"><p class="first last">extrapolated concentration at zero time point</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Cdk4</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 4</p></td></tr><tr><td class="NLM_term">d/w</td><td class="NLM_def"><p class="first last">distilled water</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">milligrams per kilogram of body weight</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung carcinoma</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline</p></td></tr><tr><td class="NLM_term">rpm</td><td class="NLM_def"><p class="first last">revolutions per minute</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">SIF</td><td class="NLM_def"><p class="first last">simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficient</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2,ß</sub></td><td class="NLM_def"><p class="first last">terminal half-life</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>last</sub></td><td class="NLM_def"><p class="first last">time at which last concentration was found</p></td></tr><tr><td class="NLM_term">USP</td><td class="NLM_def"><p class="first last">United States Pharmacopoeia</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>dss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdks, cyclins and CKIs: roles beyond cell cycle regulation</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">3079</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=3079-3093&author=S.+Limauthor=P.+Kaldis&title=Cdks%2C+cyclins+and+CKIs%3A+roles+beyond+cell+cycle+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdks%252C%2520cyclins%2520and%2520CKIs%253A%2520roles%2520beyond%2520cell%2520cycle%2520regulation%26jtitle%3DDevelopment%26date%3D2013%26volume%3D140%26spage%3D3079%26epage%3D3093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.coph.2005.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15964238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=366-373&author=I.+Collinsauthor=M.+D.+Garrett&title=Targeting+the+cell+division+cycle+in+cancer%3A+CDK+and+cell+cycle+checkpoint+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span></div><div class="casAuthors">Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">366-373</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression through each stage of the cell division cycle and as such are major targets for deregulation in cancer.  This has led to the development of several small-mol. inhibitors of CDKs as potential therapeutic agents for the treatment of this disease.  Progression through the cell cycle is also monitored at several positions known as cell cycle checkpoints, 2 of which occur during G1 and G2 in response to DNA damage.  These are often defective in cancer, leading to the suggestion that inhibition of one or both of the cell cycle checkpoint kinases CHK1 and CHK2 may drive a cancer cell that already has defects in its cell cycle checkpoints towards death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqcFxaO9gh7Vg90H21EOLACvtfcHk0liym1pYnpNdFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D&md5=40607fa37e866766581683b322829a13</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DTargeting%2520the%2520cell%2520division%2520cycle%2520in%2520cancer%253A%2520CDK%2520and%2520cell%2520cycle%2520checkpoint%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.2174%2F1568026053507688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15853645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=167-179&author=H.+Hiraiauthor=N.+Kawanishiauthor=Y.+Iwasawa&title=Recent+advances+in+the+development+of+selective+small+molecule+inhibitors+for+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of selective small molecule inhibitors for Cyclin-dependent kinases</span></div><div class="casAuthors">Hirai, Hiroshi; Kawanishi, Nobuhiko; Iwasawa, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Loss of normal cell cycle regulation is the hallmark of human cancers, and alteration of the components involved in cell cycle regulation occurs in most human tumors.  This suggests that Cyclin dependent kinases (CDKs) are an attractive target for the development of pharmacol. agents for the treatment of cancer.  Recently, CDK family members that are not directly involved in cell cycle regulation were identified.  This includes CDK7, CDK8, and CDK9, which participate in transcription regulation, and CDK5, which plays a role in neuronal and secretory functions.  Given the involvement of CDKs in multiple cellular processes, development of selective small mol. inhibitors for specific CDKs is expected to help clarify whether improved specificity of cell cycle CDK inhibitors will enhance their therapeutic potential in cancer treatment.  Selective inhibitors are also needed as tools to explore the biol. of diseases in which CDKs may participate and to help develop therapeutics to treat them.  Intensive screening and drug design based on CDK/inhibitor co-crystal structure and SAR studies have led to the identification of a large variety of chem. inhibitors of CDKs.  Although they are competitive with ATP at the catalytic site, their kinase selectivity varies greatly, and inhibitors selective for certain CDKs have begun to be identified.  There are currently 2 categories of selective CDK inhibitors: those that are selective for CDK2 and CDK1 and those that are selective for CDK4/6.  These 2 types of inhibitors have different effects on tumor cells and are expected to be useful in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooiAF6UAza_7Vg90H21EOLACvtfcHk0lhaKnLN2_2ktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D&md5=2fceab02ebbaaca45061a80884571ef7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026053507688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507688%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520selective%2520small%2520molecule%2520inhibitors%2520for%2520cyclin-dependent%2520kinases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Marahatta, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makaju, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petmitr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petmitr, S.</span><span> </span><span class="NLM_article-title">Cancer: determinants and progression</span> <span class="citation_source-journal">Nepal Med. Coll. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16295727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A280%3ADC%252BD2MngvFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=65-71&author=S.+B.+Marahattaauthor=N.+Sharmaauthor=R.+Kojuauthor=R.+K.+Makajuauthor=P.+Petmitrauthor=S.+Petmitr&title=Cancer%3A+determinants+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer: determinants and progression</span></div><div class="casAuthors">Marahatta Sujan Babu; Sharma Nastu; Koju Rajendra; Makaju Ramesh Kumar; Petmitr Porntip; Petmitr Songsak</div><div class="citationInfo"><span class="NLM_cas:title">Nepal Medical College journal : NMCJ</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer is the combination of uncontrolled cellular proliferation and immortality.  It is a multi-step disease with a multi-factorial etiology.  The determinants of cancer are many and varied including genetic predisposition, environmental influences, infectious agents, nutritional factors, hormonal and reproductive factors, radiation etc.  However, the extent of the genetic involvement and their interaction with environment in tumorigenesis is still elusive.  The six essential alterations in cell are proposed which determines the transition from normal cell to malignant.  It includes--self-sufficiency in growth signals, insensitivity to growth-inhibitory (antigrowth) signals, evasion of programmed cell death (apoptosis), limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  Nevertheless, the last two decades have seen rapid improvements in understanding the complex molecular mechanisms underlying tumorigenesis, yet the quest for unraveling the mystery is not over.  Further study in this area is indispensable that could hold the promise of increasing our understanding of cancer etiology and possible preventive strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGqBxaUwso-e_Q9URG6Dx8fW6udTcc2eZeeRu5kIlCMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MngvFGiug%253D%253D&md5=2143a0d5b5f450aa2a0adf628a19416e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarahatta%26aufirst%3DS.%2BB.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DKoju%26aufirst%3DR.%26aulast%3DMakaju%26aufirst%3DR.%2BK.%26aulast%3DPetmitr%26aufirst%3DP.%26aulast%3DPetmitr%26aufirst%3DS.%26atitle%3DCancer%253A%2520determinants%2520and%2520progression%26jtitle%3DNepal%2520Med.%2520Coll.%2520J.%26date%3D2005%26volume%3D7%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lhaKnLN2_2ktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Connell-Crowley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodrich, D. W.</span><span> </span><span class="NLM_article-title">Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1091%2Fmbc.8.2.287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=9190208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaK2sXhsV2itr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=287-301&author=L.+Connell-Crowleyauthor=J.+W.+Harperauthor=D.+W.+Goodrich&title=Cyclin+D1%2FCdk4+regulates+retinoblastoma+protein-mediated+cell+cycle+arrest+by+site-specific+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation</span></div><div class="casAuthors">Connell-Crowley, Lisa; Harper, J. Wade; Goodrich, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-301</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The retinoblastoma protein (pRb) inhibits progression through the cell cycle.  Although pRb is phosphorylated when G1 cyclin-dependent kinases (Cdks) are active, the mechanisms underlying pRb regulation are unknown.  In vitro phosphorylation by cyclin D1/Cdk4 leads to inactivation of pRb in a microinjection-based in vivo cell cycle assay.  In contrast, phosphorylation of pRb by Cdk2 or Cdk3 in complexes with A- or E-type cyclins is not sufficient to inactivate pRb function in this assay, despite extensive phosphorylation and conversion to a slowly migrating "hyperphosphorylated form." The differential effects of phosphorylation on pRb function coincide with modification of distinct sets of sites.  Serine 795 is phosphorylated efficiently by Cdk4, even in the absence of an intact LXCXE motif in cyclin D, but not by Cdk2 or Cdk3.  Mutation of serine 795 to alanine prevents pRb inactivation by Cdk4 phosphorylation in the microinjection assay.  This study identifies a residue whose phosphorylation is crit. for inactivation of pRb-mediated growth suppression, and it indicates that hyperphosphorylation and inactivation of pRb are not necessarily synonymous.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuGVSOFEDFLVg90H21EOLACvtfcHk0lgbHoLQXz_Jig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsV2itr0%253D&md5=4e25b2edd6f4bcb0aeb6beff4465c5de</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1091%2Fmbc.8.2.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.8.2.287%26sid%3Dliteratum%253Aachs%26aulast%3DConnell-Crowley%26aufirst%3DL.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DGoodrich%26aufirst%3DD.%2BW.%26atitle%3DCyclin%2520D1%252FCdk4%2520regulates%2520retinoblastoma%2520protein-mediated%2520cell%2520cycle%2520arrest%2520by%2520site-specific%2520phosphorylation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1997%26volume%3D8%26spage%3D287%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Morgan, D. O.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases: engines, clocks, and microprocessors</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1146%2Fannurev.cellbio.13.1.261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=9442875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1997&pages=261-291&author=D.+O.+Morgan&title=Cyclin-dependent+kinases%3A+engines%2C+clocks%2C+and+microprocessors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases: engines, clocks, and microprocessors</span></div><div class="casAuthors">Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-291</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 133 refs.  Cyclin-dependent kinases (Cdks) play a well-established role in the regulation of the eukaryotic cell division cycle and have also been implicated in the control of gene transcription and other processes.  Cdk activity is governed by a complex network of regulatory subunits and phosphorylation events whose precise effects on Cdk conformation have been revealed by recent crystallog. studies.  In the cell, these regulatory mechanisms generate an interlinked series of Cdk oscillators that trigger the events of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDw-roxCwtY7Vg90H21EOLACvtfcHk0lgbHoLQXz_Jig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D&md5=9b9b161d0beaef5e7934bab158906dcd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.13.1.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.13.1.261%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DCyclin-dependent%2520kinases%253A%2520engines%252C%2520clocks%252C%2520and%2520microprocessors%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D261%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span> </span><span class="NLM_article-title">Cancer cell cycles</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1672</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1672-1677&author=C.+J.+Sherr&title=Cancer+cell+cycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26atitle%3DCancer%2520cell%2520cycles%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1672%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Soni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumstein-Mecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=877-884&author=R.+Soniauthor=L.+Mullerauthor=P.+Furetauthor=J.+Schoepferauthor=C.+Stephanauthor=S.+Zumstein-Meckerauthor=H.+Fretzauthor=B.+Chaudhuri&title=Inhibition+of+cyclin-dependent+kinase+4+%28Cdk4%29+by+fascaplysin%2C+a+marine+natural+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoni%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DZumstein-Mecker%26aufirst%3DS.%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520cyclin-dependent%2520kinase%25204%2520%2528Cdk4%2529%2520by%2520fascaplysin%252C%2520a%2520marine%2520natural%2520product%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D275%26spage%3D877%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=194-199&author=Y.+Gengauthor=Q.+Yuauthor=E.+Sicinskaauthor=M.+Dasauthor=R.+T.+Bronsonauthor=P.+Sicinski&title=Deletion+of+the+p27Kip1+gene+restores+normal+development+in+cyclin+D1-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DDas%26aufirst%3DM.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DDeletion%2520of%2520the%2520p27Kip1%2520gene%2520restores%2520normal%2520development%2520in%2520cyclin%2520D1-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D194%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span> </span><span class="NLM_article-title">The consensus motif for phosphorylation by cyclin D1–Cdk4 is different from that for phosphorylation by cyclin A/E–Cdk2</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7060</span><span class="NLM_x">–</span> <span class="NLM_lpage">7069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=7060-7069&author=M.+Kitagawaauthor=H.+Higashiauthor=H.+K.+Jungauthor=I.+Suzuki-Takahashiauthor=M.+Ikedaauthor=K.+Tamaiauthor=J.+Katoauthor=K.+Segawaauthor=E.+Yoshidaauthor=S.+Nishimuraauthor=Y.+Taya&title=The+consensus+motif+for+phosphorylation+by+cyclin+D1%E2%80%93Cdk4+is+different+from+that+for+phosphorylation+by+cyclin+A%2FE%E2%80%93Cdk2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DH.%2BK.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DJ.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DE.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DTaya%26aufirst%3DY.%26atitle%3DThe%2520consensus%2520motif%2520for%2520phosphorylation%2520by%2520cyclin%2520D1%25E2%2580%2593Cdk4%2520is%2520different%2520from%2520that%2520for%2520phosphorylation%2520by%2520cyclin%2520A%252FE%25E2%2580%2593Cdk2%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D7060%26epage%3D7069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odajima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=591-598&author=A.+Martinauthor=J.+Odajimaauthor=S.+L.+Huntauthor=P.+Dubusauthor=S.+Ortegaauthor=M.+Malumbresauthor=M.+Barbacid&title=Cdk2+is+dispensable+for+cell+cycle+inhibition+and+tumor+suppression+mediated+by+p27%28Kip1%29+and+p21%28Cip1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DOdajima%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DS.%2BL.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCdk2%2520is%2520dispensable%2520for%2520cell%2520cycle%2520inhibition%2520and%2520tumor%2520suppression%2520mediated%2520by%2520p27%2528Kip1%2529%2520and%2520p21%2528Cip1%2529%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D591%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of cancer cells despite CDK2 inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Is cyclin D1–CDK4 kinase a bona fide cancer target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=2-4&author=M.+Malumbresauthor=M.+Barbacid&title=Is+cyclin+D1%E2%80%93CDK4+kinase+a+bona+fide+cancer+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DIs%2520cyclin%2520D1%25E2%2580%2593CDK4%2520kinase%2520a%2520bona%2520fide%2520cancer%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D2%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=O.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0ljJ6R0zZ0DdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DO.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkiewicz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, E. S.</span><span> </span><span class="NLM_article-title">CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6512-6525&author=J.+Francoauthor=A.+K.+Witkiewiczauthor=E.+S.+Knudsen&title=CDK4%2F6+inhibitors+have+potent+activity+in+combination+with+pathway+selective+therapeutic+agents+in+models+of+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DJ.%26aulast%3DWitkiewicz%26aufirst%3DA.%2BK.%26aulast%3DKnudsen%26aufirst%3DE.%2BS.%26atitle%3DCDK4%252F6%2520inhibitors%2520have%2520potent%2520activity%2520in%2520combination%2520with%2520pathway%2520selective%2520therapeutic%2520agents%2520in%2520models%2520of%2520pancreatic%2520cancer%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D6512%26epage%3D6525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Breault, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midgley, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minshull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimization of substituted 2,4-bis anilino pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2961-2966&author=G.+A.+Breaultauthor=R.+P.+Ellstonauthor=S.+Greenauthor=S.+R.+Jamesauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+A.+Pauptitauthor=C.+A.+Minshullauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+2%3A+identification+and+optimization+of+substituted+2%2C4-bis+anilino+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DS.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25202%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25202%252C4-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2961%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sanchez-Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumrich, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeHahn, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Considine, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span> </span><span class="NLM_article-title">Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1–CDK4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3835</span><span class="NLM_x">–</span> <span class="NLM_lpage">3839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3835-3839&author=C.+Sanchez-Martinezauthor=C.+Shihauthor=M.+M.+Faulauthor=G.+Zhuauthor=M.+Paalauthor=C.+Somozaauthor=T.+Liauthor=C.+A.+Kumrichauthor=L.+L.+Winneroskiauthor=Z.+Xunauthor=H.+B.+Brooksauthor=B.+K.+Patelauthor=R.+M.+Schultzauthor=T.+B.+DeHahnauthor=C.+D.+Spencerauthor=S.+A.+Watkinsauthor=E.+Considineauthor=J.+A.+Dempseyauthor=C.+A.+Oggauthor=R.+M.+Campbellauthor=B.+A.+Andersonauthor=J.+Wagner&title=Aryl%5Ba%5Dpyrrolo%5B3%2C4-c%5Dcarbazoles+as+selective+cyclin+D1%E2%80%93CDK4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Martinez%26aufirst%3DC.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DPaal%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DKumrich%26aufirst%3DC.%2BA.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DXun%26aufirst%3DZ.%26aulast%3DBrooks%26aufirst%3DH.%2BB.%26aulast%3DPatel%26aufirst%3DB.%2BK.%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26aulast%3DDeHahn%26aufirst%3DT.%2BB.%26aulast%3DSpencer%26aufirst%3DC.%2BD.%26aulast%3DWatkins%26aufirst%3DS.%2BA.%26aulast%3DConsidine%26aufirst%3DE.%26aulast%3DDempsey%26aufirst%3DJ.%2BA.%26aulast%3DOgg%26aufirst%3DC.%2BA.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DAnderson%26aufirst%3DB.%2BA.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DAryl%255Ba%255Dpyrrolo%255B3%252C4-c%255Dcarbazoles%2520as%2520selective%2520cyclin%2520D1%25E2%2580%2593CDK4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3835%26epage%3D3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lik3VpWbgqdhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2371</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049355%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2371-2387&author=S.+N.+VanderWelauthor=P.+J.+Harveyauthor=D.+J.+McNamaraauthor=J.+T.+Repineauthor=P.+R.+Kellerauthor=J.+Quinauthor=R.+J.+Boothauthor=W.+L.+Elliottauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=P.+L.+Toogood&title=Pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+specific+inhibitors+of+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm049355%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049355%252B%26sid%3Dliteratum%253Aachs%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2371%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Beattie, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breault, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midgley, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naven, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minshull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimization of substituted 4,6-bis anilino pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2955</span><span class="NLM_x">–</span> <span class="NLM_lpage">2960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2955-2960&author=J.+F.+Beattieauthor=G.+A.+Breaultauthor=R.+P.+Ellstonauthor=S.+Greenauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+T.+Navenauthor=C.+A.+Minshullauthor=R.+A.+Pauptitauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+1%3A+identification+and+optimization+of+substituted+4%2C6-bis+anilino+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DJ.%2BF.%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DNaven%26aufirst%3DR.%2BT.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25201%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25204%252C6-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2955%26epage%3D2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tap, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gounder, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbone, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ustoyev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2024</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1200%2FJCO.2012.46.5476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=23569312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=2024-2028&author=M.+A.+Dicksonauthor=W.+D.+Tapauthor=M.+L.+Keohanauthor=S.+P.+D%E2%80%99Angeloauthor=M.+M.+Gounderauthor=C.+R.+Antonescuauthor=J.+Landaauthor=L.+X.+Qinauthor=D.+D.+Rathboneauthor=M.+M.+Condyauthor=Y.+Ustoyevauthor=A.+M.+Cragoauthor=S.+Singerauthor=G.+K.+Schwartz&title=Phase+II+trial+of+the+CDK4+inhibitor+PD0332991+in+patients+with+advanced+CDK4-amplified+well-differentiated+or+dedifferentiated+liposarcoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span></div><div class="casAuthors">Dickson, Mark A.; Tap, William D.; Keohan, Mary Louise; D'Angelo, Sandra P.; Gounder, Mrinal M.; Antonescu, Cristina R.; Landa, Jonathan; Qin, Li-Xuan; Rathbone, Dustin D.; Condy, Mercedes M.; Ustoyev, Yelena; Crago, Aimee M.; Singer, Samuel; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2024-2028</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose CDK4 is amplified in > 90% of well-differentiated (WDLS) and dedifferentiated liposarcomas (DDLS).  The selective cyclin-dependent kinase 4 (CDK4)/CDK6 inhibitor PD0332991 inhibits growth and induces senescence in cell lines and xenografts.  In a phase I trial of PD0332991, several patients with WDLS or DDLS experienced prolonged stable disease.  We performed an open-label phase II study to det. the safety and efficacy of PD0332991 in patients with advanced WDLS/DDLS.  Patients and Methods Patients age ≥ 18 years experiencing disease progression while receiving systemic therapy before enrollment received PD0332991 200 mg orally once per day for 14 consecutive days in 21-day cycles.  All were required to have CDK4 amplification by fluorescence in situ hybridization and retinoblastoma protein (RB) expression by immunohistochem. (≥ 1 +).  The primary end point was progression-free survival (PFS) at 12 wk, with 12-wk PFS of ≥ 40% considered promising and ≤ 20% not promising.  If ≥ nine of 28 patients were progression free at 12 wk, PD0332991 would be considered active.  Results We screened 48 patients (44 of 48 had CDK4 amplification; 41 of 44 were RB pos.).  Of those, 30 were enrolled, and 29 were evaluable for the primary end point.  Grade 3 to 4 events included anemia (17%), thrombocytopenia (30%), neutropenia (50%), and febrile neutropenia (3%).  At 12 wk, PFS was 66% (90% CI, 51 % to 100%), significantly exceeding the primary end point.  The median PFS was 18 wk.  There was one partial response.  Conclusion Treatment with the CDK4 inhibitor PD0332991 was assocd. with a favorable progression-free rate in patients with CDK4-amplified and RB-expressing WDLS/DDLS who had progressive disease despite systemic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNBEhZMJmyrVg90H21EOLACvtfcHk0liQu1Em4-vblw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL&md5=d0c2be513ba6cda5014428939c7ec975</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.46.5476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.46.5476%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DKeohan%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DS.%2BP.%26aulast%3DGounder%26aufirst%3DM.%2BM.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLanda%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DL.%2BX.%26aulast%3DRathbone%26aufirst%3DD.%2BD.%26aulast%3DCondy%26aufirst%3DM.%2BM.%26aulast%3DUstoyev%26aufirst%3DY.%26aulast%3DCrago%26aufirst%3DA.%2BM.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DPhase%2520II%2520trial%2520of%2520the%2520CDK4%2520inhibitor%2520PD0332991%2520in%2520patients%2520with%2520advanced%2520CDK4-amplified%2520well-differentiated%2520or%2520dedifferentiated%2520liposarcoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D2024%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cadoo, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gucalp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traina, T. A.</span><span> </span><span class="NLM_article-title">Palbociclib: an evidence-based review of its potential in the treatment of breast cancer</span> <span class="citation_source-journal">Breast Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=123-133&author=K.+A.+Cadooauthor=A.+Gucalpauthor=T.+A.+Traina&title=Palbociclib%3A+an+evidence-based+review+of+its+potential+in+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCadoo%26aufirst%3DK.%2BA.%26aulast%3DGucalp%26aufirst%3DA.%26aulast%3DTraina%26aufirst%3DT.%2BA.%26atitle%3DPalbociclib%253A%2520an%2520evidence-based%2520review%2520of%2520its%2520potential%2520in%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%26date%3D2014%26volume%3D6%26spage%3D123%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gelbert, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Prado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallena, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajamie, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreklau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Dios, A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1007%2Fs10637-014-0120-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=24919854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWrt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=825-837&author=L.+M.+Gelbertauthor=S.+Caiauthor=X.+Linauthor=C.+Sanchez-Martinezauthor=M.+Del+Pradoauthor=M.+J.+Lallenaauthor=R.+Torresauthor=R.+T.+Ajamieauthor=G.+N.+Wishartauthor=R.+S.+Flackauthor=B.+L.+Neubauerauthor=J.+Youngauthor=E.+M.+Chanauthor=P.+Iversenauthor=D.+Cronierauthor=E.+Kreklauauthor=A.+de+Dios&title=Preclinical+characterization+of+the+CDK4%2F6+inhibitor+LY2835219%3A+in-vivo+cell+cycle-dependent%2Findependent+anti-tumor+activities+alone%2Fin+combination+with+gemcitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine</span></div><div class="casAuthors">Gelbert, Lawrence M.; Cai, Shufen; Lin, Xi; Sanchez-Martinez, Concepcion; del Prado, Miriam; Lallena, Maria Jose; Torres, Raquel; Ajamie, Rose T.; Wishart, Graham N.; Flack, Robert Steven; Neubauer, Blake Lee; Young, Jamie; Chan, Edward M.; Iversen, Philip; Cronier, Damien; Kreklau, Emiko; de Dios, Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">825-837</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The G1 restriction point is crit. for regulating the cell cycle and is controlled by the Rb pathway (CDK4/6-cyclin D1-Rb-p16/ink4a).  This pathway is important because of its inactivation in a majority of human tumors.  Transition through the restriction point requires phosphorylation of retinoblastoma protein (Rb) by CDK4/6, which are highly validated cancer drug targets.  We present the identification and characterization of a potent CDK4/6 inhibitor, LY2835219.  LY2835219 inhibits CDK4 and CDK6 with low nanomolar potency, inhibits Rb phosphorylation resulting in a G1 arrest and inhibition of proliferation, and its activity is specific for Rb-proficient cells.  In vivo target inhibition studies show LY2835219 is a potent inhibitor of Rb phosphorylation, induces a complete cell cycle arrest and suppresses expression of several Rb-E2F-regulated proteins 24 h after a single dose.  Oral administration of LY2835219 inhibits tumor growth in human tumor xenografts representing different histologies in tumor-bearing mice.  LY2835219 is effective and well tolerated when administered up to 56 days in immunodeficient mice without significant loss of body wt. or tumor outgrowth.  In calu-6 xenografts, LY2835219 in combination with gemcitabine enhanced in vivo antitumor activity without a G1 cell cycle arrest, but was assocd. with a redn. of ribonucleotide reductase expression.  These results suggest LY2835219 may be used alone or in combination with std.-of-care cytotoxic therapy.  In summary, we have identified a potent, orally active small-mol. inhibitor of CDK4/6 that is active in xenograft tumors.  LY2835219 is currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQrFS1mDbyCrVg90H21EOLACvtfcHk0lidsAE_V3SIFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWrt7%252FN&md5=a90fee83bfe8da7e4a7474ccf02fc59a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10637-014-0120-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-014-0120-7%26sid%3Dliteratum%253Aachs%26aulast%3DGelbert%26aufirst%3DL.%2BM.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DSanchez-Martinez%26aufirst%3DC.%26aulast%3DDel%2BPrado%26aufirst%3DM.%26aulast%3DLallena%26aufirst%3DM.%2BJ.%26aulast%3DTorres%26aufirst%3DR.%26aulast%3DAjamie%26aufirst%3DR.%2BT.%26aulast%3DWishart%26aufirst%3DG.%2BN.%26aulast%3DFlack%26aufirst%3DR.%2BS.%26aulast%3DNeubauer%26aufirst%3DB.%2BL.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DIversen%26aufirst%3DP.%26aulast%3DCronier%26aufirst%3DD.%26aulast%3DKreklau%26aufirst%3DE.%26aulast%3Dde%2BDios%26aufirst%3DA.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520CDK4%252F6%2520inhibitor%2520LY2835219%253A%2520in-vivo%2520cell%2520cycle-dependent%252Findependent%2520anti-tumor%2520activities%2520alone%252Fin%2520combination%2520with%2520gemcitabine%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2014%26volume%3D32%26spage%3D825%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcastro, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diskin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parasuraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caponigro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnepp, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6173</span><span class="NLM_x">–</span> <span class="NLM_lpage">6182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1158%2F1078-0432.CCR-13-1675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=24045179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6173-6182&author=J.+Raderauthor=M.+R.+Russellauthor=L.+S.+Hartauthor=M.+S.+Nakazawaauthor=L.+T.+Belcastroauthor=D.+Martinezauthor=Y.+Liauthor=E.+L.+Carpenterauthor=E.+F.+Attiyehauthor=S.+J.+Diskinauthor=S.+Kimauthor=S.+Parasuramanauthor=G.+Caponigroauthor=R.+W.+Schneppauthor=A.+C.+Woodauthor=B.+Pawelauthor=K.+A.+Coleauthor=J.+M.+Maris&title=Dual+CDK4%2FCDK6+inhibition+induces+cell-cycle+arrest+and+senescence+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma</span></div><div class="casAuthors">Rader, JulieAnn; Russell, Mike R.; Hart, Lori S.; Nakazawa, Michael S.; Belcastro, Lili T.; Martinez, Daniel; Li, Yimei; Carpenter, Erica L.; Attiyeh, Edward F.; Diskin, Sharon J.; Kim, Sunkyu; Parasuraman, Sudha; Caponigro, Giordano; Schnepp, Robert W.; Wood, Andrew C.; Pawel, Bruce; Cole, Kristina A.; Maris, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6173-6182</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Neuroblastoma is a pediatric cancer that continues to exact significant morbidity and mortality.  Recently, a no. of cell-cycle proteins, particularly those within the Cyclin D/CDK4/CDK6/RB network, have been shown to exert oncogenic roles in neuroblastoma, suggesting that their therapeutic exploitation might improve patient outcomes.  Exptl. Procedures: We evaluated the effect of dual CDK4/CDK6 inhibition on neuroblastoma viability using LEE011 (Novartis Oncol.), a highly specific CDK4/6 inhibitor.  Results: Treatment with LEE011 significantly reduced proliferation in 12 of 17 human neuroblastoma-derived cell lines by inducing cytostasis at nanomolar concns. (mean IC50 = 307 ± 68 nmol/L in sensitive lines).  LEE011 caused cell-cycle arrest and cellular senescence that was attributed to dose-dependent decreases in phosphorylated RB and FOXM1, resp.  In addn., responsiveness of neuroblastoma xenografts to LEE011 translated to the in vivo setting in that there was a direct correlation of in vitro IC50 values with degree of s.c. xenograft growth delay.  Although our data indicate that neuroblastomas sensitive to LEE011 were more likely to contain genomic amplification of MYCN (P = 0.01), the identification of addnl. clin. accessible biomarkers is of high importance.  Conclusions: Taken together, our data show that LEE011 is active in a large subset of neuroblastoma cell line and xenograft models, and supports the clin. development of this CDK4/6 inhibitor as a therapy for patients with this disease.  Clin Cancer Res; 19(22); 6173-82. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowEpLsvDNwSLVg90H21EOLACvtfcHk0lgJLyXnuL3TnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7rL&md5=5fd1f23125cca7e087d0e14d4c66c3c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1675%26sid%3Dliteratum%253Aachs%26aulast%3DRader%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DM.%2BR.%26aulast%3DHart%26aufirst%3DL.%2BS.%26aulast%3DNakazawa%26aufirst%3DM.%2BS.%26aulast%3DBelcastro%26aufirst%3DL.%2BT.%26aulast%3DMartinez%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCarpenter%26aufirst%3DE.%2BL.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DDiskin%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DParasuraman%26aufirst%3DS.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DSchnepp%26aufirst%3DR.%2BW.%26aulast%3DWood%26aufirst%3DA.%2BC.%26aulast%3DPawel%26aufirst%3DB.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DDual%2520CDK4%252FCDK6%2520inhibition%2520induces%2520cell-cycle%2520arrest%2520and%2520senescence%2520in%2520neuroblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6173%26epage%3D6182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Segraves, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Said, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietraszkiewicz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeriote, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, P.</span><span> </span><span class="NLM_article-title">Comparison of fascaplysin and related alkaloids: a study of structures, cytotoxicities, and sources</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span></span><div class="citationLinks">[<a href="/doi/10.1021/np049935%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVSqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=783-792&author=N.+L.+Segravesauthor=S.+J.+Robinsonauthor=D.+Garciaauthor=S.+A.+Saidauthor=X.+Fuauthor=F.+J.+Schmitzauthor=H.+Pietraszkiewiczauthor=F.+A.+Valerioteauthor=P.+Crews&title=Comparison+of+fascaplysin+and+related+alkaloids%3A+a+study+of+structures%2C+cytotoxicities%2C+and+sources"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of fascaplysin and related alkaloids: A study of structures, cytotoxicities, and sources</span></div><div class="casAuthors">Segraves, Nathaniel L.; Robinson, Sarah J.; Garcia, Daniel; Said, Sadri A.; Fu, Xiong; Schmitz, Francis J.; Pietraszkiewicz, Halina; Valeriote, Frederick A.; Crews, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fascaplysin class of compds. have been further investigated from six organisms consisting of four sponge collections (Fascaplysinopsis reticulata) and two tunicate collections (Didemnum sp.).  This work is an extension of an earlier communication and reports the isolation of 12 new fascaplysin derivs.: 10-bromofascaplysin, 3,10-dibromofascaplysin, homofascaplysate A , homofascaplysin B-1, 3-bromohomofascaplysins B, B-1, and C, 7,14-dibromoreticulatine , reticulatol, 14-bromoreticulatol, and 3-bromosecofascaplysins A and B, along with known compds.: fascaplysin, reticulatine, 3-bromofascaplysin, and homofascaplysin C.  Selected compds. were screened in a cell-based cytotoxicity assay with compds. fascaplysin, 3-bromofascaplysin, and fascaplysin A also screened in the NCI 60 cell line panel.  A biogenetic pathway for the brominated fascaplysins and brominated related alkaloids is proposed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvi-WY3GdExLVg90H21EOLACvtfcHk0lgJLyXnuL3TnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVSqs7g%253D&md5=6b6e947c135a9ebe94ba32fbbd15008e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fnp049935%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049935%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSegraves%26aufirst%3DN.%2BL.%26aulast%3DRobinson%26aufirst%3DS.%2BJ.%26aulast%3DGarcia%26aufirst%3DD.%26aulast%3DSaid%26aufirst%3DS.%2BA.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DSchmitz%26aufirst%3DF.%2BJ.%26aulast%3DPietraszkiewicz%26aufirst%3DH.%26aulast%3DValeriote%26aufirst%3DF.%2BA.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DComparison%2520of%2520fascaplysin%2520and%2520related%2520alkaloids%253A%2520a%2520study%2520of%2520structures%252C%2520cytotoxicities%252C%2520and%2520sources%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D783%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bharate, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mupparapu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwakarma, R. A.</span><span> </span><span class="NLM_article-title">Chemistry and biology of fascaplysin, a potent marine-derived CDK-4 inhibitor</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=650-664&author=S.+B.+Bharateauthor=S.+Mandaauthor=N.+Mupparapuauthor=N.+Battiniauthor=R.+A.+Vishwakarma&title=Chemistry+and+biology+of+fascaplysin%2C+a+potent+marine-derived+CDK-4+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBharate%26aufirst%3DS.%2BB.%26aulast%3DManda%26aufirst%3DS.%26aulast%3DMupparapu%26aufirst%3DN.%26aulast%3DBattini%26aufirst%3DN.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DChemistry%2520and%2520biology%2520of%2520fascaplysin%252C%2520a%2520potent%2520marine-derived%2520CDK-4%2520inhibitor%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D650%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bharate, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwakarma, R. A.</span><span> </span><span class="NLM_article-title">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1039%2Fc2md20076g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1098-1103&author=S.+B.+Bharateauthor=S.+Mandaauthor=P.+Joshiauthor=B.+Singhauthor=R.+A.+Vishwakarma&title=Total+synthesis+and+anti-cholinesterase+activity+of+marine-derived+bis-indole+alkaloid+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fc2md20076g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20076g%26sid%3Dliteratum%253Aachs%26aulast%3DBharate%26aufirst%3DS.%2BB.%26aulast%3DManda%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DTotal%2520synthesis%2520and%2520anti-cholinesterase%2520activity%2520of%2520marine-derived%2520bis-indole%2520alkaloid%2520fascaplysin%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1098%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hamilton, G.</span><span> </span><span class="NLM_article-title">Cytotoxic effects of fascaplysin against small cell lung cancer cell lines</span> <span class="citation_source-journal">Mar. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.3390%2Fmd12031377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=24608973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A280%3ADC%252BC2crhs1Clsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1377-1389&author=G.+Hamilton&title=Cytotoxic+effects+of+fascaplysin+against+small+cell+lung+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of fascaplysin against small cell lung cancer cell lines</span></div><div class="casAuthors">Hamilton Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Marine drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1377-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fascaplysin, the natural product of a marine sponge, exhibits anticancer activity against a broad range of tumor cells, presumably through interaction with DNA, and/or as a highly selective cyclin-dependent kinase 4 (CDK4) inhibitor.  In this study, cytotoxic activity of fascaplysin against a panel of small cell lung cancer (SCLC) cell lines and putative synergism with chemotherapeutics was investigated.  SCLC responds to first-line chemotherapy with platinum-based drugs/etoposide, but relapses early with topotecan remaining as the single approved therapeutic agent.  Fascaplysin was found to show high cytotoxicity against SCLC cells and to induce cell cycle arrest in G1/0 at lower and S-phase at higher concentrations, respectively.  The compound generated reactive oxygen species (ROS) and induced apoptotic cell death in the chemoresistant NCI-H417 SCLC cell line.  Furthermore, fascaplysin revealed marked synergism with the topoisomerase I-directed camptothecin and 10-hydroxy-camptothecin.  The Poly(ADP-ribose)-Polymerase 1 (PARP1) inhibitor BYK 204165 antagonized the cytotoxic activity of fascaplysin, pointing to the involvement of DNA repair in response to the anticancer activity of the drug.  In conclusion, fascaplysin seems to be suitable for treatment of SCLC, based on high cytotoxic activity through multiple routes of action, affecting topoisomerase I, integrity of DNA and generation of ROS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSy9ppxZfx-fFHFYivNCdPRfW6udTcc2eaOalTvVINmWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhs1Clsg%253D%253D&md5=59292fc6adb9bcb2640d82907f0b95ef</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fmd12031377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd12031377%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DG.%26atitle%3DCytotoxic%2520effects%2520of%2520fascaplysin%2520against%2520small%2520cell%2520lung%2520cancer%2520cell%2520lines%26jtitle%3DMar.%2520Drugs%26date%3D2014%26volume%3D12%26spage%3D1377%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, P.</span><span> </span><span class="NLM_article-title">Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.ejps.2011.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=21569843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=251-259&author=X.+Yanauthor=H.+Chenauthor=X.+Luauthor=F.+Wangauthor=W.+Xuauthor=H.+Jinauthor=P.+Zhu&title=Fascaplysin+exert+anti-tumor+effects+through+apoptotic+and+anti-angiogenesis+pathways+in+sarcoma+mice+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model</span></div><div class="casAuthors">Yan, Xiaojun; Chen, Haimin; Lu, Xiaoling; Wang, Feng; Xu, Weifeng; Jin, Haixiao; Zhu, Peng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-259</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies indicated that fascaplysin derived from marine sponge can induce tumor cell death by apoptosis and possesses anti-angiogenesis activity.  In order to verify these 2 effects in animal model and to identify action mechanisms, we established a sarcoma mice model, and treated mice with fascaplysin for 10 days.  The tumor tissues were examd. morphol. and immunohistochem.  The differential gene expression was also investigated by mRNA array.  Fascaplysin treatment resulted in a significant suppression of tumor growth.  Typical apoptotic phenomena were obsd. by transmission electron microscope and histol. detection.  Tissue sections were stained with monoclonal antibody directed to proliferating cell nuclear antigen (PCNA) and CD31.  The decreased PCNA and CD31 antigen staining indicate the redn. of tumor cell proliferation and tumor vasculature property of fascaplysin in vivo.  Microarrays were used to examine the gene expression profiles of tumors on CapitalBio mouse genome oligo array.  The regulated genes analyzed from the expression level showed overlapping gene ontol. (GO) categories and pathway mapping.  These findings indicate that cell cycle arrest, apoptosis, regulation of actin cytoskeleton, and cell adhesion all play important roles in the onset of fascaplysin.  Detailed anal. by real time PCR of key genes confirmed the exptl. results of microarrays.  From these findings, it can be considered that fascaplysin can inhibit the growth of S180 cell implanted tumor, and the action mechanisms may involve in apoptosis, anti-angiogenesis, or cell cycle arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo543O3ShB2BrVg90H21EOLACvtfcHk0litzHLEA46Euw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejs7k%253D&md5=03c9178e9e35a6abbb98443c307a326b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2011.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2011.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DP.%26atitle%3DFascaplysin%2520exert%2520anti-tumor%2520effects%2520through%2520apoptotic%2520and%2520anti-angiogenesis%2520pathways%2520in%2520sarcoma%2520mice%2520model%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D43%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Shafiq, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R.</span><span> </span><span class="NLM_article-title">Fascaplysin as a specific inhibitor for CDK4: insights from molecular modelling</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e42612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e42612&author=M.+I.+Shafiqauthor=T.+Steinbrecherauthor=R.+Schmid&title=Fascaplysin+as+a+specific+inhibitor+for+CDK4%3A+insights+from+molecular+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShafiq%26aufirst%3DM.%2BI.%26aulast%3DSteinbrecher%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DR.%26atitle%3DFascaplysin%2520as%2520a%2520specific%2520inhibitor%2520for%2520CDK4%253A%2520insights%2520from%2520molecular%2520modelling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De42612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingston, D. G.</span><span> </span><span class="NLM_article-title">Sesterterpenoids and an alkaloid from a <i>Thorectandra</i> sp. as inhibitors of the phosphatase Cdc25B</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5094</span><span class="NLM_x">–</span> <span class="NLM_lpage">5098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=5094-5098&author=S.+Caoauthor=C.+Fosterauthor=J.+S.+Lazoauthor=D.+G.+Kingston&title=Sesterterpenoids+and+an+alkaloid+from+a+Thorectandra+sp.+as+inhibitors+of+the+phosphatase+Cdc25B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DKingston%26aufirst%3DD.%2BG.%26atitle%3DSesterterpenoids%2520and%2520an%2520alkaloid%2520from%2520a%2520Thorectandra%2520sp.%2520as%2520inhibitors%2520of%2520the%2520phosphatase%2520Cdc25B%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D5094%26epage%3D5098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kirsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminsky, R.</span><span> </span><span class="NLM_article-title">A new bioactive sesterterpene and antiplasmodial alkaloids from the marine sponge <i>Hyrtios cf. erecta</i></span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks">[<a href="/doi/10.1021/np990555b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2000&pages=825-829&author=G.+Kirschauthor=G.+M.+Kongauthor=A.+D.+Wrightauthor=R.+Kaminsky&title=A+new+bioactive+sesterterpene+and+antiplasmodial+alkaloids+from+the+marine+sponge+Hyrtios+cf.+erecta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp990555b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp990555b%26sid%3Dliteratum%253Aachs%26aulast%3DKirsch%26aufirst%3DG.%26aulast%3DKong%26aufirst%3DG.%2BM.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DKaminsky%26aufirst%3DR.%26atitle%3DA%2520new%2520bioactive%2520sesterterpene%2520and%2520antiplasmodial%2520alkaloids%2520from%2520the%2520marine%2520sponge%2520Hyrtios%2520cf.%2520erecta%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2000%26volume%3D63%26spage%3D825%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Charan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Cytotoxic alkaloids from the marine sponge <i>Thorectandra</i> sp</span> <span class="citation_source-journal">Nat. Prod. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1080%2F14786410310001622077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15143832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFCisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=225-229&author=R.+D.+Charanauthor=T.+C.+McKeeauthor=M.+R.+Boyd&title=Cytotoxic+alkaloids+from+the+marine+sponge+Thorectandra+sp"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic alkaloids from the marine sponge Thorectandra sp.</span></div><div class="casAuthors">Charan, Romila D.; McKee, Tawnya C.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-229</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Three β-carboline alkaloids, Compd. (I), 1-deoxysecofascaplysin A (II), and fascaplysine, were isolated from the aq. and org. exts. of the marine sponge Thorectandra sp.  The structures of I and II were detd. on the basis of spectral data.  Compd. I inhibited the growth of MCF-7 (breast) with an IC50 of 5.9 μg/mL while Compd. II inhibited the growth of MCF-7 as well as OVCAR-3 (ovarian) human tumor cell lines with IC50s of 1.5 and 2.2 μg/mL, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_TBR6dguoIrVg90H21EOLACvtfcHk0lhD_NpHPD8COw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFCisLc%253D&md5=dedfaf73b4d5398baaaf42943b56280b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F14786410310001622077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786410310001622077%26sid%3Dliteratum%253Aachs%26aulast%3DCharan%26aufirst%3DR.%2BD.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DCytotoxic%2520alkaloids%2520from%2520the%2520marine%2520sponge%2520Thorectandra%2520sp%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2004%26volume%3D18%26spage%3D225%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hormann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span> </span><span class="NLM_article-title">DNA binding properties of the marine sponge pigment fascaplysin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=917-921&author=A.+Hormannauthor=B.+Chaudhuriauthor=H.+Fretz&title=DNA+binding+properties+of+the+marine+sponge+pigment+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHormann%26aufirst%3DA.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DFretz%26aufirst%3DH.%26atitle%3DDNA%2520binding%2520properties%2520of%2520the%2520marine%2520sponge%2520pigment%2520fascaplysin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D9%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">1696</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1696-1697&author=C.+Aubryauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffe&title=New+fascaplysin-based+CDK4-specific+inhibitors%3A+design%2C+synthesis+and+biological+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DNew%2520fascaplysin-based%2520CDK4-specific%2520inhibitors%253A%2520design%252C%2520synthesis%2520and%2520biological%2520activity%26jtitle%3DChem.%2520Commun.%26date%3D2004%26spage%3D1696%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maréchal, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span> </span><span class="NLM_article-title">The design and synthesis of novel 3-[2-indol-1-yl-ethyl]-1<i>H</i>-indole derivatives as selective inhibitors of CDK4</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1423-1425&author=C.+Aubryauthor=A.+Patelauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.-D.+Mar%C3%A9chalauthor=M.+J.+Sutcliffeauthor=P.+R.+Jenkins&title=The+design+and+synthesis+of+novel+3-%5B2-indol-1-yl-ethyl%5D-1H-indole+derivatives+as+selective+inhibitors+of+CDK4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMar%25C3%25A9chal%26aufirst%3DJ.-D.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520novel%25203-%255B2-indol-1-yl-ethyl%255D-1H-indole%2520derivatives%2520as%2520selective%2520inhibitors%2520of%2520CDK4%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D1423%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=787-801&author=C.+Aubryauthor=A.+J.+Wilsonauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffe&title=Design%2C+synthesis+and+biological+activity+of+new+CDK4-specific+inhibitors%2C+based+on+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520new%2520CDK4-specific%2520inhibitors%252C%2520based%2520on%2520fascaplysin%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin</span> <span class="citation_source-journal">Bioorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.bioorg.2006.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16904725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Ohur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=287-297&author=S.+Mahaleauthor=C.+Aubryauthor=P.+R.+Jenkinsauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffeauthor=B.+Chaudhuri&title=Inhibition+of+cancer+cell+growth+by+cyclin+dependent+kinase+4+inhibitors+synthesized+based+on+the+structure+of+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin</span></div><div class="casAuthors">Mahale, Sachin; Aubry, Carine; Jenkins, Paul R.; Marechal, Jean-Didier; Sutcliffe, Michael J.; Chaudhuri, Bhabatosh</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tryptamine derivs., a new structural class of cyclin dependent kinase 4 inhibitors, have been identified during extensive biol. screening of synthetic mols.  The mols. were synthesized based on the structure of fascaplysin, which is not only a specific inhibitor of the Cdk4-cyclin D1 enzyme but also a relatively toxic mol., probably because it binds and intercalates DNA.  Interestingly, the new structural analogs of fascaplysin do not interact or intercalate with double-stranded DNA, although they inhibit Cdk4-cyclin D1 specifically.  We found that compd. CA199 was the most potent mol., showing at least 25-fold specificity towards Cdk4-cyclin D1 (IC50 for Cdk4-cyclin D1=20 μM, Cdk2>500 μM).  CA199 inhibits the growth of different cancer cell lines at concns. ranging from 10-40 μM.  It blocks growth of asynchronous cells at G0/G1 in a retinoblastoma protein (pRb) dependent manner.  Moreover, CA199 blocks growth only at early G1 in synchronized cells released from a mimosine-induced G1/S block.  These observations are reminiscent of a true Cdk4 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDM1ujQ5HiPbVg90H21EOLACvtfcHk0lhaRrnsLBnWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Ohur4%253D&md5=7c70789d1743071825a55417dc85f282</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2006.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2006.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520cancer%2520cell%2520growth%2520by%2520cyclin%2520dependent%2520kinase%25204%2520inhibitors%2520synthesized%2520based%2520on%2520the%2520structure%2520of%2520fascaplysin%26jtitle%3DBioorg.%2520Chem.%26date%3D2006%26volume%3D34%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4272</span><span class="NLM_x">–</span> <span class="NLM_lpage">4278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4272-4278&author=S.+Mahaleauthor=C.+Aubryauthor=A.+James+Wilsonauthor=P.+R.+Jenkinsauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffeauthor=B.+Chaudhuri&title=CA224%2C+a+non-planar+analogue+of+fascaplysin%2C+inhibits+Cdk4+but+not+Cdk2+and+arrests+cells+at+G0%2FG1+inhibiting+pRB+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DJames%2BWilson%26aufirst%3DA.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DCA224%252C%2520a%2520non-planar%2520analogue%2520of%2520fascaplysin%252C%2520inhibits%2520Cdk4%2520but%2520not%2520Cdk2%2520and%2520arrests%2520cells%2520at%2520G0%252FG1%2520inhibiting%2520pRB%2520phosphorylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4272%26epage%3D4278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hastie, S. B.</span><span> </span><span class="NLM_article-title">Interactions of colchicine with tubulin</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2F0163-7258%2891%2990067-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=1792241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaK38Xht1ShsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=377-401&author=S.+B.+Hastie&title=Interactions+of+colchicine+with+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of colchicine with tubulin</span></div><div class="casAuthors">Hastie, Susan Bane</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-401</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼230 refs.  Colchicine exerts its biol. effects through binding to the sol. tubulin heterodimer, the major component of the microtubule.  The colchicine-binding abilities of tubulins from a variety of sources are summarized, and the mechanism of colchicine binding to brain tubulin is explored in depth.  The relationship between colchicinoid structure and tubulin binding activity provides insight into the structural features of colchicine responsible for high affinity binding to tubulin and is reviewed for analogs in the colchicine series.  The thermodn. and kinetic aspects of the assocn. are described and evaluated in terms of the binding mechanism.  Colchicine binding to tubulin results in unusual alterations in the low energy electronic spectra of colchicine.  The spectroscopic features of colchicine bound to tubulin are discussed in terms of the nature of the colchicine-tubulin complex.  Attempts to locate the high affinity colchicine binding site on tubulin are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJ1hpeu3pB7Vg90H21EOLACvtfcHk0lhaRrnsLBnWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1ShsLw%253D&md5=13a53c4b603f19fa2d1f1464782b11fc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2891%2990067-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252891%252990067-V%26sid%3Dliteratum%253Aachs%26aulast%3DHastie%26aufirst%3DS.%2BB.%26atitle%3DInteractions%2520of%2520colchicine%2520with%2520tubulin%26jtitle%3DPharmacol.%2520Ther.%26date%3D1991%26volume%3D51%26spage%3D377%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrzanowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suffness, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverton, J.</span><span> </span><span class="NLM_article-title">Colchicine and its analogues: recent findings</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1002%2Fmed.2610080105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=3278182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVGks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1988&pages=77-94&author=A.+Brossiauthor=H.+J.+Yehauthor=M.+Chrzanowskaauthor=J.+Wolffauthor=E.+Hamelauthor=C.+M.+Linauthor=F.+Quinauthor=M.+Suffnessauthor=J.+Silverton&title=Colchicine+and+its+analogues%3A+recent+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Colchicine and its analogs:  recent findings</span></div><div class="casAuthors">Brossi, Arnold; Yeh, Herman J. C.; Chrzanowska, Maria; Wolff, J.; Hamel, Ernest; Lin, Chii M.; Quin, Frank; Suffness, Matthew; Silverton, James</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-94</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review with 61 refs. examg. the binding of colchicine and its analogs to tubulin proteins, NMR studies of phenyl-tropolone atropisomerism in such binding, x-ray anal. of colchicinoids, the antitumor and anti-inflammatory activities of colchicinoids, and the prepn. and formation of colchicine analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH6IqwYcoiKLVg90H21EOLACvtfcHk0li-ZK6jA93u4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVGks7c%253D&md5=1dc2d7f97b2c8735c6fa7a9e405151eb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610080105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610080105%26sid%3Dliteratum%253Aachs%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DYeh%26aufirst%3DH.%2BJ.%26aulast%3DChrzanowska%26aufirst%3DM.%26aulast%3DWolff%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DQuin%26aufirst%3DF.%26aulast%3DSuffness%26aufirst%3DM.%26aulast%3DSilverton%26aufirst%3DJ.%26atitle%3DColchicine%2520and%2520its%2520analogues%253A%2520recent%2520findings%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1988%26volume%3D8%26spage%3D77%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bhattacharyya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, M.</span><span> </span><span class="NLM_article-title">Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1002%2Fmed.20097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=17464966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=155-183&author=B.+Bhattacharyyaauthor=D.+Pandaauthor=S.+Guptaauthor=M.+Banerjee&title=Anti-mitotic+activity+of+colchicine+and+the+structural+basis+for+its+interaction+with+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin</span></div><div class="casAuthors">Bhattacharyya, Bhabatarak; Panda, Dulal; Gupta, Suvroma; Banerjee, Mithu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-183</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In this review, an attempt has been made to throw light on the mechanism of action of colchicine and its different analogs as anti-cancer agents.  Colchicine interacts with tubulin and perturbs the assembly dynamics of microtubules.  Though its use has been limited because of its toxicity, colchicine can still be used as a lead compd. for the generation of potent anti-cancer drugs.  Colchicine binds to tubulin in a poorly reversible manner with high activation energy.  The binding interaction is favored entropically.  In contrast, binding of its simple analogs AC or DAAC is enthalpically favored and commences with comparatively low activation energy.  Colchicine-tubulin interaction, which is normally pH dependent, has been found to be independent of pH in the presence of microtubule-assocd. proteins, salts or upon cleavage of carboxy termini of tubulin.  Biphasic kinetics of colchicines-tubulin interaction has been explained in light of the variation in the residues around the drug-binding site on β-tubulin.  Using the crystal structure of the tubulin-DAMAcolchicine complex, a detailed discussion on the pharmacophore concept that explains the variation of affinity for different colchicine site inhibitors (CSI) has been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9F4KA4GVMr7Vg90H21EOLACvtfcHk0li-ZK6jA93u4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D&md5=720f26c98a40dd91634dbe558d982e98</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fmed.20097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20097%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DB.%26aulast%3DPanda%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DM.%26atitle%3DAnti-mitotic%2520activity%2520of%2520colchicine%2520and%2520the%2520structural%2520basis%2520for%2520its%2520interaction%2520with%2520tubulin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D155%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Judge, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakoli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fronda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambegia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClintock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLachlan, I.</span><span> </span><span class="NLM_article-title">Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1172%2FJCI37515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=19229107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2ktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=661-673&author=A.+D.+Judgeauthor=M.+Robbinsauthor=I.+Tavakoliauthor=J.+Leviauthor=L.+Huauthor=A.+Frondaauthor=E.+Ambegiaauthor=K.+McClintockauthor=I.+MacLachlan&title=Confirming+the+RNAi-mediated+mechanism+of+action+of+siRNA-based+cancer+therapeutics+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice</span></div><div class="casAuthors">Judge, Adam D.; Robbins, Marjorie; Tavakoli, Iran; Levi, Jasna; Hu, Lina; Fronda, Anna; Ambegia, Ellen; McClintock, Kevin; MacLachlan, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-673</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">SiRNAs that specifically silence the expression of cancer-related genes offer a therapeutic approach in oncol.  However, it remains crit. to det. the true mechanism of their therapeutic effects.  Here, we describe the preclin. development of chem. modified siRNA targeting the essential cell-cycle proteins polo-like kinase 1 (PLK1) and kinesin spindle protein (KSP) in mice.  SiRNA formulated in stable nucleic acid lipid particles (SNALP) displayed potent antitumor efficacy in both hepatic and s.c. tumor models.  This was correlated with target gene silencing following a single i.v. administration that was sufficient to cause extensive mitotic disruption and tumor cell apoptosis.  Our siRNA formulations induced no measurable immune response, minimizing the potential for nonspecific effects.  Addnl., RNAi-specific mRNA cleavage products were found in tumor cells, and their presence correlated with the duration of target mRNA silencing.  Histol. biomarkers confirmed that RNAi-mediated gene silencing effectively inhibited the target's biol. activity.  This report supports an RNAi-mediated mechanism of action for siRNA antitumor effects, suggesting a new methodol. for targeting other key genes in cancer development with siRNA-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqfVQCE9Q37Vg90H21EOLACvtfcHk0li-ZK6jA93u4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2ktLc%253D&md5=4ed79a06421ab2c0eba797f7b4e40518</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1172%2FJCI37515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI37515%26sid%3Dliteratum%253Aachs%26aulast%3DJudge%26aufirst%3DA.%2BD.%26aulast%3DRobbins%26aufirst%3DM.%26aulast%3DTavakoli%26aufirst%3DI.%26aulast%3DLevi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DFronda%26aufirst%3DA.%26aulast%3DAmbegia%26aufirst%3DE.%26aulast%3DMcClintock%26aufirst%3DK.%26aulast%3DMacLachlan%26aufirst%3DI.%26atitle%3DConfirming%2520the%2520RNAi-mediated%2520mechanism%2520of%2520action%2520of%2520siRNA-based%2520cancer%2520therapeutics%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D661%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span> </span><span class="NLM_article-title">Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2FS1074-5521%2801%2900097-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=11841942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtF2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=93-101&author=M.+A.+Jordanauthor=I.+Ojimaauthor=F.+Rosasauthor=M.+Distefanoauthor=L.+Wilsonauthor=G.+Scambiaauthor=C.+Ferlini&title=Effects+of+novel+taxanes+SB-T-1213+and+IDN5109+on+tubulin+polymerization+and+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Novel Taxanes SB-T-1213 and IDN5109 on Tubulin Polymerization and Mitosis</span></div><div class="casAuthors">Jordan, Mary Ann; Ojima, Iwao; Rosas, Francisco; Distefano, Mariagrazia; Wilson, Leslie; Scambia, Giovanni; Ferlini, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">SB-T-1213 and IDN5109 are semisynthetic, orally available taxanes that are up to 400-fold more active than paclitaxel against drug-resistant cells.  IDN5109 is in clin. trials.  We investigated the primary target for SB-T-1213 and IDN5109 and whether the compds. interact with microtubules differently than paclitaxel.  Unlike paclitaxel, at 1-10 μM both novel taxanes initiate microtubule polymn. in vitro with no lag.  They enhance polymn. equally or more potently than paclitaxel.  SB-T-1213 induces unusual microtubules with attached extra protofilaments or open sheets, and IDN5109 induces large protofilamentous sheets.  Both inhibit HeLa cell proliferation, block mitosis at the metaphase/anaphase transition, bundle microtubules at high drug concns., and induce abnormal metaphase spindles and apoptosis.  They target microtubules but alter their polymn. and structure differently than paclitaxel.  These differences may play a role in their enhanced cytotoxicity and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRgPoAecBPO7Vg90H21EOLACvtfcHk0liQm5n-j9vHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtF2isbw%253D&md5=936f9ddc6e9d551de108dc809f785265</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900097-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900097-7%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DOjima%26aufirst%3DI.%26aulast%3DRosas%26aufirst%3DF.%26aulast%3DDistefano%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DScambia%26aufirst%3DG.%26aulast%3DFerlini%26aufirst%3DC.%26atitle%3DEffects%2520of%2520novel%2520taxanes%2520SB-T-1213%2520and%2520IDN5109%2520on%2520tubulin%2520polymerization%2520and%2520mitosis%26jtitle%3DChem.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timasheff, S. N.</span><span> </span><span class="NLM_article-title">In vitro reconstitution of calf brain microtubules: effects of solution variables</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1754</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00627a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1977&pages=1754-1764&author=J.+C.+Leeauthor=S.+N.+Timasheff&title=In+vitro+reconstitution+of+calf+brain+microtubules%3A+effects+of+solution+variables"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbi00627a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00627a037%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTimasheff%26aufirst%3DS.%2BN.%26atitle%3DIn%2520vitro%2520reconstitution%2520of%2520calf%2520brain%2520microtubules%253A%2520effects%2520of%2520solution%2520variables%26jtitle%3DBiochemistry%26date%3D1977%26volume%3D16%26spage%3D1754%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Sandra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendarmin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Inhibition of Akt and MAPK pathways elevated potential of TNFalpha in inducing apoptosis in ameloblastoma</span> <span class="citation_source-journal">Oral Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16140562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=39-45&author=F.+Sandraauthor=L.+Hendarminauthor=Y.+Nakaoauthor=N.+Nakamuraauthor=S.+Nakamura&title=Inhibition+of+Akt+and+MAPK+pathways+elevated+potential+of+TNFalpha+in+inducing+apoptosis+in+ameloblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Akt and MAPK pathways elevated potential of TNFα in inducing apoptosis in ameloblastoma</span></div><div class="casAuthors">Sandra, Ferry; Hendarmin, Laifa; Nakao, Yu; Nakamura, Norifumi; Nakamura, Seiji</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-45</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor alpha (TNFα) can trigger both cell survival and apoptosis.  In the present study, from the flow cytometry results, we found that the prolonged-treatment of TNFα until 24 h, resulted apoptosis in AM-1 cells (ameloblastoma cell line).  These results were confirmed by DAPI staining, which showed nuclear fragmentation feature of AM-1 cells under treatment of TNFα.  Our further investigation using specific caspase inhibitors showed that caspase-3 played a crucial role in mediating TNFα-induced apoptosis in AM-1 cells.  In addn., significant elevation of TNFα potential in inducing apoptosis was seen by applying LY294002, phosphatidylinositol-3-OH kinase (PI3K) inhibitor, or U0126, mitogen-activated extracellular-regulated kinase (MEK1/2) inhibitor, prior to the treatment of TNFα in AM-1 cells.  These results suggested that TNFα induced both cell survival and apoptosis pathways in ameloblastoma and potential of TNFα in inducing apoptosis can be improved by inhibiting TNFα-induced Akt and p44/42 mitogen-activated protein kinase (MAPK) cell survival pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2XjCaI5q0LVg90H21EOLACvtfcHk0liQm5n-j9vHcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrnL&md5=94910209e6e9e3c395b4169d7adbbf28</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandra%26aufirst%3DF.%26aulast%3DHendarmin%26aufirst%3DL.%26aulast%3DNakao%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520Akt%2520and%2520MAPK%2520pathways%2520elevated%2520potential%2520of%2520TNFalpha%2520in%2520inducing%2520apoptosis%2520in%2520ameloblastoma%26jtitle%3DOral%2520Oncol.%26date%3D2006%26volume%3D42%26spage%3D39%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Crespi, C. L.</span><span> </span><span class="NLM_article-title">Microplate plate assays for inhibition of human drug metabolizing cytochrome P450</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1997&pages=188-190&author=C.+L.+Crespi&title=Microplate+plate+assays+for+inhibition+of+human+drug+metabolizing+cytochrome+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DMicroplate%2520plate%2520assays%2520for%2520inhibition%2520of%2520human%2520drug%2520metabolizing%2520cytochrome%2520P450%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D248%26spage%3D188%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Mohammad, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almatchy, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flake, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dergham, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Katib, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaitkevicius, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, F. H.</span><span> </span><span class="NLM_article-title">Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents</span> <span class="citation_source-journal">Pancreas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=19-25&author=R.+M.+Mohammadauthor=M.+C.+Duganauthor=A.+N.+Mohamedauthor=V.+P.+Almatchyauthor=T.+M.+Flakeauthor=S.+T.+Derghamauthor=A.+F.+Shieldsauthor=A.+A.+Al-Katibauthor=V.+K.+Vaitkeviciusauthor=F.+H.+Sarkar&title=Establishment+of+a+human+pancreatic+tumor+xenograft+model%3A+potential+application+for+preclinical+evaluation+of+novel+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DR.%2BM.%26aulast%3DDugan%26aufirst%3DM.%2BC.%26aulast%3DMohamed%26aufirst%3DA.%2BN.%26aulast%3DAlmatchy%26aufirst%3DV.%2BP.%26aulast%3DFlake%26aufirst%3DT.%2BM.%26aulast%3DDergham%26aufirst%3DS.%2BT.%26aulast%3DShields%26aufirst%3DA.%2BF.%26aulast%3DAl-Katib%26aufirst%3DA.%2BA.%26aulast%3DVaitkevicius%26aufirst%3DV.%2BK.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DEstablishment%2520of%2520a%2520human%2520pancreatic%2520tumor%2520xenograft%2520model%253A%2520potential%2520application%2520for%2520preclinical%2520evaluation%2520of%2520novel%2520therapeutic%2520agents%26jtitle%3DPancreas%26date%3D1998%26volume%3D16%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Mohammad, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdan, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abubakr, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">al-Katib, A.</span><span> </span><span class="NLM_article-title">Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=130-137&author=R.+M.+Mohammadauthor=A.+N.+Mohamedauthor=M.+Y.+Hamdanauthor=T.+Voauthor=B.+Chenauthor=K.+Katatoauthor=Y.+A.+Abubakrauthor=M.+C.+Duganauthor=A.+al-Katib&title=Establishment+of+a+human+B-CLL+xenograft+model%3A+utility+as+a+preclinical+therapeutic+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DR.%2BM.%26aulast%3DMohamed%26aufirst%3DA.%2BN.%26aulast%3DHamdan%26aufirst%3DM.%2BY.%26aulast%3DVo%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DKatato%26aufirst%3DK.%26aulast%3DAbubakr%26aufirst%3DY.%2BA.%26aulast%3DDugan%26aufirst%3DM.%2BC.%26aulast%3Dal-Katib%26aufirst%3DA.%26atitle%3DEstablishment%2520of%2520a%2520human%2520B-CLL%2520xenograft%2520model%253A%2520utility%2520as%2520a%2520preclinical%2520therapeutic%2520model%26jtitle%3DLeukemia%26date%3D1996%26volume%3D10%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Tashiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span> </span><span class="NLM_article-title">Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1007%2FBF00300241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=2544308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2qs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1989&pages=187-192&author=T.+Tashiroauthor=M.+Inabaauthor=T.+Kobayashiauthor=Y.+Sakuraiauthor=K.+Maruoauthor=Y.+Ohnishiauthor=Y.+Ueyamaauthor=T.+Nomura&title=Responsiveness+of+human+lung+cancer%2Fnude+mouse+to+antitumor+agents+in+a+model+using+clinically+equivalent+doses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses</span></div><div class="casAuthors">Tashiro, Tazuko; Inaba, Makoto; Kobayashi, Tomowo; Sakurai, Yoshio; Maruo, Koji; Ohnishi, Yasuyuki; Ueyama, Yoshito; Nomura, Tatsuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-92</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The responses of 14 lines of human lung cancer xenografts in BALB/c-nu/nu mice to 8 antitumor agents were investigated.  The xenografts consisted of 4 small-cell carcinomas (SCLC) and 10 non-small-cell carcinomas (NSCLC).  The doses used were the max. tolerated dose (MTD) in nude mice and the rational dose (RD), the latter considered to be pharmacokinetically equiv. to the clin. dose.  When given at MTDs, all the drugs except 5-fluorouracil (5-FU) and methotrexate were extremely effective against NSCLC as well as SCLC.  The response rates of drug-sensitive SCLC to mitomycin C (MMC), ACNU, and vinblastine (VLB) were 100%, and those to adriamycin and vincristine were 75%.  The response rates of even drug-resistant NSCLC to MMC and VLB were 70% and 90%, resp.  The response rates of NSCLC to RDs of the drugs were reduced to <40% and corresponded well to the resp. clin. rates.  In SCLC, a good correlation of exptl. and clin. response rates was obsd. with 4 drugs (cyclophosphamide, ACNU, VLB, and 5-FU).  A more reasonable prediction of the clin. effectiveness of antitumor agents can be made by a protocol using clin. equiv. doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHcAegAJGEGrVg90H21EOLACvtfcHk0lgB_zub-QFHkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2qs7w%253D&md5=2b75e7dc54dacb6b74caaa58eeae049d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF00300241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00300241%26sid%3Dliteratum%253Aachs%26aulast%3DTashiro%26aufirst%3DT.%26aulast%3DInaba%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DMaruo%26aufirst%3DK.%26aulast%3DOhnishi%26aufirst%3DY.%26aulast%3DUeyama%26aufirst%3DY.%26aulast%3DNomura%26aufirst%3DT.%26atitle%3DResponsiveness%2520of%2520human%2520lung%2520cancer%252Fnude%2520mouse%2520to%2520antitumor%2520agents%2520in%2520a%2520model%2520using%2520clinically%2520equivalent%2520doses%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1989%26volume%3D24%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holding, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal structure of human CDK4 in complex with a D-type cyclin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">4166</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4166-4170&author=P.+J.+Dayauthor=A.+Cleasbyauthor=I.+J.+Tickleauthor=M.+O%E2%80%99Reillyauthor=J.+E.+Coyleauthor=F.+P.+Holdingauthor=R.+L.+McMenaminauthor=J.+Yonauthor=R.+Chopraauthor=C.+Lengauerauthor=H.+Jhoti&title=Crystal+structure+of+human+CDK4+in+complex+with+a+D-type+cyclin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DHolding%26aufirst%3DF.%2BP.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520human%2520CDK4%2520in%2520complex%2520with%2520a%2520D-type%2520cyclin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D4166%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Jeffrey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Mechanism of CDK activation revealed by the structure of a cyclinA–CDK2 complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=313-320&author=P.+D.+Jeffreyauthor=A.+A.+Russoauthor=K.+Polyakauthor=E.+Gibbsauthor=J.+Hurwitzauthor=J.+Massagueauthor=N.+P.+Pavletich&title=Mechanism+of+CDK+activation+revealed+by+the+structure+of+a+cyclinA%E2%80%93CDK2+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPolyak%26aufirst%3DK.%26aulast%3DGibbs%26aufirst%3DE.%26aulast%3DHurwitz%26aufirst%3DJ.%26aulast%3DMassague%26aufirst%3DJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DMechanism%2520of%2520CDK%2520activation%2520revealed%2520by%2520the%2520structure%2520of%2520a%2520cyclinA%25E2%2580%2593CDK2%2520complex%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D313%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+tubulin+regulation+from+a+complex+with+colchicine+and+a+stathmin-like+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lgaFVYE3uDL_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520tubulin%2520regulation%2520from%2520a%2520complex%2520with%2520colchicine%2520and%2520a%2520stathmin-like%2520domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref55':['cit55'],'ref56':['cit56']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jia Chen, Hua Liu, Shao-Yong Zhang, Hu Li, Kun-Yuan Ma, Ying-Qian Liu, Xiao-Dan Yin, Rui Zhou, Yin-Fang Yan, Ren-Xuan Wang, Ying-Hui He, Qing-Ru Chu, <span class="NLM_string-name hlFld-ContribAuthor">Chen Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Antifungal Evaluation of Cryptolepine Derivatives against Phytopathogenic Fungi. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2021,</strong> <em>69 </em>
                                    (4)
                                     , 1259-1271. <a href="https://doi.org/10.1021/acs.jafc.0c06480" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c06480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c06480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c06480%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAntifungal%252BEvaluation%252Bof%252BCryptolepine%252BDerivatives%252Bagainst%252BPhytopathogenic%252BFungi%26aulast%3DChen%26aufirst%3DYong-Jia%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D12102020%26date%3D13012021%26date%3D07012021%26date%3D26012021%26volume%3D69%26issue%3D4%26spage%3D1259%26epage%3D1271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Johanne Outin, Pauline Quellier, <span class="NLM_string-name hlFld-ContribAuthor">Guillaume Bélanger</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential One-Pot Vilsmeier–Haack and Organocatalyzed Mannich Cyclizations to Functionalized Benzoindolizidines and Benzoquinolizidines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (7)
                                     , 4712-4729. <a href="https://doi.org/10.1021/acs.joc.9b03449" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03449%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSequential%252BOne-Pot%252BVilsmeier%2525E2%252580%252593Haack%252Band%252BOrganocatalyzed%252BMannich%252BCyclizations%252Bto%252BFunctionalized%252BBenzoindolizidines%252Band%252BBenzoquinolizidines%26aulast%3DOutin%26aufirst%3DJohanne%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30122019%26date%3D19032020%26volume%3D85%26issue%3D7%26spage%3D4712%26epage%3D4729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rajni Sharma, Ibidapo S. Williams, Linda Gatchie, Vinay R. Sonawane, Bhabatosh Chaudhuri, <span class="NLM_string-name hlFld-ContribAuthor">Sandip B. Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Khellinoflavanone, a Semisynthetic Derivative of Khellin, Overcomes Benzo[a]pyrene Toxicity in Human Normal and Cancer Cells That Express CYP1A1. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (8)
                                     , 8553-8566. <a href="https://doi.org/10.1021/acsomega.8b01088" title="DOI URL">https://doi.org/10.1021/acsomega.8b01088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01088%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DKhellinoflavanone%25252C%252Ba%252BSemisynthetic%252BDerivative%252Bof%252BKhellin%25252C%252BOvercomes%252BBenzo%25255Ba%25255Dpyrene%252BToxicity%252Bin%252BHuman%252BNormal%252Band%252BCancer%252BCells%252BThat%252BExpress%252BCYP1A1%26aulast%3DSharma%26aufirst%3DRajni%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22052018%26date%3D19072018%26volume%3D3%26issue%3D8%26spage%3D8553%26epage%3D8566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant  Joshi</span>, <span class="hlFld-ContribAuthor ">Glen J. P.  McCann</span>, <span class="hlFld-ContribAuthor ">Vinay R.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Bhabatosh  Chaudhuri</span>, and <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Potent and Selective CYP1A1 Inhibitors via Combined Ligand and Structure-Based Virtual Screening and Their in Vitro Validation in Sacchrosomes and Live Human Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (6)
                                     , 1309-1320. <a href="https://doi.org/10.1021/acs.jcim.7b00095" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00095%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BPotent%252Band%252BSelective%252BCYP1A1%252BInhibitors%252Bvia%252BCombined%252BLigand%252Band%252BStructure-Based%252BVirtual%252BScreening%252Band%252BTheir%252Bin%252BVitro%252BValidation%252Bin%252BSacchrosomes%252Band%252BLive%252BHuman%252BCells%26aulast%3DJoshi%26aufirst%3DPrashant%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17022017%26date%3D22052017%26date%3D26062017%26date%3D10052017%26volume%3D57%26issue%3D6%26spage%3D1309%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodion  Khotimchenko</span>, <span class="hlFld-ContribAuthor ">Igor  Bryukhovetskiy</span>, <span class="hlFld-ContribAuthor ">Maksim  Khotimchenko</span>, <span class="hlFld-ContribAuthor ">Yuri  Khotimchenko</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive Compounds with Antiglioma Activity from Marine Species. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (8)
                                     , 886. <a href="https://doi.org/10.3390/biomedicines9080886" title="DOI URL">https://doi.org/10.3390/biomedicines9080886</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9080886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9080886%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DBioactive%252BCompounds%252Bwith%252BAntiglioma%252BActivity%252Bfrom%252BMarine%252BSpecies%26aulast%3DKhotimchenko%26aufirst%3DRodion%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D8%26spage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Liang</span>, <span class="hlFld-ContribAuthor ">Huili  Quan</span>, <span class="hlFld-ContribAuthor ">Tong  Bu</span>, <span class="hlFld-ContribAuthor ">Xuedong  Li</span>, <span class="hlFld-ContribAuthor ">Xingang  Liu</span>, <span class="hlFld-ContribAuthor ">Songsong  Wang</span>, <span class="hlFld-ContribAuthor ">Dian  He</span>, <span class="hlFld-ContribAuthor ">Qingzhong  Jia</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the Inhibitory Binding Modes Between the Planar Fascaplysin and Its Nonplanar Tetrahydro-β-carboline Analogs in CDK4. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.614154" title="DOI URL">https://doi.org/10.3389/fchem.2021.614154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.614154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.614154%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DComparison%252Bof%252Bthe%252BInhibitory%252BBinding%252BModes%252BBetween%252Bthe%252BPlanar%252BFascaplysin%252Band%252BIts%252BNonplanar%252BTetrahydro-%2525CE%2525B2-carboline%252BAnalogs%252Bin%252BCDK4%26aulast%3DLiang%26aufirst%3DYan%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojiao  Luo</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Pan  Tang</span>, <span class="hlFld-ContribAuthor ">Xingkai  Du</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Qingying  Wang</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Jun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em>
                                    (1)
                                     , 367-382. <a href="https://doi.org/10.1007/s11030-020-10120-3" title="DOI URL">https://doi.org/10.1007/s11030-020-10120-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10120-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10120-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDiscovery%252Bof%252Bnew%252Bsmall-molecule%252Bcyclin-dependent%252Bkinase%252B6%252Binhibitors%252Bthrough%252Bcomputational%252Bapproaches%26aulast%3DLuo%26aufirst%3DXiaojiao%26date%3D2021%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D367%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raosaheb S.  Patil</span>, <span class="hlFld-ContribAuthor ">Atul S.  Patil</span>, <span class="hlFld-ContribAuthor ">Vikas S.  Patil</span>, <span class="hlFld-ContribAuthor ">Pramod P.  Mahulikar</span>. </span><span class="cited-content_cbyCitation_article-title">Base Promoted Synthesis of 2-((5-methoxynaphthalen-1-yl)methyl)-3-methyl-5-sec-amino-[1,1′-biphenyl]-4-carbonitrilederivatives: Photophysical, Solvatochromic and DFT studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1226 </em>, 129339. <a href="https://doi.org/10.1016/j.molstruc.2020.129339" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DBase%252BPromoted%252BSynthesis%252Bof%252B2-%252528%2525285-methoxynaphthalen-1-yl%252529methyl%252529-3-methyl-5-sec-amino-%25255B1%25252C1%2525E2%252580%2525B2-biphenyl%25255D-4-carbonitrilederivatives%25253A%252BPhotophysical%25252C%252BSolvatochromic%252Band%252BDFT%252Bstudies%26aulast%3DPatil%26aufirst%3DRaosaheb%2BS.%26date%3D2021%26volume%3D1226%26spage%3D129339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa Rao  Ambati</span>, <span class="hlFld-ContribAuthor ">Jeevan Lal  Patel</span>, <span class="hlFld-ContribAuthor ">Satish  Gudala</span>, <span class="hlFld-ContribAuthor ">Komal  Chandrakar</span>, <span class="hlFld-ContribAuthor ">Santhosh  Penta</span>, <span class="hlFld-ContribAuthor ">S. P.  Mahapatra</span>, <span class="hlFld-ContribAuthor ">Subhash  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel coumarinyl-pyrido[2,3-
              d
              ]pyrimidine-2,4-diones using task-specific magnetic ionic liquid, [AcMIm]FeCl
              4
              as catalyst. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2020,</strong> <em>50 </em>
                                    (1)
                                     , 104-111. <a href="https://doi.org/10.1080/00397911.2019.1686526" title="DOI URL">https://doi.org/10.1080/00397911.2019.1686526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2019.1686526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2019.1686526%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252Bnovel%252Bcoumarinyl-pyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine-2%25252C4-diones%252Busing%252Btask-specific%252Bmagnetic%252Bionic%252Bliquid%25252C%252B%25255BAcMIm%25255DFeCl%252B4%252Bas%252Bcatalyst%26aulast%3DAmbati%26aufirst%3DSrinivasa%2BRao%26date%3D2020%26date%3D2019%26volume%3D50%26issue%3D1%26spage%3D104%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pingping  Chen</span>, <span class="hlFld-ContribAuthor ">Yinqiu  Xu</span>, <span class="hlFld-ContribAuthor ">Xuanyi  Li</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 127-145. <a href="https://doi.org/10.4155/fmc-2019-0062" title="DOI URL">https://doi.org/10.4155/fmc-2019-0062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0062%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BCDK4%25252F6%252Binhibitors%26aulast%3DChen%26aufirst%3DPingping%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D127%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinay R.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Mohd Usman Mohd  Siddique</span>, <span class="hlFld-ContribAuthor ">Linda  Gatchie</span>, <span class="hlFld-ContribAuthor ">Ibidapo S.  Williams</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Venkatesan  Jayaprakash</span>, <span class="hlFld-ContribAuthor ">Barij N.  Sinha</span>, <span class="hlFld-ContribAuthor ">Bhabatosh  Chaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2019,</strong> <em>131 </em>, 177-194. <a href="https://doi.org/10.1016/j.ejps.2019.02.016" title="DOI URL">https://doi.org/10.1016/j.ejps.2019.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2019.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2019.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DCYP%252Benzymes%25252C%252Bexpressed%252Bwithin%252Blive%252Bhuman%252Bsuspension%252Bcells%25252C%252Bare%252Bsuperior%252Bto%252Bwidely-used%252Bmicrosomal%252Benzymes%252Bin%252Bidentifying%252Bpotent%252BCYP1A1%25252FCYP1B1%252Binhibitors%25253A%252BIdentification%252Bof%252Bquinazolinones%252Bas%252BCYP1A1%25252FCYP1B1%252Binhibitors%252Bthat%252Befficiently%252Breverse%252BB%25255Ba%25255DP%252Btoxicity%252Band%252Bcisplatin%252Bresistance%26aulast%3DSonawane%26aufirst%3DVinay%2BR.%26date%3D2019%26volume%3D131%26spage%3D177%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinay  Sonawane</span>, <span class="hlFld-ContribAuthor ">Mohd Usman  Mohd Siddique</span>, <span class="hlFld-ContribAuthor ">Surender Singh  Jadav</span>, <span class="hlFld-ContribAuthor ">Barij Nayan  Sinha</span>, <span class="hlFld-ContribAuthor ">Venkatesan  Jayaprakash</span>, <span class="hlFld-ContribAuthor ">Bhabatosh  Chaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>165 </em>, 115-132. <a href="https://doi.org/10.1016/j.ejmech.2019.01.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCink4T%25252C%252Ba%252Bquinazolinone-based%252Bdual%252Binhibitor%252Bof%252BCdk4%252Band%252Btubulin%252Bpolymerization%25252C%252Bidentified%252Bvia%252Bligand-based%252Bvirtual%252Bscreening%25252C%252Bfor%252Befficient%252Banticancer%252Btherapy%26aulast%3DSonawane%26aufirst%3DVinay%26date%3D2019%26volume%3D165%26spage%3D115%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Sonali S.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Engineering solid dispersions of anticancer preclinical lead, IIIM-985: Physicochemical characterization and in vivo pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Delivery Science and Technology</span><span> <strong>2019,</strong> <em>49 </em>, 594-602. <a href="https://doi.org/10.1016/j.jddst.2018.12.028" title="DOI URL">https://doi.org/10.1016/j.jddst.2018.12.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jddst.2018.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jddst.2018.12.028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Delivery%2520Science%2520and%2520Technology%26atitle%3DEngineering%252Bsolid%252Bdispersions%252Bof%252Banticancer%252Bpreclinical%252Blead%25252C%252BIIIM-985%25253A%252BPhysicochemical%252Bcharacterization%252Band%252Bin%252Bvivo%252Bpharmacokinetics%26aulast%3DKumar%26aufirst%3DVikas%26date%3D2019%26volume%3D49%26spage%3D594%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Mudududdla</span>, <span class="hlFld-ContribAuthor ">Dinesh  Mohanakrishnan</span>, <span class="hlFld-ContribAuthor ">Sonali S.  Bharate</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Dinkar  Sahal</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Orally Effective Aminoalkyl 10
              H
              ‐Indolo[3,2‐
              b
              ]quinoline‐11‐carboxamide Kills the Malaria Parasite by Inhibiting Host Hemoglobin Uptake. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (23)
                                     , 2581-2598. <a href="https://doi.org/10.1002/cmdc.201800579" title="DOI URL">https://doi.org/10.1002/cmdc.201800579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800579%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOrally%252BEffective%252BAminoalkyl%252B10%252BH%252B%2525E2%252580%252590Indolo%25255B3%25252C2%2525E2%252580%252590%252Bb%252B%25255Dquinoline%2525E2%252580%25259011%2525E2%252580%252590carboxamide%252BKills%252Bthe%252BMalaria%252BParasite%252Bby%252BInhibiting%252BHost%252BHemoglobin%252BUptake%26aulast%3DMudududdla%26aufirst%3DRamesh%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D23%26spage%3D2581%26epage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajni  Sharma</span>, <span class="hlFld-ContribAuthor ">Ibidapo S.  Williams</span>, <span class="hlFld-ContribAuthor ">Linda  Gatchie</span>, <span class="hlFld-ContribAuthor ">Vinay R.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Bhabatosh  Chaudhuri</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Furanoflavones pongapin and lanceolatin B blocks the cell cycle and induce senescence in CYP1A1-overexpressing breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (23-24)
                                     , 6076-6086. <a href="https://doi.org/10.1016/j.bmc.2018.11.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFuranoflavones%252Bpongapin%252Band%252Blanceolatin%252BB%252Bblocks%252Bthe%252Bcell%252Bcycle%252Band%252Binduce%252Bsenescence%252Bin%252BCYP1A1-overexpressing%252Bbreast%252Bcancer%252Bcells%26aulast%3DSharma%26aufirst%3DRajni%26date%3D2018%26volume%3D26%26issue%3D23-24%26spage%3D6076%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Sun</span>, <span class="hlFld-ContribAuthor ">Hongdie  Li</span>, <span class="hlFld-ContribAuthor ">Zhaoqi  Wu</span>, <span class="hlFld-ContribAuthor ">Chunmei  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Ren</span>, <span class="hlFld-ContribAuthor ">Furen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component Strategy for Synthesis of Dihydropyrido[2,3-
              d
              ]pyrimidine and Spirooxindole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (10)
                                     , 2270-2276. <a href="https://doi.org/10.1002/jhet.3278" title="DOI URL">https://doi.org/10.1002/jhet.3278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3278%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DThree-component%252BStrategy%252Bfor%252BSynthesis%252Bof%252BDihydropyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Band%252BSpirooxindole%252BDerivatives%26aulast%3DSun%26aufirst%3DTing%26date%3D2018%26date%3D2018%26volume%3D55%26issue%3D10%26spage%3D2270%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Rath</span>, <span class="hlFld-ContribAuthor ">Maximilian  Hochmair</span>, <span class="hlFld-ContribAuthor ">Adelina  Plangger</span>, <span class="hlFld-ContribAuthor ">Gerhard  Hamilton</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2018,</strong> <em>16 </em>
                                    (10)
                                     , 383. <a href="https://doi.org/10.3390/md16100383" title="DOI URL">https://doi.org/10.3390/md16100383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md16100383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd16100383%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DAnticancer%252BActivity%252Bof%252BFascaplysin%252Bagainst%252BLung%252BCancer%252BCell%252Band%252BSmall%252BCell%252BLung%252BCancer%252BCirculating%252BTumor%252BCell%252BLines%26aulast%3DRath%26aufirst%3DBarbara%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D10%26spage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant  Joshi</span>, <span class="hlFld-ContribAuthor ">Vinay R.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Ibidapo S.  Williams</span>, <span class="hlFld-ContribAuthor ">Glen J. P.  McCann</span>, <span class="hlFld-ContribAuthor ">Linda  Gatchie</span>, <span class="hlFld-ContribAuthor ">Rajni  Sharma</span>, <span class="hlFld-ContribAuthor ">Naresh  Satti</span>, <span class="hlFld-ContribAuthor ">Bhabatosh  Chaudhuri</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy
              via
              screening of a natural product repository. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 371-382. <a href="https://doi.org/10.1039/C7MD00388A" title="DOI URL">https://doi.org/10.1039/C7MD00388A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00388A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00388A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Bkaranjin%252Bisolated%252Bfrom%252Bthe%252BIndian%252Bbeech%252Btree%252Bas%252Ba%252Bpotent%252BCYP1%252Benzyme%252Binhibitor%252Bwith%252Bcellular%252Befficacy%252Bvia%252Bscreening%252Bof%252Ba%252Bnatural%252Bproduct%252Brepository%26aulast%3DJoshi%26aufirst%3DPrashant%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D371%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neill J.  Horley</span>, <span class="hlFld-ContribAuthor ">Kenneth J.M.  Beresford</span>, <span class="hlFld-ContribAuthor ">Tarun  Chawla</span>, <span class="hlFld-ContribAuthor ">Glen J.P.  McCann</span>, <span class="hlFld-ContribAuthor ">Ketan C.  Ruparelia</span>, <span class="hlFld-ContribAuthor ">Linda  Gatchie</span>, <span class="hlFld-ContribAuthor ">Vinay R.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Ibidapo S.  Williams</span>, <span class="hlFld-ContribAuthor ">Hoon L.  Tan</span>, <span class="hlFld-ContribAuthor ">Prashant  Joshi</span>, <span class="hlFld-ContribAuthor ">Sonali S.  Bharate</span>, <span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Bhabatosh  Chaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>129 </em>, 159-174. <a href="https://doi.org/10.1016/j.ejmech.2017.02.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bnovel%252BCYP1B1%252Binhibitors%252Bbased%252Bon%252Bheterocyclic%252Bchalcones%25253A%252BOvercoming%252Bcisplatin%252Bresistance%252Bin%252BCYP1B1-overexpressing%252Blines%26aulast%3DHorley%26aufirst%3DNeill%2BJ.%26date%3D2017%26volume%3D129%26spage%3D159%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmad  Shaabani</span>, <span class="hlFld-ContribAuthor ">Heshmatollah  Sepahvand</span>, <span class="hlFld-ContribAuthor ">Mahmoud Borjian  Boroujeni</span>, <span class="hlFld-ContribAuthor ">Mohammad Tayeb  Faroghi</span>. </span><span class="cited-content_cbyCitation_article-title">A green one-pot three-component cascade reaction: the synthesis of 2-amino-5,8-dihydro-3H-pyrido[2,3-D]pyrimidin-4-ones in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2017,</strong> <em>21 </em>
                                    (1)
                                     , 147-153. <a href="https://doi.org/10.1007/s11030-016-9712-9" title="DOI URL">https://doi.org/10.1007/s11030-016-9712-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-016-9712-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-016-9712-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DA%252Bgreen%252Bone-pot%252Bthree-component%252Bcascade%252Breaction%25253A%252Bthe%252Bsynthesis%252Bof%252B2-amino-5%25252C8-dihydro-3H-pyrido%25255B2%25252C3-D%25255Dpyrimidin-4-ones%252Bin%252Baqueous%252Bmedium%26aulast%3DShaabani%26aufirst%3DAhmad%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D1%26spage%3D147%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Jin  Hu</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Kui  Yang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Yu-Rong  Chen</span>, <span class="hlFld-ContribAuthor ">Tian-Zhu  Ma</span>, <span class="hlFld-ContribAuthor ">Ling  Lu</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (6)
                                     , 1491-1500. <a href="https://doi.org/10.1111/cbdd.12616" title="DOI URL">https://doi.org/10.1111/cbdd.12616</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12616%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BNovel%252BIndole-Pyrimidine%252BHybrids%252Bas%252BTubulin%252BPolymerization%252BInhibitors%26aulast%3DHu%26aufirst%3DMeng-Jin%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D6%26spage%3D1491%26epage%3D1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Mahale</span>, <span class="hlFld-ContribAuthor ">S B  Bharate</span>, <span class="hlFld-ContribAuthor ">S  Manda</span>, <span class="hlFld-ContribAuthor ">P  Joshi</span>, <span class="hlFld-ContribAuthor ">P R  Jenkins</span>, <span class="hlFld-ContribAuthor ">R A  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">B  Chaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , e1743-e1743. <a href="https://doi.org/10.1038/cddis.2015.96" title="DOI URL">https://doi.org/10.1038/cddis.2015.96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2015.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2015.96%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DAntitumour%252Bpotential%252Bof%252BBPT%25253A%252Ba%252Bdual%252Binhibitor%252Bof%252Bcdk4%252Band%252Btubulin%252Bpolymerization%26aulast%3DMahale%26aufirst%3DS%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3De1743%26epage%3De1743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Biphenyl-4-carboxylic Acid [2-(1<i>H</i>-Indol-3-yl)-ethyl]-methylamide (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl chloroformate, NaOH 4 N, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, 90%; (b) LiAlH<sub>4</sub>, THF, N<sub>2</sub>, reflux, 1 h, 85%; (c) NaOH 4 N, CH<sub>2</sub>Cl<sub>2</sub>, 3 h, 45%.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular modeling studies of compound <b>1</b> with Cdk4 and Cdk2. (a) Interactions of the <i>cis</i> and <i>trans</i> conformations of compound <b>1</b> with Cdk2 and Cdk4, respectively. (<i>Cis</i> and <i>trans</i> conformations of compound <b>1</b> are shown in orange and green, respectively. Similarly, labels for the residues of Cdk2 and Cdk4 are shown in orange and green, respectively.) (b) Compound <b>1</b>–Cdk4 interaction histogram with different binding site residues during a 10 ns MD simulation of the compound <b>1</b>–Cdk4 protein complex. (c) Amino acid comparison between Cdk4 and Cdk2 at the ATP binding site (black residues indicate common interacting residues of Cdk4/Cdk2, whereas red residues are those that differ in the interaction pattern of these two Cdks).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cell cycle analysis of compound <b>1</b>-treated cells. (A–D) Response of mitotic spindle checkpoint-proficient human lung cancer cell lines, A549 and NCI-H1299, to compound <b>1</b>. Flow cytometric analysis of asynchronous cells show that the majority of cells are arrested in G<sub>2</sub>/M phase of the cell cycle (4n DNA content) in both cell lines: A549 untreated (A), treatment with the IC<sub>50</sub> concentration of compound <b>1</b> for 24 h (B), NCI-H1299 untreated or control (C), and treatment with the IC<sub>50</sub> concentration of compound <b>1</b> for 24 h (D). (E–L) Analysis of NCI-H358 cells using flow cytometry. G<sub>2</sub>/M and G<sub>1</sub>/S synchronized cells, by nocodazole and hydroxyurea, respectively, were released either in fresh medium or in fresh medium containing the IC<sub>50</sub> concentration of compound <b>1</b>, which demonstrated a greater tendency of compound <b>1</b> to block cell growth at G<sub>2</sub>/M. For the nocodazole block experiment, shown are untreated or control cells (E), cells treated with 1 μM nocodazole for 18 h (F), cells treated with 1 μM nocodazole for 18 h and released in fresh medium (G), and cells treated with 1 μM nocodazole for 18 h and released in the presence of compound <b>1</b> at its IC<sub>50</sub> (H). For the hydroxyurea block experiment, shown are untreated or control cells (I), cells treated with 250 μM hydroxyurea for 18 h (J), cells treated with 250 μM hydroxyurea for 18 h and released in fresh medium (K), and cells treated with 250 μM hydroxyurea for 18 h and released in the presence of compound <b>1</b> at its IC<sub>50</sub> (L). (M–P) Selective apoptosis of SV-40 transformed cells by compound <b>1</b>, analyzed by FACS. BNL CL2 (mouse embryonic normal hepatic cells) exposed to compound <b>1</b> for 48 h at its IC<sub>50</sub> concentration (N) show prominent G<sub>2</sub>/M arrest. BNL SV A.8 (mouse embryonic SV-40 transformed hepatic cells) underwent apoptotic cell death upon incubation with compound <b>1</b>. The apoptosis was quantitated by measuring the percent of cells appearing in the sub-G<sub>1</sub> peak: 31 and 44% of cells were found in the sub-G<sub>1</sub> peak after a 48 h exposure with compound <b>1</b> at its IC<sub>50</sub> (P) concentration. The untreated cells (O) did not show any apoptosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis of p53+ cells, A549 and LS174T. Treatment with compound <b>1</b> at its IC<sub>50</sub> concentration for 24 h resulted in induction of tumor suppressor protein p53; thereby, global Cdk inhibitor p21<sup>CIP1/WAF1</sup> (p21) was also induced. The levels of global p27<sup>KIP1</sup> (p27) were elevated, whereas cyclin B1 and Cdk1 levels were downregulated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Purified tubulin polymerization assay in vitro. The ability of compound <b>1</b> to inhibit tubulin polymerization in vitro was investigated as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Paclitaxel and nocodazole were used in the assay as a known enhancer and inhibitor of tubulin polymerization, respectively. Compound <b>1</b> was tested over a range of concentrations for which it show inhibition of cell growth in vitro. The change in the <i>V</i><sub>max</sub> value was used as an indicator of tubulin–ligand interactions. The polymerization curves indicate that 2.5, 5, 10, and 25 μM compound <b>1</b> reduced the <i>V</i><sub>max</sub> value from 19 mOD/min (control) to 6.2, 2.1, 1.1, and 0.4 mOD/min, respectively. The curves shown are the average of three independent experiments. (B) Compound <b>1</b> interactions at the α/β-tubulin interphase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Western blot analysis of the effect of compound <b>1</b> on tubulin polymerization. Western blots show the response of tubulin polymerization to compound <b>1</b> in the presence of paclitaxel and the effect of compound <b>1</b> on paclitaxel-stabilized tubulin. The assay was performed in whole cells (A549) after 30 min of compound treatment at the concentrations indicated. Supernatant and pellet represent unassembled and assembled tubulin, respectively. Tubulin polymerization is indicated by an increase of tubulin in the pellet and its disappearance from the supernatant. The simultaneous treatment with paclitaxel and compound <b>1</b> inhibited tubulin polymerization by compound <b>1</b> in a dose-dependent manner and resulted in accumulation of unassembled tubulin in the supernatant. It was observed that compound <b>1</b> also acts as an enhancer for tubulin depolymerization in a dose-dependent manner when paclitaxel-stabilized tubulin was subjected to compound <b>1</b> treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>1</b> in colony formation assays. A549 and Calu-1 cells were investigated for their long-term survival efficiency after treatment with different concentrations of compound <b>1</b>. Colony formation efficiency is expressed as the percentage of colonies formed in the treated cultures compared with that in untreated cultures. (A) Representative plates show A549 untreated (a), treated with compound <b>1</b> at 3.12 μM (b), treated with <b>1</b> at 6.25 μM (c), treated with compound <b>1</b> at 12.5 μM (d), and treated with compound <b>2</b> at 0.8 μM (e); Calu-1 untreated (f), treated with <b>1</b> at 3.12 μM (g), treated with compound <b>1</b> at 6.25 μM (h), treated with compound <b>1</b> at 12.5 μM, and (i) treated with compound <b>2</b> at 1 μM (j). (B) The curves represent the colony formation efficiencies of A549 and Calu-1 cells with increasing concentrations of compound <b>1</b>. All results represent the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Induction of apoptotic cell death analyzed by DAPI staining and FACS. Incubation of A549 cells with increasing concentrations of compound <b>1</b> for 24 h shows a dose-dependent induction of fragmented nuclei, distrupted cell membrane, and apoptotic cell death (A). The fluorescence microscopic images were captured at 40× magnification after staining with DAPI. (A) A549 untreated (a), treated with compound <b>1</b> at 1 μM (b), treated with compound <b>1</b> at 2.5 μM (c), treated with compound <b>1</b> at 5 μM (d), and treated with compound <b>1</b> at 10 μM (e). The preapoptotic and apoptotic cells are indicated with arrows. (B) Percent of apoptosis induced in three cancer cell lines by treatment with compound <b>1</b>, as determined by FACS analysis. The percent apoptosis is depicted as the percent of cells in the sub-G<sub>1</sub> peak during cell cycle analysis. Apoptosis increased with the concentration of <b>1</b> and with its time of incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Time versus plasma concentration profile of compound <b>1</b> in BALB/c mice; (B) pharmacokinetics parameters determined for compound <b>1</b> after IV and PO administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/medium/jm-2014-014743_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Tumor growth inhibition curves for compound <b>1</b> in an in vivo HCT116 xenograft model. Graphs depict tumor growth inhibition in a group of animals treated with compound <b>1</b> at 100 mg/kg compared to that of the untreated group (shown in the graphs as the control group). Tumor sizes were recorded at 2–5 day intervals. Tumor weight (mg) was estimated according to the formula for a prolate ellipsoid: length (mm) × width (mm)<sup>2</sup> × 0.5, assuming specific gravity to be 1 and π to be three. Compound <b>1</b> shows statistically significant tumor growth inhibition in vivo, <i>p</i> < 0.05 (Student’s <i>t</i> test was used for comparisons of different groups versus control). (B) Animal weight profile in the HCT116 SCID mice xenograft model. The body weight of animals untreated or treated with compound <b>1</b> (100 mg/kg) was monitored by taking measurements daily during the treatment schedule. By considering the body weight at the start of treatment as 100%, the percent weight loss was calculated on subsequent days of treatment. (C) Tumor growth inhibition curves for compound <b>1</b> in the in vivo NCI-H460 tumor model. Graphs depict tumor growth inhibition in a group of animals treated with a specific compound compared to that of the untreated group (shown in the graphs as the control group). Tumor sizes were recorded at 2–5 day intervals. Tumor weight (mg) was estimated according to the formula for a prolate ellipsoid: length (mm) × width (mm)<sup>2</sup> × 0.5, assuming specific gravity to be 2 and π to be three. Compound <b>1</b> shows statistically significant tumor growth inhibition in vivo, <i>p</i> < 0.05 (Student’s <i>t</i> test was used for comparisons of different groups versus control). (D) Control and treatment groups of SCID mice showing NCI-H460 tumor growth inhibition followed by treatment with compound <b>1</b>. These pictures were obtained after treatment with compound <b>1</b> at 100 mg/kg. The treatments were continued for 9 consecutive days (intraperitoneally) when tumors had reached about 4–6 mm in diameter, which was about 6 days following tumor cell injection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5014743/20141120/images/large/jm-2014-014743_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5014743&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdks, cyclins and CKIs: roles beyond cell cycle regulation</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">3079</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=3079-3093&author=S.+Limauthor=P.+Kaldis&title=Cdks%2C+cyclins+and+CKIs%3A+roles+beyond+cell+cycle+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdks%252C%2520cyclins%2520and%2520CKIs%253A%2520roles%2520beyond%2520cell%2520cycle%2520regulation%26jtitle%3DDevelopment%26date%3D2013%26volume%3D140%26spage%3D3079%26epage%3D3093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.coph.2005.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15964238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=366-373&author=I.+Collinsauthor=M.+D.+Garrett&title=Targeting+the+cell+division+cycle+in+cancer%3A+CDK+and+cell+cycle+checkpoint+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span></div><div class="casAuthors">Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">366-373</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression through each stage of the cell division cycle and as such are major targets for deregulation in cancer.  This has led to the development of several small-mol. inhibitors of CDKs as potential therapeutic agents for the treatment of this disease.  Progression through the cell cycle is also monitored at several positions known as cell cycle checkpoints, 2 of which occur during G1 and G2 in response to DNA damage.  These are often defective in cancer, leading to the suggestion that inhibition of one or both of the cell cycle checkpoint kinases CHK1 and CHK2 may drive a cancer cell that already has defects in its cell cycle checkpoints towards death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqcFxaO9gh7Vg90H21EOLACvtfcHk0li1W4NKKNSqlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D&md5=40607fa37e866766581683b322829a13</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DTargeting%2520the%2520cell%2520division%2520cycle%2520in%2520cancer%253A%2520CDK%2520and%2520cell%2520cycle%2520checkpoint%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.2174%2F1568026053507688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15853645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=167-179&author=H.+Hiraiauthor=N.+Kawanishiauthor=Y.+Iwasawa&title=Recent+advances+in+the+development+of+selective+small+molecule+inhibitors+for+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of selective small molecule inhibitors for Cyclin-dependent kinases</span></div><div class="casAuthors">Hirai, Hiroshi; Kawanishi, Nobuhiko; Iwasawa, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Loss of normal cell cycle regulation is the hallmark of human cancers, and alteration of the components involved in cell cycle regulation occurs in most human tumors.  This suggests that Cyclin dependent kinases (CDKs) are an attractive target for the development of pharmacol. agents for the treatment of cancer.  Recently, CDK family members that are not directly involved in cell cycle regulation were identified.  This includes CDK7, CDK8, and CDK9, which participate in transcription regulation, and CDK5, which plays a role in neuronal and secretory functions.  Given the involvement of CDKs in multiple cellular processes, development of selective small mol. inhibitors for specific CDKs is expected to help clarify whether improved specificity of cell cycle CDK inhibitors will enhance their therapeutic potential in cancer treatment.  Selective inhibitors are also needed as tools to explore the biol. of diseases in which CDKs may participate and to help develop therapeutics to treat them.  Intensive screening and drug design based on CDK/inhibitor co-crystal structure and SAR studies have led to the identification of a large variety of chem. inhibitors of CDKs.  Although they are competitive with ATP at the catalytic site, their kinase selectivity varies greatly, and inhibitors selective for certain CDKs have begun to be identified.  There are currently 2 categories of selective CDK inhibitors: those that are selective for CDK2 and CDK1 and those that are selective for CDK4/6.  These 2 types of inhibitors have different effects on tumor cells and are expected to be useful in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooiAF6UAza_7Vg90H21EOLACvtfcHk0li1W4NKKNSqlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbw%253D&md5=2fceab02ebbaaca45061a80884571ef7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F1568026053507688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507688%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520selective%2520small%2520molecule%2520inhibitors%2520for%2520cyclin-dependent%2520kinases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Marahatta, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makaju, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petmitr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petmitr, S.</span><span> </span><span class="NLM_article-title">Cancer: determinants and progression</span> <span class="citation_source-journal">Nepal Med. Coll. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16295727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A280%3ADC%252BD2MngvFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=65-71&author=S.+B.+Marahattaauthor=N.+Sharmaauthor=R.+Kojuauthor=R.+K.+Makajuauthor=P.+Petmitrauthor=S.+Petmitr&title=Cancer%3A+determinants+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer: determinants and progression</span></div><div class="casAuthors">Marahatta Sujan Babu; Sharma Nastu; Koju Rajendra; Makaju Ramesh Kumar; Petmitr Porntip; Petmitr Songsak</div><div class="citationInfo"><span class="NLM_cas:title">Nepal Medical College journal : NMCJ</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer is the combination of uncontrolled cellular proliferation and immortality.  It is a multi-step disease with a multi-factorial etiology.  The determinants of cancer are many and varied including genetic predisposition, environmental influences, infectious agents, nutritional factors, hormonal and reproductive factors, radiation etc.  However, the extent of the genetic involvement and their interaction with environment in tumorigenesis is still elusive.  The six essential alterations in cell are proposed which determines the transition from normal cell to malignant.  It includes--self-sufficiency in growth signals, insensitivity to growth-inhibitory (antigrowth) signals, evasion of programmed cell death (apoptosis), limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  Nevertheless, the last two decades have seen rapid improvements in understanding the complex molecular mechanisms underlying tumorigenesis, yet the quest for unraveling the mystery is not over.  Further study in this area is indispensable that could hold the promise of increasing our understanding of cancer etiology and possible preventive strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGqBxaUwso-e_Q9URG6Dx8fW6udTcc2eYUXiOi2jTQqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MngvFGiug%253D%253D&md5=2143a0d5b5f450aa2a0adf628a19416e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarahatta%26aufirst%3DS.%2BB.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DKoju%26aufirst%3DR.%26aulast%3DMakaju%26aufirst%3DR.%2BK.%26aulast%3DPetmitr%26aufirst%3DP.%26aulast%3DPetmitr%26aufirst%3DS.%26atitle%3DCancer%253A%2520determinants%2520and%2520progression%26jtitle%3DNepal%2520Med.%2520Coll.%2520J.%26date%3D2005%26volume%3D7%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell cycle, CDKs and cancer: a changing paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+cycle%2C+CDKs+and+cancer%3A+a+changing+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lgGC3fQ63WUmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520cycle%252C%2520CDKs%2520and%2520cancer%253A%2520a%2520changing%2520paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Connell-Crowley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodrich, D. W.</span><span> </span><span class="NLM_article-title">Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1091%2Fmbc.8.2.287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=9190208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaK2sXhsV2itr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=287-301&author=L.+Connell-Crowleyauthor=J.+W.+Harperauthor=D.+W.+Goodrich&title=Cyclin+D1%2FCdk4+regulates+retinoblastoma+protein-mediated+cell+cycle+arrest+by+site-specific+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation</span></div><div class="casAuthors">Connell-Crowley, Lisa; Harper, J. Wade; Goodrich, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-301</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">The retinoblastoma protein (pRb) inhibits progression through the cell cycle.  Although pRb is phosphorylated when G1 cyclin-dependent kinases (Cdks) are active, the mechanisms underlying pRb regulation are unknown.  In vitro phosphorylation by cyclin D1/Cdk4 leads to inactivation of pRb in a microinjection-based in vivo cell cycle assay.  In contrast, phosphorylation of pRb by Cdk2 or Cdk3 in complexes with A- or E-type cyclins is not sufficient to inactivate pRb function in this assay, despite extensive phosphorylation and conversion to a slowly migrating "hyperphosphorylated form." The differential effects of phosphorylation on pRb function coincide with modification of distinct sets of sites.  Serine 795 is phosphorylated efficiently by Cdk4, even in the absence of an intact LXCXE motif in cyclin D, but not by Cdk2 or Cdk3.  Mutation of serine 795 to alanine prevents pRb inactivation by Cdk4 phosphorylation in the microinjection assay.  This study identifies a residue whose phosphorylation is crit. for inactivation of pRb-mediated growth suppression, and it indicates that hyperphosphorylation and inactivation of pRb are not necessarily synonymous.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuGVSOFEDFLVg90H21EOLACvtfcHk0lgGC3fQ63WUmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsV2itr0%253D&md5=4e25b2edd6f4bcb0aeb6beff4465c5de</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1091%2Fmbc.8.2.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.8.2.287%26sid%3Dliteratum%253Aachs%26aulast%3DConnell-Crowley%26aufirst%3DL.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DGoodrich%26aufirst%3DD.%2BW.%26atitle%3DCyclin%2520D1%252FCdk4%2520regulates%2520retinoblastoma%2520protein-mediated%2520cell%2520cycle%2520arrest%2520by%2520site-specific%2520phosphorylation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D1997%26volume%3D8%26spage%3D287%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Morgan, D. O.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases: engines, clocks, and microprocessors</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1146%2Fannurev.cellbio.13.1.261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=9442875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1997&pages=261-291&author=D.+O.+Morgan&title=Cyclin-dependent+kinases%3A+engines%2C+clocks%2C+and+microprocessors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases: engines, clocks, and microprocessors</span></div><div class="casAuthors">Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-291</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 133 refs.  Cyclin-dependent kinases (Cdks) play a well-established role in the regulation of the eukaryotic cell division cycle and have also been implicated in the control of gene transcription and other processes.  Cdk activity is governed by a complex network of regulatory subunits and phosphorylation events whose precise effects on Cdk conformation have been revealed by recent crystallog. studies.  In the cell, these regulatory mechanisms generate an interlinked series of Cdk oscillators that trigger the events of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDw-roxCwtY7Vg90H21EOLACvtfcHk0lgbKXUz9q0N_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSktA%253D%253D&md5=9b9b161d0beaef5e7934bab158906dcd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.13.1.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.13.1.261%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DCyclin-dependent%2520kinases%253A%2520engines%252C%2520clocks%252C%2520and%2520microprocessors%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D1997%26volume%3D13%26spage%3D261%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span> </span><span class="NLM_article-title">Cancer cell cycles</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1672</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1672-1677&author=C.+J.+Sherr&title=Cancer+cell+cycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26atitle%3DCancer%2520cell%2520cycles%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1672%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Soni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumstein-Mecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=877-884&author=R.+Soniauthor=L.+Mullerauthor=P.+Furetauthor=J.+Schoepferauthor=C.+Stephanauthor=S.+Zumstein-Meckerauthor=H.+Fretzauthor=B.+Chaudhuri&title=Inhibition+of+cyclin-dependent+kinase+4+%28Cdk4%29+by+fascaplysin%2C+a+marine+natural+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoni%26aufirst%3DR.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DZumstein-Mecker%26aufirst%3DS.%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520cyclin-dependent%2520kinase%25204%2520%2528Cdk4%2529%2520by%2520fascaplysin%252C%2520a%2520marine%2520natural%2520product%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D275%26spage%3D877%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=194-199&author=Y.+Gengauthor=Q.+Yuauthor=E.+Sicinskaauthor=M.+Dasauthor=R.+T.+Bronsonauthor=P.+Sicinski&title=Deletion+of+the+p27Kip1+gene+restores+normal+development+in+cyclin+D1-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DDas%26aufirst%3DM.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DDeletion%2520of%2520the%2520p27Kip1%2520gene%2520restores%2520normal%2520development%2520in%2520cyclin%2520D1-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D194%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kitagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taya, Y.</span><span> </span><span class="NLM_article-title">The consensus motif for phosphorylation by cyclin D1–Cdk4 is different from that for phosphorylation by cyclin A/E–Cdk2</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7060</span><span class="NLM_x">–</span> <span class="NLM_lpage">7069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=7060-7069&author=M.+Kitagawaauthor=H.+Higashiauthor=H.+K.+Jungauthor=I.+Suzuki-Takahashiauthor=M.+Ikedaauthor=K.+Tamaiauthor=J.+Katoauthor=K.+Segawaauthor=E.+Yoshidaauthor=S.+Nishimuraauthor=Y.+Taya&title=The+consensus+motif+for+phosphorylation+by+cyclin+D1%E2%80%93Cdk4+is+different+from+that+for+phosphorylation+by+cyclin+A%2FE%E2%80%93Cdk2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DJung%26aufirst%3DH.%2BK.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DTamai%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DJ.%26aulast%3DSegawa%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DE.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DTaya%26aufirst%3DY.%26atitle%3DThe%2520consensus%2520motif%2520for%2520phosphorylation%2520by%2520cyclin%2520D1%25E2%2580%2593Cdk4%2520is%2520different%2520from%2520that%2520for%2520phosphorylation%2520by%2520cyclin%2520A%252FE%25E2%2580%2593Cdk2%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D7060%26epage%3D7069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odajima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=591-598&author=A.+Martinauthor=J.+Odajimaauthor=S.+L.+Huntauthor=P.+Dubusauthor=S.+Ortegaauthor=M.+Malumbresauthor=M.+Barbacid&title=Cdk2+is+dispensable+for+cell+cycle+inhibition+and+tumor+suppression+mediated+by+p27%28Kip1%29+and+p21%28Cip1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DOdajima%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DS.%2BL.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCdk2%2520is%2520dispensable%2520for%2520cell%2520cycle%2520inhibition%2520and%2520tumor%2520suppression%2520mediated%2520by%2520p27%2528Kip1%2529%2520and%2520p21%2528Cip1%2529%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D591%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of cancer cells despite CDK2 inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Is cyclin D1–CDK4 kinase a bona fide cancer target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=2-4&author=M.+Malumbresauthor=M.+Barbacid&title=Is+cyclin+D1%E2%80%93CDK4+kinase+a+bona+fide+cancer+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DIs%2520cyclin%2520D1%25E2%2580%2593CDK4%2520kinase%2520a%2520bona%2520fide%2520cancer%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D2%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=O.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0ljB4DVpIE-s6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DO.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkiewicz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, E. S.</span><span> </span><span class="NLM_article-title">CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">6512</span><span class="NLM_x">–</span> <span class="NLM_lpage">6525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6512-6525&author=J.+Francoauthor=A.+K.+Witkiewiczauthor=E.+S.+Knudsen&title=CDK4%2F6+inhibitors+have+potent+activity+in+combination+with+pathway+selective+therapeutic+agents+in+models+of+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranco%26aufirst%3DJ.%26aulast%3DWitkiewicz%26aufirst%3DA.%2BK.%26aulast%3DKnudsen%26aufirst%3DE.%2BS.%26atitle%3DCDK4%252F6%2520inhibitors%2520have%2520potent%2520activity%2520in%2520combination%2520with%2520pathway%2520selective%2520therapeutic%2520agents%2520in%2520models%2520of%2520pancreatic%2520cancer%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D6512%26epage%3D6525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Breault, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midgley, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minshull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimization of substituted 2,4-bis anilino pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2961-2966&author=G.+A.+Breaultauthor=R.+P.+Ellstonauthor=S.+Greenauthor=S.+R.+Jamesauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+A.+Pauptitauthor=C.+A.+Minshullauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+2%3A+identification+and+optimization+of+substituted+2%2C4-bis+anilino+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DS.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25202%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25202%252C4-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2961%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sanchez-Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumrich, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeHahn, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Considine, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span> </span><span class="NLM_article-title">Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1–CDK4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3835</span><span class="NLM_x">–</span> <span class="NLM_lpage">3839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3835-3839&author=C.+Sanchez-Martinezauthor=C.+Shihauthor=M.+M.+Faulauthor=G.+Zhuauthor=M.+Paalauthor=C.+Somozaauthor=T.+Liauthor=C.+A.+Kumrichauthor=L.+L.+Winneroskiauthor=Z.+Xunauthor=H.+B.+Brooksauthor=B.+K.+Patelauthor=R.+M.+Schultzauthor=T.+B.+DeHahnauthor=C.+D.+Spencerauthor=S.+A.+Watkinsauthor=E.+Considineauthor=J.+A.+Dempseyauthor=C.+A.+Oggauthor=R.+M.+Campbellauthor=B.+A.+Andersonauthor=J.+Wagner&title=Aryl%5Ba%5Dpyrrolo%5B3%2C4-c%5Dcarbazoles+as+selective+cyclin+D1%E2%80%93CDK4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Martinez%26aufirst%3DC.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DPaal%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DKumrich%26aufirst%3DC.%2BA.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DXun%26aufirst%3DZ.%26aulast%3DBrooks%26aufirst%3DH.%2BB.%26aulast%3DPatel%26aufirst%3DB.%2BK.%26aulast%3DSchultz%26aufirst%3DR.%2BM.%26aulast%3DDeHahn%26aufirst%3DT.%2BB.%26aulast%3DSpencer%26aufirst%3DC.%2BD.%26aulast%3DWatkins%26aufirst%3DS.%2BA.%26aulast%3DConsidine%26aufirst%3DE.%26aulast%3DDempsey%26aufirst%3DJ.%2BA.%26aulast%3DOgg%26aufirst%3DC.%2BA.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DAnderson%26aufirst%3DB.%2BA.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DAryl%255Ba%255Dpyrrolo%255B3%252C4-c%255Dcarbazoles%2520as%2520selective%2520cyclin%2520D1%25E2%2580%2593CDK4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3835%26epage%3D3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lg28jfVfE75hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrusin, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toogood, P. L.</span><span> </span><span class="NLM_article-title">Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2371</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049355%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2371-2387&author=S.+N.+VanderWelauthor=P.+J.+Harveyauthor=D.+J.+McNamaraauthor=J.+T.+Repineauthor=P.+R.+Kellerauthor=J.+Quinauthor=R.+J.+Boothauthor=W.+L.+Elliottauthor=E.+M.+Dobrusinauthor=D.+W.+Fryauthor=P.+L.+Toogood&title=Pyrido%5B2%2C3-d%5Dpyrimidin-7-ones+as+specific+inhibitors+of+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm049355%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049355%252B%26sid%3Dliteratum%253Aachs%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DQuin%26aufirst%3DJ.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DDobrusin%26aufirst%3DE.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26atitle%3DPyrido%255B2%252C3-d%255Dpyrimidin-7-ones%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2371%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Beattie, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breault, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midgley, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naven, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minshull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, J. E.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimization of substituted 4,6-bis anilino pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2955</span><span class="NLM_x">–</span> <span class="NLM_lpage">2960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2955-2960&author=J.+F.+Beattieauthor=G.+A.+Breaultauthor=R.+P.+Ellstonauthor=S.+Greenauthor=P.+J.+Jewsburyauthor=C.+J.+Midgleyauthor=R.+T.+Navenauthor=C.+A.+Minshullauthor=R.+A.+Pauptitauthor=J.+A.+Tuckerauthor=J.+E.+Pease&title=Cyclin-dependent+kinase+4+inhibitors+as+a+treatment+for+cancer.+Part+1%3A+identification+and+optimization+of+substituted+4%2C6-bis+anilino+pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DJ.%2BF.%26aulast%3DBreault%26aufirst%3DG.%2BA.%26aulast%3DEllston%26aufirst%3DR.%2BP.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMidgley%26aufirst%3DC.%2BJ.%26aulast%3DNaven%26aufirst%3DR.%2BT.%26aulast%3DMinshull%26aufirst%3DC.%2BA.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DPease%26aufirst%3DJ.%2BE.%26atitle%3DCyclin-dependent%2520kinase%25204%2520inhibitors%2520as%2520a%2520treatment%2520for%2520cancer.%2520Part%25201%253A%2520identification%2520and%2520optimization%2520of%2520substituted%25204%252C6-bis%2520anilino%2520pyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2955%26epage%3D2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Dickson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tap, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gounder, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbone, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ustoyev, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2024</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1200%2FJCO.2012.46.5476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=23569312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=2024-2028&author=M.+A.+Dicksonauthor=W.+D.+Tapauthor=M.+L.+Keohanauthor=S.+P.+D%E2%80%99Angeloauthor=M.+M.+Gounderauthor=C.+R.+Antonescuauthor=J.+Landaauthor=L.+X.+Qinauthor=D.+D.+Rathboneauthor=M.+M.+Condyauthor=Y.+Ustoyevauthor=A.+M.+Cragoauthor=S.+Singerauthor=G.+K.+Schwartz&title=Phase+II+trial+of+the+CDK4+inhibitor+PD0332991+in+patients+with+advanced+CDK4-amplified+well-differentiated+or+dedifferentiated+liposarcoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma</span></div><div class="casAuthors">Dickson, Mark A.; Tap, William D.; Keohan, Mary Louise; D'Angelo, Sandra P.; Gounder, Mrinal M.; Antonescu, Cristina R.; Landa, Jonathan; Qin, Li-Xuan; Rathbone, Dustin D.; Condy, Mercedes M.; Ustoyev, Yelena; Crago, Aimee M.; Singer, Samuel; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2024-2028</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose CDK4 is amplified in > 90% of well-differentiated (WDLS) and dedifferentiated liposarcomas (DDLS).  The selective cyclin-dependent kinase 4 (CDK4)/CDK6 inhibitor PD0332991 inhibits growth and induces senescence in cell lines and xenografts.  In a phase I trial of PD0332991, several patients with WDLS or DDLS experienced prolonged stable disease.  We performed an open-label phase II study to det. the safety and efficacy of PD0332991 in patients with advanced WDLS/DDLS.  Patients and Methods Patients age ≥ 18 years experiencing disease progression while receiving systemic therapy before enrollment received PD0332991 200 mg orally once per day for 14 consecutive days in 21-day cycles.  All were required to have CDK4 amplification by fluorescence in situ hybridization and retinoblastoma protein (RB) expression by immunohistochem. (≥ 1 +).  The primary end point was progression-free survival (PFS) at 12 wk, with 12-wk PFS of ≥ 40% considered promising and ≤ 20% not promising.  If ≥ nine of 28 patients were progression free at 12 wk, PD0332991 would be considered active.  Results We screened 48 patients (44 of 48 had CDK4 amplification; 41 of 44 were RB pos.).  Of those, 30 were enrolled, and 29 were evaluable for the primary end point.  Grade 3 to 4 events included anemia (17%), thrombocytopenia (30%), neutropenia (50%), and febrile neutropenia (3%).  At 12 wk, PFS was 66% (90% CI, 51 % to 100%), significantly exceeding the primary end point.  The median PFS was 18 wk.  There was one partial response.  Conclusion Treatment with the CDK4 inhibitor PD0332991 was assocd. with a favorable progression-free rate in patients with CDK4-amplified and RB-expressing WDLS/DDLS who had progressive disease despite systemic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNBEhZMJmyrVg90H21EOLACvtfcHk0liz5WDxix-EQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtbnL&md5=d0c2be513ba6cda5014428939c7ec975</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.46.5476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.46.5476%26sid%3Dliteratum%253Aachs%26aulast%3DDickson%26aufirst%3DM.%2BA.%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DKeohan%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DS.%2BP.%26aulast%3DGounder%26aufirst%3DM.%2BM.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLanda%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DL.%2BX.%26aulast%3DRathbone%26aufirst%3DD.%2BD.%26aulast%3DCondy%26aufirst%3DM.%2BM.%26aulast%3DUstoyev%26aufirst%3DY.%26aulast%3DCrago%26aufirst%3DA.%2BM.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DPhase%2520II%2520trial%2520of%2520the%2520CDK4%2520inhibitor%2520PD0332991%2520in%2520patients%2520with%2520advanced%2520CDK4-amplified%2520well-differentiated%2520or%2520dedifferentiated%2520liposarcoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26spage%3D2024%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cadoo, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gucalp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traina, T. A.</span><span> </span><span class="NLM_article-title">Palbociclib: an evidence-based review of its potential in the treatment of breast cancer</span> <span class="citation_source-journal">Breast Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=123-133&author=K.+A.+Cadooauthor=A.+Gucalpauthor=T.+A.+Traina&title=Palbociclib%3A+an+evidence-based+review+of+its+potential+in+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCadoo%26aufirst%3DK.%2BA.%26aulast%3DGucalp%26aufirst%3DA.%26aulast%3DTraina%26aufirst%3DT.%2BA.%26atitle%3DPalbociclib%253A%2520an%2520evidence-based%2520review%2520of%2520its%2520potential%2520in%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%26date%3D2014%26volume%3D6%26spage%3D123%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gelbert, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Prado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallena, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajamie, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreklau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Dios, A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1007%2Fs10637-014-0120-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=24919854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWrt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=825-837&author=L.+M.+Gelbertauthor=S.+Caiauthor=X.+Linauthor=C.+Sanchez-Martinezauthor=M.+Del+Pradoauthor=M.+J.+Lallenaauthor=R.+Torresauthor=R.+T.+Ajamieauthor=G.+N.+Wishartauthor=R.+S.+Flackauthor=B.+L.+Neubauerauthor=J.+Youngauthor=E.+M.+Chanauthor=P.+Iversenauthor=D.+Cronierauthor=E.+Kreklauauthor=A.+de+Dios&title=Preclinical+characterization+of+the+CDK4%2F6+inhibitor+LY2835219%3A+in-vivo+cell+cycle-dependent%2Findependent+anti-tumor+activities+alone%2Fin+combination+with+gemcitabine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine</span></div><div class="casAuthors">Gelbert, Lawrence M.; Cai, Shufen; Lin, Xi; Sanchez-Martinez, Concepcion; del Prado, Miriam; Lallena, Maria Jose; Torres, Raquel; Ajamie, Rose T.; Wishart, Graham N.; Flack, Robert Steven; Neubauer, Blake Lee; Young, Jamie; Chan, Edward M.; Iversen, Philip; Cronier, Damien; Kreklau, Emiko; de Dios, Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">825-837</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The G1 restriction point is crit. for regulating the cell cycle and is controlled by the Rb pathway (CDK4/6-cyclin D1-Rb-p16/ink4a).  This pathway is important because of its inactivation in a majority of human tumors.  Transition through the restriction point requires phosphorylation of retinoblastoma protein (Rb) by CDK4/6, which are highly validated cancer drug targets.  We present the identification and characterization of a potent CDK4/6 inhibitor, LY2835219.  LY2835219 inhibits CDK4 and CDK6 with low nanomolar potency, inhibits Rb phosphorylation resulting in a G1 arrest and inhibition of proliferation, and its activity is specific for Rb-proficient cells.  In vivo target inhibition studies show LY2835219 is a potent inhibitor of Rb phosphorylation, induces a complete cell cycle arrest and suppresses expression of several Rb-E2F-regulated proteins 24 h after a single dose.  Oral administration of LY2835219 inhibits tumor growth in human tumor xenografts representing different histologies in tumor-bearing mice.  LY2835219 is effective and well tolerated when administered up to 56 days in immunodeficient mice without significant loss of body wt. or tumor outgrowth.  In calu-6 xenografts, LY2835219 in combination with gemcitabine enhanced in vivo antitumor activity without a G1 cell cycle arrest, but was assocd. with a redn. of ribonucleotide reductase expression.  These results suggest LY2835219 may be used alone or in combination with std.-of-care cytotoxic therapy.  In summary, we have identified a potent, orally active small-mol. inhibitor of CDK4/6 that is active in xenograft tumors.  LY2835219 is currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQrFS1mDbyCrVg90H21EOLACvtfcHk0liz5WDxix-EQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWrt7%252FN&md5=a90fee83bfe8da7e4a7474ccf02fc59a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10637-014-0120-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-014-0120-7%26sid%3Dliteratum%253Aachs%26aulast%3DGelbert%26aufirst%3DL.%2BM.%26aulast%3DCai%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DSanchez-Martinez%26aufirst%3DC.%26aulast%3DDel%2BPrado%26aufirst%3DM.%26aulast%3DLallena%26aufirst%3DM.%2BJ.%26aulast%3DTorres%26aufirst%3DR.%26aulast%3DAjamie%26aufirst%3DR.%2BT.%26aulast%3DWishart%26aufirst%3DG.%2BN.%26aulast%3DFlack%26aufirst%3DR.%2BS.%26aulast%3DNeubauer%26aufirst%3DB.%2BL.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DE.%2BM.%26aulast%3DIversen%26aufirst%3DP.%26aulast%3DCronier%26aufirst%3DD.%26aulast%3DKreklau%26aufirst%3DE.%26aulast%3Dde%2BDios%26aufirst%3DA.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520CDK4%252F6%2520inhibitor%2520LY2835219%253A%2520in-vivo%2520cell%2520cycle-dependent%252Findependent%2520anti-tumor%2520activities%2520alone%252Fin%2520combination%2520with%2520gemcitabine%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2014%26volume%3D32%26spage%3D825%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazawa, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belcastro, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diskin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parasuraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caponigro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnepp, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6173</span><span class="NLM_x">–</span> <span class="NLM_lpage">6182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1158%2F1078-0432.CCR-13-1675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=24045179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6173-6182&author=J.+Raderauthor=M.+R.+Russellauthor=L.+S.+Hartauthor=M.+S.+Nakazawaauthor=L.+T.+Belcastroauthor=D.+Martinezauthor=Y.+Liauthor=E.+L.+Carpenterauthor=E.+F.+Attiyehauthor=S.+J.+Diskinauthor=S.+Kimauthor=S.+Parasuramanauthor=G.+Caponigroauthor=R.+W.+Schneppauthor=A.+C.+Woodauthor=B.+Pawelauthor=K.+A.+Coleauthor=J.+M.+Maris&title=Dual+CDK4%2FCDK6+inhibition+induces+cell-cycle+arrest+and+senescence+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma</span></div><div class="casAuthors">Rader, JulieAnn; Russell, Mike R.; Hart, Lori S.; Nakazawa, Michael S.; Belcastro, Lili T.; Martinez, Daniel; Li, Yimei; Carpenter, Erica L.; Attiyeh, Edward F.; Diskin, Sharon J.; Kim, Sunkyu; Parasuraman, Sudha; Caponigro, Giordano; Schnepp, Robert W.; Wood, Andrew C.; Pawel, Bruce; Cole, Kristina A.; Maris, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6173-6182</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Neuroblastoma is a pediatric cancer that continues to exact significant morbidity and mortality.  Recently, a no. of cell-cycle proteins, particularly those within the Cyclin D/CDK4/CDK6/RB network, have been shown to exert oncogenic roles in neuroblastoma, suggesting that their therapeutic exploitation might improve patient outcomes.  Exptl. Procedures: We evaluated the effect of dual CDK4/CDK6 inhibition on neuroblastoma viability using LEE011 (Novartis Oncol.), a highly specific CDK4/6 inhibitor.  Results: Treatment with LEE011 significantly reduced proliferation in 12 of 17 human neuroblastoma-derived cell lines by inducing cytostasis at nanomolar concns. (mean IC50 = 307 ± 68 nmol/L in sensitive lines).  LEE011 caused cell-cycle arrest and cellular senescence that was attributed to dose-dependent decreases in phosphorylated RB and FOXM1, resp.  In addn., responsiveness of neuroblastoma xenografts to LEE011 translated to the in vivo setting in that there was a direct correlation of in vitro IC50 values with degree of s.c. xenograft growth delay.  Although our data indicate that neuroblastomas sensitive to LEE011 were more likely to contain genomic amplification of MYCN (P = 0.01), the identification of addnl. clin. accessible biomarkers is of high importance.  Conclusions: Taken together, our data show that LEE011 is active in a large subset of neuroblastoma cell line and xenograft models, and supports the clin. development of this CDK4/6 inhibitor as a therapy for patients with this disease.  Clin Cancer Res; 19(22); 6173-82. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowEpLsvDNwSLVg90H21EOLACvtfcHk0liViKwEdKZAbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7rL&md5=5fd1f23125cca7e087d0e14d4c66c3c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1675%26sid%3Dliteratum%253Aachs%26aulast%3DRader%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DM.%2BR.%26aulast%3DHart%26aufirst%3DL.%2BS.%26aulast%3DNakazawa%26aufirst%3DM.%2BS.%26aulast%3DBelcastro%26aufirst%3DL.%2BT.%26aulast%3DMartinez%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCarpenter%26aufirst%3DE.%2BL.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DDiskin%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DParasuraman%26aufirst%3DS.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DSchnepp%26aufirst%3DR.%2BW.%26aulast%3DWood%26aufirst%3DA.%2BC.%26aulast%3DPawel%26aufirst%3DB.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DDual%2520CDK4%252FCDK6%2520inhibition%2520induces%2520cell-cycle%2520arrest%2520and%2520senescence%2520in%2520neuroblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6173%26epage%3D6182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Segraves, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Said, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietraszkiewicz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valeriote, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, P.</span><span> </span><span class="NLM_article-title">Comparison of fascaplysin and related alkaloids: a study of structures, cytotoxicities, and sources</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span></span><div class="citationLinks">[<a href="/doi/10.1021/np049935%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVSqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=783-792&author=N.+L.+Segravesauthor=S.+J.+Robinsonauthor=D.+Garciaauthor=S.+A.+Saidauthor=X.+Fuauthor=F.+J.+Schmitzauthor=H.+Pietraszkiewiczauthor=F.+A.+Valerioteauthor=P.+Crews&title=Comparison+of+fascaplysin+and+related+alkaloids%3A+a+study+of+structures%2C+cytotoxicities%2C+and+sources"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of fascaplysin and related alkaloids: A study of structures, cytotoxicities, and sources</span></div><div class="casAuthors">Segraves, Nathaniel L.; Robinson, Sarah J.; Garcia, Daniel; Said, Sadri A.; Fu, Xiong; Schmitz, Francis J.; Pietraszkiewicz, Halina; Valeriote, Frederick A.; Crews, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fascaplysin class of compds. have been further investigated from six organisms consisting of four sponge collections (Fascaplysinopsis reticulata) and two tunicate collections (Didemnum sp.).  This work is an extension of an earlier communication and reports the isolation of 12 new fascaplysin derivs.: 10-bromofascaplysin, 3,10-dibromofascaplysin, homofascaplysate A , homofascaplysin B-1, 3-bromohomofascaplysins B, B-1, and C, 7,14-dibromoreticulatine , reticulatol, 14-bromoreticulatol, and 3-bromosecofascaplysins A and B, along with known compds.: fascaplysin, reticulatine, 3-bromofascaplysin, and homofascaplysin C.  Selected compds. were screened in a cell-based cytotoxicity assay with compds. fascaplysin, 3-bromofascaplysin, and fascaplysin A also screened in the NCI 60 cell line panel.  A biogenetic pathway for the brominated fascaplysins and brominated related alkaloids is proposed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvi-WY3GdExLVg90H21EOLACvtfcHk0liViKwEdKZAbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVSqs7g%253D&md5=6b6e947c135a9ebe94ba32fbbd15008e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fnp049935%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049935%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSegraves%26aufirst%3DN.%2BL.%26aulast%3DRobinson%26aufirst%3DS.%2BJ.%26aulast%3DGarcia%26aufirst%3DD.%26aulast%3DSaid%26aufirst%3DS.%2BA.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DSchmitz%26aufirst%3DF.%2BJ.%26aulast%3DPietraszkiewicz%26aufirst%3DH.%26aulast%3DValeriote%26aufirst%3DF.%2BA.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DComparison%2520of%2520fascaplysin%2520and%2520related%2520alkaloids%253A%2520a%2520study%2520of%2520structures%252C%2520cytotoxicities%252C%2520and%2520sources%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D783%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bharate, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mupparapu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battini, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwakarma, R. A.</span><span> </span><span class="NLM_article-title">Chemistry and biology of fascaplysin, a potent marine-derived CDK-4 inhibitor</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=650-664&author=S.+B.+Bharateauthor=S.+Mandaauthor=N.+Mupparapuauthor=N.+Battiniauthor=R.+A.+Vishwakarma&title=Chemistry+and+biology+of+fascaplysin%2C+a+potent+marine-derived+CDK-4+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBharate%26aufirst%3DS.%2BB.%26aulast%3DManda%26aufirst%3DS.%26aulast%3DMupparapu%26aufirst%3DN.%26aulast%3DBattini%26aufirst%3DN.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DChemistry%2520and%2520biology%2520of%2520fascaplysin%252C%2520a%2520potent%2520marine-derived%2520CDK-4%2520inhibitor%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D650%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bharate, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwakarma, R. A.</span><span> </span><span class="NLM_article-title">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1039%2Fc2md20076g" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1098-1103&author=S.+B.+Bharateauthor=S.+Mandaauthor=P.+Joshiauthor=B.+Singhauthor=R.+A.+Vishwakarma&title=Total+synthesis+and+anti-cholinesterase+activity+of+marine-derived+bis-indole+alkaloid+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fc2md20076g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20076g%26sid%3Dliteratum%253Aachs%26aulast%3DBharate%26aufirst%3DS.%2BB.%26aulast%3DManda%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DTotal%2520synthesis%2520and%2520anti-cholinesterase%2520activity%2520of%2520marine-derived%2520bis-indole%2520alkaloid%2520fascaplysin%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1098%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hamilton, G.</span><span> </span><span class="NLM_article-title">Cytotoxic effects of fascaplysin against small cell lung cancer cell lines</span> <span class="citation_source-journal">Mar. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.3390%2Fmd12031377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=24608973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A280%3ADC%252BC2crhs1Clsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=1377-1389&author=G.+Hamilton&title=Cytotoxic+effects+of+fascaplysin+against+small+cell+lung+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of fascaplysin against small cell lung cancer cell lines</span></div><div class="casAuthors">Hamilton Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Marine drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1377-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fascaplysin, the natural product of a marine sponge, exhibits anticancer activity against a broad range of tumor cells, presumably through interaction with DNA, and/or as a highly selective cyclin-dependent kinase 4 (CDK4) inhibitor.  In this study, cytotoxic activity of fascaplysin against a panel of small cell lung cancer (SCLC) cell lines and putative synergism with chemotherapeutics was investigated.  SCLC responds to first-line chemotherapy with platinum-based drugs/etoposide, but relapses early with topotecan remaining as the single approved therapeutic agent.  Fascaplysin was found to show high cytotoxicity against SCLC cells and to induce cell cycle arrest in G1/0 at lower and S-phase at higher concentrations, respectively.  The compound generated reactive oxygen species (ROS) and induced apoptotic cell death in the chemoresistant NCI-H417 SCLC cell line.  Furthermore, fascaplysin revealed marked synergism with the topoisomerase I-directed camptothecin and 10-hydroxy-camptothecin.  The Poly(ADP-ribose)-Polymerase 1 (PARP1) inhibitor BYK 204165 antagonized the cytotoxic activity of fascaplysin, pointing to the involvement of DNA repair in response to the anticancer activity of the drug.  In conclusion, fascaplysin seems to be suitable for treatment of SCLC, based on high cytotoxic activity through multiple routes of action, affecting topoisomerase I, integrity of DNA and generation of ROS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSy9ppxZfx-fFHFYivNCdPRfW6udTcc2ea8znMyjmBmLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhs1Clsg%253D%253D&md5=59292fc6adb9bcb2640d82907f0b95ef</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fmd12031377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd12031377%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DG.%26atitle%3DCytotoxic%2520effects%2520of%2520fascaplysin%2520against%2520small%2520cell%2520lung%2520cancer%2520cell%2520lines%26jtitle%3DMar.%2520Drugs%26date%3D2014%26volume%3D12%26spage%3D1377%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, P.</span><span> </span><span class="NLM_article-title">Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.ejps.2011.04.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=21569843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=251-259&author=X.+Yanauthor=H.+Chenauthor=X.+Luauthor=F.+Wangauthor=W.+Xuauthor=H.+Jinauthor=P.+Zhu&title=Fascaplysin+exert+anti-tumor+effects+through+apoptotic+and+anti-angiogenesis+pathways+in+sarcoma+mice+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model</span></div><div class="casAuthors">Yan, Xiaojun; Chen, Haimin; Lu, Xiaoling; Wang, Feng; Xu, Weifeng; Jin, Haixiao; Zhu, Peng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-259</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies indicated that fascaplysin derived from marine sponge can induce tumor cell death by apoptosis and possesses anti-angiogenesis activity.  In order to verify these 2 effects in animal model and to identify action mechanisms, we established a sarcoma mice model, and treated mice with fascaplysin for 10 days.  The tumor tissues were examd. morphol. and immunohistochem.  The differential gene expression was also investigated by mRNA array.  Fascaplysin treatment resulted in a significant suppression of tumor growth.  Typical apoptotic phenomena were obsd. by transmission electron microscope and histol. detection.  Tissue sections were stained with monoclonal antibody directed to proliferating cell nuclear antigen (PCNA) and CD31.  The decreased PCNA and CD31 antigen staining indicate the redn. of tumor cell proliferation and tumor vasculature property of fascaplysin in vivo.  Microarrays were used to examine the gene expression profiles of tumors on CapitalBio mouse genome oligo array.  The regulated genes analyzed from the expression level showed overlapping gene ontol. (GO) categories and pathway mapping.  These findings indicate that cell cycle arrest, apoptosis, regulation of actin cytoskeleton, and cell adhesion all play important roles in the onset of fascaplysin.  Detailed anal. by real time PCR of key genes confirmed the exptl. results of microarrays.  From these findings, it can be considered that fascaplysin can inhibit the growth of S180 cell implanted tumor, and the action mechanisms may involve in apoptosis, anti-angiogenesis, or cell cycle arrest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo543O3ShB2BrVg90H21EOLACvtfcHk0lhLSPDKvnRBPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejs7k%253D&md5=03c9178e9e35a6abbb98443c307a326b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2011.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2011.04.018%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DP.%26atitle%3DFascaplysin%2520exert%2520anti-tumor%2520effects%2520through%2520apoptotic%2520and%2520anti-angiogenesis%2520pathways%2520in%2520sarcoma%2520mice%2520model%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D43%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Shafiq, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R.</span><span> </span><span class="NLM_article-title">Fascaplysin as a specific inhibitor for CDK4: insights from molecular modelling</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e42612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e42612&author=M.+I.+Shafiqauthor=T.+Steinbrecherauthor=R.+Schmid&title=Fascaplysin+as+a+specific+inhibitor+for+CDK4%3A+insights+from+molecular+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShafiq%26aufirst%3DM.%2BI.%26aulast%3DSteinbrecher%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DR.%26atitle%3DFascaplysin%2520as%2520a%2520specific%2520inhibitor%2520for%2520CDK4%253A%2520insights%2520from%2520molecular%2520modelling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De42612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingston, D. G.</span><span> </span><span class="NLM_article-title">Sesterterpenoids and an alkaloid from a <i>Thorectandra</i> sp. as inhibitors of the phosphatase Cdc25B</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5094</span><span class="NLM_x">–</span> <span class="NLM_lpage">5098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=5094-5098&author=S.+Caoauthor=C.+Fosterauthor=J.+S.+Lazoauthor=D.+G.+Kingston&title=Sesterterpenoids+and+an+alkaloid+from+a+Thorectandra+sp.+as+inhibitors+of+the+phosphatase+Cdc25B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DKingston%26aufirst%3DD.%2BG.%26atitle%3DSesterterpenoids%2520and%2520an%2520alkaloid%2520from%2520a%2520Thorectandra%2520sp.%2520as%2520inhibitors%2520of%2520the%2520phosphatase%2520Cdc25B%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D5094%26epage%3D5098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kirsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminsky, R.</span><span> </span><span class="NLM_article-title">A new bioactive sesterterpene and antiplasmodial alkaloids from the marine sponge <i>Hyrtios cf. erecta</i></span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks">[<a href="/doi/10.1021/np990555b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2000&pages=825-829&author=G.+Kirschauthor=G.+M.+Kongauthor=A.+D.+Wrightauthor=R.+Kaminsky&title=A+new+bioactive+sesterterpene+and+antiplasmodial+alkaloids+from+the+marine+sponge+Hyrtios+cf.+erecta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp990555b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp990555b%26sid%3Dliteratum%253Aachs%26aulast%3DKirsch%26aufirst%3DG.%26aulast%3DKong%26aufirst%3DG.%2BM.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DKaminsky%26aufirst%3DR.%26atitle%3DA%2520new%2520bioactive%2520sesterterpene%2520and%2520antiplasmodial%2520alkaloids%2520from%2520the%2520marine%2520sponge%2520Hyrtios%2520cf.%2520erecta%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2000%26volume%3D63%26spage%3D825%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Charan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Cytotoxic alkaloids from the marine sponge <i>Thorectandra</i> sp</span> <span class="citation_source-journal">Nat. Prod. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1080%2F14786410310001622077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15143832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFCisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=225-229&author=R.+D.+Charanauthor=T.+C.+McKeeauthor=M.+R.+Boyd&title=Cytotoxic+alkaloids+from+the+marine+sponge+Thorectandra+sp"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic alkaloids from the marine sponge Thorectandra sp.</span></div><div class="casAuthors">Charan, Romila D.; McKee, Tawnya C.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-229</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Three β-carboline alkaloids, Compd. (I), 1-deoxysecofascaplysin A (II), and fascaplysine, were isolated from the aq. and org. exts. of the marine sponge Thorectandra sp.  The structures of I and II were detd. on the basis of spectral data.  Compd. I inhibited the growth of MCF-7 (breast) with an IC50 of 5.9 μg/mL while Compd. II inhibited the growth of MCF-7 as well as OVCAR-3 (ovarian) human tumor cell lines with IC50s of 1.5 and 2.2 μg/mL, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_TBR6dguoIrVg90H21EOLACvtfcHk0lhGbv31p67NtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFCisLc%253D&md5=dedfaf73b4d5398baaaf42943b56280b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F14786410310001622077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786410310001622077%26sid%3Dliteratum%253Aachs%26aulast%3DCharan%26aufirst%3DR.%2BD.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DCytotoxic%2520alkaloids%2520from%2520the%2520marine%2520sponge%2520Thorectandra%2520sp%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2004%26volume%3D18%26spage%3D225%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hormann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span> </span><span class="NLM_article-title">DNA binding properties of the marine sponge pigment fascaplysin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">921</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=917-921&author=A.+Hormannauthor=B.+Chaudhuriauthor=H.+Fretz&title=DNA+binding+properties+of+the+marine+sponge+pigment+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHormann%26aufirst%3DA.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DFretz%26aufirst%3DH.%26atitle%3DDNA%2520binding%2520properties%2520of%2520the%2520marine%2520sponge%2520pigment%2520fascaplysin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D9%26spage%3D917%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">1696</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1696-1697&author=C.+Aubryauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffe&title=New+fascaplysin-based+CDK4-specific+inhibitors%3A+design%2C+synthesis+and+biological+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DNew%2520fascaplysin-based%2520CDK4-specific%2520inhibitors%253A%2520design%252C%2520synthesis%2520and%2520biological%2520activity%26jtitle%3DChem.%2520Commun.%26date%3D2004%26spage%3D1696%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maréchal, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span> </span><span class="NLM_article-title">The design and synthesis of novel 3-[2-indol-1-yl-ethyl]-1<i>H</i>-indole derivatives as selective inhibitors of CDK4</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1423-1425&author=C.+Aubryauthor=A.+Patelauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.-D.+Mar%C3%A9chalauthor=M.+J.+Sutcliffeauthor=P.+R.+Jenkins&title=The+design+and+synthesis+of+novel+3-%5B2-indol-1-yl-ethyl%5D-1H-indole+derivatives+as+selective+inhibitors+of+CDK4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMar%25C3%25A9chal%26aufirst%3DJ.-D.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520novel%25203-%255B2-indol-1-yl-ethyl%255D-1H-indole%2520derivatives%2520as%2520selective%2520inhibitors%2520of%2520CDK4%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D1423%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=787-801&author=C.+Aubryauthor=A.+J.+Wilsonauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffe&title=Design%2C+synthesis+and+biological+activity+of+new+CDK4-specific+inhibitors%2C+based+on+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520new%2520CDK4-specific%2520inhibitors%252C%2520based%2520on%2520fascaplysin%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin</span> <span class="citation_source-journal">Bioorg. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2Fj.bioorg.2006.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16904725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Ohur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=287-297&author=S.+Mahaleauthor=C.+Aubryauthor=P.+R.+Jenkinsauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffeauthor=B.+Chaudhuri&title=Inhibition+of+cancer+cell+growth+by+cyclin+dependent+kinase+4+inhibitors+synthesized+based+on+the+structure+of+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin</span></div><div class="casAuthors">Mahale, Sachin; Aubry, Carine; Jenkins, Paul R.; Marechal, Jean-Didier; Sutcliffe, Michael J.; Chaudhuri, Bhabatosh</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tryptamine derivs., a new structural class of cyclin dependent kinase 4 inhibitors, have been identified during extensive biol. screening of synthetic mols.  The mols. were synthesized based on the structure of fascaplysin, which is not only a specific inhibitor of the Cdk4-cyclin D1 enzyme but also a relatively toxic mol., probably because it binds and intercalates DNA.  Interestingly, the new structural analogs of fascaplysin do not interact or intercalate with double-stranded DNA, although they inhibit Cdk4-cyclin D1 specifically.  We found that compd. CA199 was the most potent mol., showing at least 25-fold specificity towards Cdk4-cyclin D1 (IC50 for Cdk4-cyclin D1=20 μM, Cdk2>500 μM).  CA199 inhibits the growth of different cancer cell lines at concns. ranging from 10-40 μM.  It blocks growth of asynchronous cells at G0/G1 in a retinoblastoma protein (pRb) dependent manner.  Moreover, CA199 blocks growth only at early G1 in synchronized cells released from a mimosine-induced G1/S block.  These observations are reminiscent of a true Cdk4 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDM1ujQ5HiPbVg90H21EOLACvtfcHk0lh_wQS3pII-dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Ohur4%253D&md5=7c70789d1743071825a55417dc85f282</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2006.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2006.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520cancer%2520cell%2520growth%2520by%2520cyclin%2520dependent%2520kinase%25204%2520inhibitors%2520synthesized%2520based%2520on%2520the%2520structure%2520of%2520fascaplysin%26jtitle%3DBioorg.%2520Chem.%26date%3D2006%26volume%3D34%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4272</span><span class="NLM_x">–</span> <span class="NLM_lpage">4278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4272-4278&author=S.+Mahaleauthor=C.+Aubryauthor=A.+James+Wilsonauthor=P.+R.+Jenkinsauthor=J.+D.+Marechalauthor=M.+J.+Sutcliffeauthor=B.+Chaudhuri&title=CA224%2C+a+non-planar+analogue+of+fascaplysin%2C+inhibits+Cdk4+but+not+Cdk2+and+arrests+cells+at+G0%2FG1+inhibiting+pRB+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DJames%2BWilson%26aufirst%3DA.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMarechal%26aufirst%3DJ.%2BD.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DCA224%252C%2520a%2520non-planar%2520analogue%2520of%2520fascaplysin%252C%2520inhibits%2520Cdk4%2520but%2520not%2520Cdk2%2520and%2520arrests%2520cells%2520at%2520G0%252FG1%2520inhibiting%2520pRB%2520phosphorylation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4272%26epage%3D4278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hastie, S. B.</span><span> </span><span class="NLM_article-title">Interactions of colchicine with tubulin</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2F0163-7258%2891%2990067-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=1792241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaK38Xht1ShsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=377-401&author=S.+B.+Hastie&title=Interactions+of+colchicine+with+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of colchicine with tubulin</span></div><div class="casAuthors">Hastie, Susan Bane</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-401</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">A review with ∼230 refs.  Colchicine exerts its biol. effects through binding to the sol. tubulin heterodimer, the major component of the microtubule.  The colchicine-binding abilities of tubulins from a variety of sources are summarized, and the mechanism of colchicine binding to brain tubulin is explored in depth.  The relationship between colchicinoid structure and tubulin binding activity provides insight into the structural features of colchicine responsible for high affinity binding to tubulin and is reviewed for analogs in the colchicine series.  The thermodn. and kinetic aspects of the assocn. are described and evaluated in terms of the binding mechanism.  Colchicine binding to tubulin results in unusual alterations in the low energy electronic spectra of colchicine.  The spectroscopic features of colchicine bound to tubulin are discussed in terms of the nature of the colchicine-tubulin complex.  Attempts to locate the high affinity colchicine binding site on tubulin are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIJ1hpeu3pB7Vg90H21EOLACvtfcHk0lih1lfPUKMq_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1ShsLw%253D&md5=13a53c4b603f19fa2d1f1464782b11fc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0163-7258%2891%2990067-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7258%252891%252990067-V%26sid%3Dliteratum%253Aachs%26aulast%3DHastie%26aufirst%3DS.%2BB.%26atitle%3DInteractions%2520of%2520colchicine%2520with%2520tubulin%26jtitle%3DPharmacol.%2520Ther.%26date%3D1991%26volume%3D51%26spage%3D377%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Brossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrzanowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suffness, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverton, J.</span><span> </span><span class="NLM_article-title">Colchicine and its analogues: recent findings</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1002%2Fmed.2610080105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=3278182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVGks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1988&pages=77-94&author=A.+Brossiauthor=H.+J.+Yehauthor=M.+Chrzanowskaauthor=J.+Wolffauthor=E.+Hamelauthor=C.+M.+Linauthor=F.+Quinauthor=M.+Suffnessauthor=J.+Silverton&title=Colchicine+and+its+analogues%3A+recent+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Colchicine and its analogs:  recent findings</span></div><div class="casAuthors">Brossi, Arnold; Yeh, Herman J. C.; Chrzanowska, Maria; Wolff, J.; Hamel, Ernest; Lin, Chii M.; Quin, Frank; Suffness, Matthew; Silverton, James</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-94</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review with 61 refs. examg. the binding of colchicine and its analogs to tubulin proteins, NMR studies of phenyl-tropolone atropisomerism in such binding, x-ray anal. of colchicinoids, the antitumor and anti-inflammatory activities of colchicinoids, and the prepn. and formation of colchicine analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH6IqwYcoiKLVg90H21EOLACvtfcHk0lih1lfPUKMq_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVGks7c%253D&md5=1dc2d7f97b2c8735c6fa7a9e405151eb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610080105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610080105%26sid%3Dliteratum%253Aachs%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DYeh%26aufirst%3DH.%2BJ.%26aulast%3DChrzanowska%26aufirst%3DM.%26aulast%3DWolff%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DQuin%26aufirst%3DF.%26aulast%3DSuffness%26aufirst%3DM.%26aulast%3DSilverton%26aufirst%3DJ.%26atitle%3DColchicine%2520and%2520its%2520analogues%253A%2520recent%2520findings%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1988%26volume%3D8%26spage%3D77%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bhattacharyya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, M.</span><span> </span><span class="NLM_article-title">Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1002%2Fmed.20097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=17464966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=155-183&author=B.+Bhattacharyyaauthor=D.+Pandaauthor=S.+Guptaauthor=M.+Banerjee&title=Anti-mitotic+activity+of+colchicine+and+the+structural+basis+for+its+interaction+with+tubulin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin</span></div><div class="casAuthors">Bhattacharyya, Bhabatarak; Panda, Dulal; Gupta, Suvroma; Banerjee, Mithu</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-183</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In this review, an attempt has been made to throw light on the mechanism of action of colchicine and its different analogs as anti-cancer agents.  Colchicine interacts with tubulin and perturbs the assembly dynamics of microtubules.  Though its use has been limited because of its toxicity, colchicine can still be used as a lead compd. for the generation of potent anti-cancer drugs.  Colchicine binds to tubulin in a poorly reversible manner with high activation energy.  The binding interaction is favored entropically.  In contrast, binding of its simple analogs AC or DAAC is enthalpically favored and commences with comparatively low activation energy.  Colchicine-tubulin interaction, which is normally pH dependent, has been found to be independent of pH in the presence of microtubule-assocd. proteins, salts or upon cleavage of carboxy termini of tubulin.  Biphasic kinetics of colchicines-tubulin interaction has been explained in light of the variation in the residues around the drug-binding site on β-tubulin.  Using the crystal structure of the tubulin-DAMAcolchicine complex, a detailed discussion on the pharmacophore concept that explains the variation of affinity for different colchicine site inhibitors (CSI) has been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9F4KA4GVMr7Vg90H21EOLACvtfcHk0lih1lfPUKMq_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVSjsA%253D%253D&md5=720f26c98a40dd91634dbe558d982e98</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fmed.20097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20097%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DB.%26aulast%3DPanda%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DM.%26atitle%3DAnti-mitotic%2520activity%2520of%2520colchicine%2520and%2520the%2520structural%2520basis%2520for%2520its%2520interaction%2520with%2520tubulin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D155%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Judge, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakoli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fronda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambegia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClintock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLachlan, I.</span><span> </span><span class="NLM_article-title">Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1172%2FJCI37515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=19229107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2ktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=661-673&author=A.+D.+Judgeauthor=M.+Robbinsauthor=I.+Tavakoliauthor=J.+Leviauthor=L.+Huauthor=A.+Frondaauthor=E.+Ambegiaauthor=K.+McClintockauthor=I.+MacLachlan&title=Confirming+the+RNAi-mediated+mechanism+of+action+of+siRNA-based+cancer+therapeutics+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice</span></div><div class="casAuthors">Judge, Adam D.; Robbins, Marjorie; Tavakoli, Iran; Levi, Jasna; Hu, Lina; Fronda, Anna; Ambegia, Ellen; McClintock, Kevin; MacLachlan, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-673</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">SiRNAs that specifically silence the expression of cancer-related genes offer a therapeutic approach in oncol.  However, it remains crit. to det. the true mechanism of their therapeutic effects.  Here, we describe the preclin. development of chem. modified siRNA targeting the essential cell-cycle proteins polo-like kinase 1 (PLK1) and kinesin spindle protein (KSP) in mice.  SiRNA formulated in stable nucleic acid lipid particles (SNALP) displayed potent antitumor efficacy in both hepatic and s.c. tumor models.  This was correlated with target gene silencing following a single i.v. administration that was sufficient to cause extensive mitotic disruption and tumor cell apoptosis.  Our siRNA formulations induced no measurable immune response, minimizing the potential for nonspecific effects.  Addnl., RNAi-specific mRNA cleavage products were found in tumor cells, and their presence correlated with the duration of target mRNA silencing.  Histol. biomarkers confirmed that RNAi-mediated gene silencing effectively inhibited the target's biol. activity.  This report supports an RNAi-mediated mechanism of action for siRNA antitumor effects, suggesting a new methodol. for targeting other key genes in cancer development with siRNA-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqfVQCE9Q37Vg90H21EOLACvtfcHk0lio1ANeWCdGPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2ktLc%253D&md5=4ed79a06421ab2c0eba797f7b4e40518</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1172%2FJCI37515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI37515%26sid%3Dliteratum%253Aachs%26aulast%3DJudge%26aufirst%3DA.%2BD.%26aulast%3DRobbins%26aufirst%3DM.%26aulast%3DTavakoli%26aufirst%3DI.%26aulast%3DLevi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DFronda%26aufirst%3DA.%26aulast%3DAmbegia%26aufirst%3DE.%26aulast%3DMcClintock%26aufirst%3DK.%26aulast%3DMacLachlan%26aufirst%3DI.%26atitle%3DConfirming%2520the%2520RNAi-mediated%2520mechanism%2520of%2520action%2520of%2520siRNA-based%2520cancer%2520therapeutics%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D661%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scambia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferlini, C.</span><span> </span><span class="NLM_article-title">Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1016%2FS1074-5521%2801%2900097-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=11841942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtF2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=93-101&author=M.+A.+Jordanauthor=I.+Ojimaauthor=F.+Rosasauthor=M.+Distefanoauthor=L.+Wilsonauthor=G.+Scambiaauthor=C.+Ferlini&title=Effects+of+novel+taxanes+SB-T-1213+and+IDN5109+on+tubulin+polymerization+and+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Novel Taxanes SB-T-1213 and IDN5109 on Tubulin Polymerization and Mitosis</span></div><div class="casAuthors">Jordan, Mary Ann; Ojima, Iwao; Rosas, Francisco; Distefano, Mariagrazia; Wilson, Leslie; Scambia, Giovanni; Ferlini, Cristiano</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">SB-T-1213 and IDN5109 are semisynthetic, orally available taxanes that are up to 400-fold more active than paclitaxel against drug-resistant cells.  IDN5109 is in clin. trials.  We investigated the primary target for SB-T-1213 and IDN5109 and whether the compds. interact with microtubules differently than paclitaxel.  Unlike paclitaxel, at 1-10 μM both novel taxanes initiate microtubule polymn. in vitro with no lag.  They enhance polymn. equally or more potently than paclitaxel.  SB-T-1213 induces unusual microtubules with attached extra protofilaments or open sheets, and IDN5109 induces large protofilamentous sheets.  Both inhibit HeLa cell proliferation, block mitosis at the metaphase/anaphase transition, bundle microtubules at high drug concns., and induce abnormal metaphase spindles and apoptosis.  They target microtubules but alter their polymn. and structure differently than paclitaxel.  These differences may play a role in their enhanced cytotoxicity and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRgPoAecBPO7Vg90H21EOLACvtfcHk0lio1ANeWCdGPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtF2isbw%253D&md5=936f9ddc6e9d551de108dc809f785265</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900097-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900097-7%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DOjima%26aufirst%3DI.%26aulast%3DRosas%26aufirst%3DF.%26aulast%3DDistefano%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DScambia%26aufirst%3DG.%26aulast%3DFerlini%26aufirst%3DC.%26atitle%3DEffects%2520of%2520novel%2520taxanes%2520SB-T-1213%2520and%2520IDN5109%2520on%2520tubulin%2520polymerization%2520and%2520mitosis%26jtitle%3DChem.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timasheff, S. N.</span><span> </span><span class="NLM_article-title">In vitro reconstitution of calf brain microtubules: effects of solution variables</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1754</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00627a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1977&pages=1754-1764&author=J.+C.+Leeauthor=S.+N.+Timasheff&title=In+vitro+reconstitution+of+calf+brain+microtubules%3A+effects+of+solution+variables"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbi00627a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00627a037%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTimasheff%26aufirst%3DS.%2BN.%26atitle%3DIn%2520vitro%2520reconstitution%2520of%2520calf%2520brain%2520microtubules%253A%2520effects%2520of%2520solution%2520variables%26jtitle%3DBiochemistry%26date%3D1977%26volume%3D16%26spage%3D1754%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Sandra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendarmin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Inhibition of Akt and MAPK pathways elevated potential of TNFalpha in inducing apoptosis in ameloblastoma</span> <span class="citation_source-journal">Oral Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=16140562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=39-45&author=F.+Sandraauthor=L.+Hendarminauthor=Y.+Nakaoauthor=N.+Nakamuraauthor=S.+Nakamura&title=Inhibition+of+Akt+and+MAPK+pathways+elevated+potential+of+TNFalpha+in+inducing+apoptosis+in+ameloblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Akt and MAPK pathways elevated potential of TNFα in inducing apoptosis in ameloblastoma</span></div><div class="casAuthors">Sandra, Ferry; Hendarmin, Laifa; Nakao, Yu; Nakamura, Norifumi; Nakamura, Seiji</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-45</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor alpha (TNFα) can trigger both cell survival and apoptosis.  In the present study, from the flow cytometry results, we found that the prolonged-treatment of TNFα until 24 h, resulted apoptosis in AM-1 cells (ameloblastoma cell line).  These results were confirmed by DAPI staining, which showed nuclear fragmentation feature of AM-1 cells under treatment of TNFα.  Our further investigation using specific caspase inhibitors showed that caspase-3 played a crucial role in mediating TNFα-induced apoptosis in AM-1 cells.  In addn., significant elevation of TNFα potential in inducing apoptosis was seen by applying LY294002, phosphatidylinositol-3-OH kinase (PI3K) inhibitor, or U0126, mitogen-activated extracellular-regulated kinase (MEK1/2) inhibitor, prior to the treatment of TNFα in AM-1 cells.  These results suggested that TNFα induced both cell survival and apoptosis pathways in ameloblastoma and potential of TNFα in inducing apoptosis can be improved by inhibiting TNFα-induced Akt and p44/42 mitogen-activated protein kinase (MAPK) cell survival pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK2XjCaI5q0LVg90H21EOLACvtfcHk0lio1ANeWCdGPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCrtrnL&md5=94910209e6e9e3c395b4169d7adbbf28</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandra%26aufirst%3DF.%26aulast%3DHendarmin%26aufirst%3DL.%26aulast%3DNakao%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520Akt%2520and%2520MAPK%2520pathways%2520elevated%2520potential%2520of%2520TNFalpha%2520in%2520inducing%2520apoptosis%2520in%2520ameloblastoma%26jtitle%3DOral%2520Oncol.%26date%3D2006%26volume%3D42%26spage%3D39%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Crespi, C. L.</span><span> </span><span class="NLM_article-title">Microplate plate assays for inhibition of human drug metabolizing cytochrome P450</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1997&pages=188-190&author=C.+L.+Crespi&title=Microplate+plate+assays+for+inhibition+of+human+drug+metabolizing+cytochrome+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DMicroplate%2520plate%2520assays%2520for%2520inhibition%2520of%2520human%2520drug%2520metabolizing%2520cytochrome%2520P450%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D248%26spage%3D188%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Mohammad, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almatchy, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flake, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dergham, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Katib, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaitkevicius, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkar, F. H.</span><span> </span><span class="NLM_article-title">Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents</span> <span class="citation_source-journal">Pancreas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=19-25&author=R.+M.+Mohammadauthor=M.+C.+Duganauthor=A.+N.+Mohamedauthor=V.+P.+Almatchyauthor=T.+M.+Flakeauthor=S.+T.+Derghamauthor=A.+F.+Shieldsauthor=A.+A.+Al-Katibauthor=V.+K.+Vaitkeviciusauthor=F.+H.+Sarkar&title=Establishment+of+a+human+pancreatic+tumor+xenograft+model%3A+potential+application+for+preclinical+evaluation+of+novel+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DR.%2BM.%26aulast%3DDugan%26aufirst%3DM.%2BC.%26aulast%3DMohamed%26aufirst%3DA.%2BN.%26aulast%3DAlmatchy%26aufirst%3DV.%2BP.%26aulast%3DFlake%26aufirst%3DT.%2BM.%26aulast%3DDergham%26aufirst%3DS.%2BT.%26aulast%3DShields%26aufirst%3DA.%2BF.%26aulast%3DAl-Katib%26aufirst%3DA.%2BA.%26aulast%3DVaitkevicius%26aufirst%3DV.%2BK.%26aulast%3DSarkar%26aufirst%3DF.%2BH.%26atitle%3DEstablishment%2520of%2520a%2520human%2520pancreatic%2520tumor%2520xenograft%2520model%253A%2520potential%2520application%2520for%2520preclinical%2520evaluation%2520of%2520novel%2520therapeutic%2520agents%26jtitle%3DPancreas%26date%3D1998%26volume%3D16%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Mohammad, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdan, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abubakr, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">al-Katib, A.</span><span> </span><span class="NLM_article-title">Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=130-137&author=R.+M.+Mohammadauthor=A.+N.+Mohamedauthor=M.+Y.+Hamdanauthor=T.+Voauthor=B.+Chenauthor=K.+Katatoauthor=Y.+A.+Abubakrauthor=M.+C.+Duganauthor=A.+al-Katib&title=Establishment+of+a+human+B-CLL+xenograft+model%3A+utility+as+a+preclinical+therapeutic+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohammad%26aufirst%3DR.%2BM.%26aulast%3DMohamed%26aufirst%3DA.%2BN.%26aulast%3DHamdan%26aufirst%3DM.%2BY.%26aulast%3DVo%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DKatato%26aufirst%3DK.%26aulast%3DAbubakr%26aufirst%3DY.%2BA.%26aulast%3DDugan%26aufirst%3DM.%2BC.%26aulast%3Dal-Katib%26aufirst%3DA.%26atitle%3DEstablishment%2520of%2520a%2520human%2520B-CLL%2520xenograft%2520model%253A%2520utility%2520as%2520a%2520preclinical%2520therapeutic%2520model%26jtitle%3DLeukemia%26date%3D1996%26volume%3D10%26spage%3D130%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Tashiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span> </span><span class="NLM_article-title">Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1007%2FBF00300241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=2544308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2qs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1989&pages=187-192&author=T.+Tashiroauthor=M.+Inabaauthor=T.+Kobayashiauthor=Y.+Sakuraiauthor=K.+Maruoauthor=Y.+Ohnishiauthor=Y.+Ueyamaauthor=T.+Nomura&title=Responsiveness+of+human+lung+cancer%2Fnude+mouse+to+antitumor+agents+in+a+model+using+clinically+equivalent+doses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses</span></div><div class="casAuthors">Tashiro, Tazuko; Inaba, Makoto; Kobayashi, Tomowo; Sakurai, Yoshio; Maruo, Koji; Ohnishi, Yasuyuki; Ueyama, Yoshito; Nomura, Tatsuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-92</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">The responses of 14 lines of human lung cancer xenografts in BALB/c-nu/nu mice to 8 antitumor agents were investigated.  The xenografts consisted of 4 small-cell carcinomas (SCLC) and 10 non-small-cell carcinomas (NSCLC).  The doses used were the max. tolerated dose (MTD) in nude mice and the rational dose (RD), the latter considered to be pharmacokinetically equiv. to the clin. dose.  When given at MTDs, all the drugs except 5-fluorouracil (5-FU) and methotrexate were extremely effective against NSCLC as well as SCLC.  The response rates of drug-sensitive SCLC to mitomycin C (MMC), ACNU, and vinblastine (VLB) were 100%, and those to adriamycin and vincristine were 75%.  The response rates of even drug-resistant NSCLC to MMC and VLB were 70% and 90%, resp.  The response rates of NSCLC to RDs of the drugs were reduced to <40% and corresponded well to the resp. clin. rates.  In SCLC, a good correlation of exptl. and clin. response rates was obsd. with 4 drugs (cyclophosphamide, ACNU, VLB, and 5-FU).  A more reasonable prediction of the clin. effectiveness of antitumor agents can be made by a protocol using clin. equiv. doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHcAegAJGEGrVg90H21EOLACvtfcHk0lhwh15FGaKY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2qs7w%253D&md5=2b75e7dc54dacb6b74caaa58eeae049d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2FBF00300241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00300241%26sid%3Dliteratum%253Aachs%26aulast%3DTashiro%26aufirst%3DT.%26aulast%3DInaba%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DMaruo%26aufirst%3DK.%26aulast%3DOhnishi%26aufirst%3DY.%26aulast%3DUeyama%26aufirst%3DY.%26aulast%3DNomura%26aufirst%3DT.%26atitle%3DResponsiveness%2520of%2520human%2520lung%2520cancer%252Fnude%2520mouse%2520to%2520antitumor%2520agents%2520in%2520a%2520model%2520using%2520clinically%2520equivalent%2520doses%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1989%26volume%3D24%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Day, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tickle, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holding, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">Crystal structure of human CDK4 in complex with a D-type cyclin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">4166</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4166-4170&author=P.+J.+Dayauthor=A.+Cleasbyauthor=I.+J.+Tickleauthor=M.+O%E2%80%99Reillyauthor=J.+E.+Coyleauthor=F.+P.+Holdingauthor=R.+L.+McMenaminauthor=J.+Yonauthor=R.+Chopraauthor=C.+Lengauerauthor=H.+Jhoti&title=Crystal+structure+of+human+CDK4+in+complex+with+a+D-type+cyclin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DTickle%26aufirst%3DI.%2BJ.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DHolding%26aufirst%3DF.%2BP.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DYon%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520human%2520CDK4%2520in%2520complex%2520with%2520a%2520D-type%2520cyclin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D4166%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Jeffrey, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Mechanism of CDK activation revealed by the structure of a cyclinA–CDK2 complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=313-320&author=P.+D.+Jeffreyauthor=A.+A.+Russoauthor=K.+Polyakauthor=E.+Gibbsauthor=J.+Hurwitzauthor=J.+Massagueauthor=N.+P.+Pavletich&title=Mechanism+of+CDK+activation+revealed+by+the+structure+of+a+cyclinA%E2%80%93CDK2+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeffrey%26aufirst%3DP.%2BD.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPolyak%26aufirst%3DK.%26aulast%3DGibbs%26aufirst%3DE.%26aulast%3DHurwitz%26aufirst%3DJ.%26aulast%3DMassague%26aufirst%3DJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DMechanism%2520of%2520CDK%2520activation%2520revealed%2520by%2520the%2520structure%2520of%2520a%2520cyclinA%25E2%2580%2593CDK2%2520complex%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D313%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ravelli, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curmi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knossow, M.</span><span> </span><span class="NLM_article-title">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm5014743&amp;key=10.1038%2Fnature02393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm5014743&amp;key=15014504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm5014743&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=198-202&author=R.+B.+Ravelliauthor=B.+Gigantauthor=P.+A.+Curmiauthor=I.+Jourdainauthor=S.+Lachkarauthor=A.+Sobelauthor=M.+Knossow&title=Insight+into+tubulin+regulation+from+a+complex+with+colchicine+and+a+stathmin-like+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</span></div><div class="casAuthors">Ravelli, Raimond B. G.; Gigant, Benoit; Curmi, Patrick A.; Jourdain, Isabelle; Lachkar, Sylvie; Sobel, Andre; Knossow, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6979</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions.  Their dynamic instability is controlled by numerous compds. and proteins, including colchicine and stathmin family proteins.  The way in which microtubule instability is regulated at the mol. level has remained elusive, mainly because of the lack of appropriate structural data.  Here, the authors present the structure, at 3.5 Å resoln., of tubulin in complex with colchicine (I) and with the stathmin-like domain (SLD) of RB3.  It showed the interaction of RB3-SLD with 2 tubulin heterodimers in a curved complex capped by the SLD N-terminal domain, which prevented the incorporation of the complexed tubulin into microtubules.  A comparison with the structure of tubulin in protofilaments showed changes in the subunits of tubulin as it switched from its straight conformation to a curved one.  These changes correlated with the loss of lateral contacts and provided a rationale for the rapid microtubule depolymn. characteristic of dynamic instability.  Moreover, the tubulin-I complex shed light on the mechanism of I activity; it was shown that I binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.  Thus, the results establish a relation between the onset and speed of microtubule disassembly and the changes in tubulin subunits when tubulin switches from its straight to its curved conformation.  The results further provide a mol. description of the interaction of RB3-SLD and I with tubulin, and may be useful for the development of novel therapeutic I analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2vePjtf347Vg90H21EOLACvtfcHk0lhwh15FGaKY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCls7g%253D&md5=9fbb1edfc64239638a3c2eac879bffe9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnature02393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02393%26sid%3Dliteratum%253Aachs%26aulast%3DRavelli%26aufirst%3DR.%2BB.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DCurmi%26aufirst%3DP.%2BA.%26aulast%3DJourdain%26aufirst%3DI.%26aulast%3DLachkar%26aufirst%3DS.%26aulast%3DSobel%26aufirst%3DA.%26aulast%3DKnossow%26aufirst%3DM.%26atitle%3DInsight%2520into%2520tubulin%2520regulation%2520from%2520a%2520complex%2520with%2520colchicine%2520and%2520a%2520stathmin-like%2520domain%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W96" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W96','PDB','2W96'); return false;">PDB: 2W96</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FIN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FIN','PDB','1FIN'); return false;">PDB: 1FIN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0','PDB','1SA0'); return false;">PDB: 1SA0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a href="/doi/suppl/10.1021/jm5014743">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_46676"></div></div></div></div></div><hr /></hr><p class="last">NMR and HPLC spectra scans and kinase profiling results. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5014743/suppl_file/jm5014743_si_001.pdf">jm5014743_si_001.pdf (1.08 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5014743&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm5014743%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5014743" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b404efe7f3d8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
